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Summary 
 
 
Previous studies have shown that articular cartilage grows by apposition from the 
joint surface, driven by proliferation of a progenitor cell sub-population residing in 
the superficial zone.  To date, there is no individual marker for this progenitor 
sub-population; however, markers located to mesenchymal stem cells have been 
identified in articular cartilage.  Using immunofluorescence, this study demonstrated 
the localisation of the stem cell markers, CD44, CD49e, CD105 and CD166 to the 
superficial zone of bovine immature articular cartilage.  CD29 and the developmental 
markers, Notch1, Delta1, Jagged1, Jagged2 and Msx1 were located in cells 
throughout the tissue.  The restricted expression of the majority of these stem cell 
markers to predominantly the superficial zone in immature bovine complements the 
appositional growth model notion and greatly suggests a resident stem cell 
population. 
 
To further investigate and quantify expression of these differentiation and stem cell 
markers, superficial zone cells were isolated, immunolabelled and analysed using 
flow cytometry.  In addition, cells were cultured for 24 hours in monolayer for 
comparison and to enable epitope recovery.  Stem cell marker expression was absent 
or reduced following cell isolation and upregulated following monolayer culture.  
Developmental markers displayed expression comparable to that seen in tissue 
following cell isolation, but expression was absent after monolayer culture.  The 
differences observed suggest cell surface marker cleavage during cell isolation and 
subsequent cell adhesion and proliferation. 
 
To assess the changes in expression, superficial zone cells were cultured for 14 days, 
to provide a proxy for dedifferentiated cells.  Superficial zone chondrocytes were 
immunolabelled at day 3, 7 and 14 and analysed using flow cytometry.  The majority 
of cell surface receptors exhibited a unimodal increase in expression indicative of a 
homogeneous population.  The number of cells expressing CD44 increased with time 
in culture, from 3 to 14 days, characteristic of cells adhering to plastic.  Bimodal 
distributions were observed with CD105 and CD117, after 14 days in culture.  This 
expression has not previously been reported and demonstrates a distinct and discrete 
subset of cells equating to 1-2% of the total superficial zone population analysed, 
comparable to chondroprogenitor percentages previously reported. 
 
The use of specific markers to isolate chondroprogenitors will allow for further 
characterisation, including a more in-depth understanding of the mechanisms of 
proliferation and differentiation within articular cartilage.  This has the potential to 
lead to an improved understanding of the role of these markers and, as such, may 
provide us with a more beneficial cell type that could significantly contribute to the 
field of articular cartilage repair. 
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CHAPTER 1: 
GENERAL INTRODUCTION 
 
 
 
 
 
 1 
1.1 The synovial joint 
 
There are several types of joints within the body: synarthrosis (fibrous), 
amphiathrosis (cartilaginous), and diarthrosis (synovial).  Synarthrosis joints are 
immoveable and occur between cranial bones; amphiathrosis joints permit limited 
movement and are present between vertebrae and at the pubic symphysis.  
Diarthrosis joints are freely moveable and possess a cavity that is lined with a 
synovial membrane.  This type of joint is mainly located within the appendicular 
skeleton and is, otherwise, known as a synovial joint (Standring and Gray, 2008).  
The synovial joint consists of a variety of tissues that all contribute to the function of 
the joint.  The ends of long bones are covered in articular cartilage that is nourished 
and lubricated by synovial fluid, which in turn, is produced by the synovial 
membrane; a fibrous capsule encapsulates the whole joint.  Ligaments, tendons and 
muscles also surround and stabilise the joint (Figure 1.1). 
 
 
Figure 1.1: Diagrammatic presentation of a synovial joint 
Articular cartilage covers the opposing surfaces of the skeletal elements, the joint 
space in filled with synovial fluid and, in the case of the knee, also contains 
fibrocartilaginous meniscus to aid stabilisation. 
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1.1.1 Development of the synovial joint 
 
Synovial joints arise from cells of mesenchymal origin; the long bones that will abut 
the presumptive joint, are initially modelled with hyaline cartilage, that is later 
replaced by mineralised bone during endochondral ossification (Khan et al., 2007).  
Initially, the presumptive joint is a continuous structure and is first recognised 
histologically by a flattening of cells in the presumptive joint region, loss of type II 
collagen and acquisition of type I collagen (Craig et al., 1987, Hyde et al., 2007, 
Archer et al., 2003, Archer et al., 1994).  Depending on species and joint location the 
presumptive joint varies, in the embryonic chick three regions are formed: two 
chondrogenous zones associated with the epiphyseal regions and a central region of 
high cell density known as the interzone (Craig et al., 1987).  In mammals, the 
interzone consists of a thin layer of cells between the developing articular surfaces 
(Edwards et al., 1994, Archer et al., 2003). 
 
As the interzone thickens, the intermediate layer is responsible for the formation of 
joint associated structures.  The outer layer cells proliferate and differentiate into 
chondrocytes and go on to form the presumptive articular surfaces.  These 
chondrocytes contribute to the initial lengthening of the elements by appositional 
growth at each of the epiphyses, this continues until the growth plates develop 
(Pacifici et al., 2006, Khan et al., 2007).  Cavitation occurs through the differential 
synthesis and secretion of glycosaminoglycans (GAGs), in particular hyaluronan 
(HA).  HA is synthesised throughout and prior to cavitation by cells of the 
chondrogenous layer in both chicken and human joints (Edwards et al., 1994, Archer 
et al., 1994, Craig et al., 1987, Bland and Ashhurst, 1996, Pitsillides, 1999).  
Cavitation is movement dependent, as paralysis of the embryo results in failure to 
cavitate or fusion of previously cavitated joints (Khan et al., 2007, Craig et al., 1990).  
It has also been shown that transforming growth factor ! (TGF-!) peptide is 
widespread during chondrogenesis, but after differentiation there is very little present.  
Insulin-like growth factor (IGF) promotes chondrogenesis through stimulation of 
matrix secretion but again; the amount and location throughout the tissue vary with 
developmental stage.  Fibroblast growth factor (FGF) promotes chondrocyte 
proliferation and inhibits terminal differentiation to hypertrophic cells (Hayes et al., 
2001). 
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The shape of the joint appears to be regulated by bone morphogenic proteins (BMPs) 
and growth and differentiation factors (GDFs).  The factors that stop the reticular 
chondrocytes from ossifying are not known. Barx-1 (homeobox family), Wnt-4 (Wnt 
family), GDF-5, hepatocyte growth factor (HGF; scatter factor) and parathyroid 
hormone-related peptide (PTHrP) may all be involved.  Barx-1 and Wnt-4 are 
involved in initial development.  GDF-5 has been seen in mouse development in all 
areas initially and later restricted to the interzone.  HGF plays a role in early skeletal 
development during chondrocyte proliferation (Pacifici et al., 2000).  FGF has also 
been shown to be involved in skeletal development (Tickle and Munsterberg, 2001).  
PTHrP and TGF-! are known to delay the maturation process.  BMP 2-7 induce 
chondrocyte maturation both in vitro and in vivo (Beier et al., 2001, Broadus et al., 
2007). 
 
1.1.2 Development and maturation of articular cartilage 
 
Articular chondrocytes develop from the chondrogenous layer of the interzone.  
Following cavitation the majority of growth in articular cartilage is achieved by 
deposition of matrix (Bland and Ashhurst, 1996), however, little is still known 
regarding the mechanisms or molecular basis of articular cartilage growth. 
 
Foetal articular cartilage is isotropic in structure, as it matures it reduces in thickness 
and cell density and becomes more anisotropic in structure (Hayes et al., 2001, Archer 
et al., 2003, Hunziker et al., 2007).  Early studies by Mankin (Mankin, 1962b, 
Mankin, 1963, Mankin, 1962a), using tritiated thymidine incorporation in immature 
rabbit knees identified two proliferative bands within immature articular cartilage; one 
below the articular surface and one above the subchondral bone, this demonstrated 
that articular cartilage grows by both appositional and interstitial growth.  Further 
work, carried out by Archer et al using South American opossum (Monodelphis 
domestica) (Archer et al., 1994), established that IGF is extensively expressed in the 
epiphyses during early development.  However, once the secondary centre of 
ossification has formed, the distribution of IGF is restricted to the surface of articular 
cartilage.  Cell proliferation activity assessed by proliferating cell nuclear antigen 
(PCNA) was also found to have a similar distribution to IGF using the marsupial, 
becoming increasingly restricted to the surface layers of articular cartilage with 
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skeletal maturity, indicative of appositional growth.  In a study by Hayes and 
colleagues (Hayes et al., 2001), bromodeoxyuridine (BrDU) was used to identify 
cycling cells in the immature South American opossum, BrDU is incorporated into 
replicating DNA during S-phase of the cell cycle.  This study demonstrated that 
flattened cells of the superficial zone incorporated BrDU after 10 days, whereas, the 
transitional zone cells labelled after 4 days.  The slow cycling time of the superficial 
zone cells is indicative of a chondroprogenitor or stem cell population; the shorter 
cycling time of the transitional zone cells is characteristic of a transit amplifying 
population. 
 
The reorganisation of articular cartilage during maturation was recently investigated 
using the immature rabbit knee joint (Hunziker et al., 2007, Hunziker, 2009).  One 
month after birth, the superficial zone cells were arranged perpendicular to the joint 
surface, but deeper layers were randomly orientated; at this stage collagen fibrils were 
also randomly arranged throughout the tissue.  By two months, cells appeared more 
anisotropic and the cell density had decreased.  At three months the cell arrangement 
was comparable to mature tissue, the depth of the tissue had decreased further and the 
arrangement of collagen fibrils was comparable to mature tissue.  After three months, 
there was no significant decrease in tissue depth.  During the first three months when 
most bone growth occurs, the bone length increase exceeds that of the decrease in 
cartilage depth, indicating that immature cartilage is not remodelled and, instead, must 
be resorbed and replaced by new tissue.  Therefore, during early postnatal 
development articular cartilage acts as a surface growth plate for lateral and 
longitudinal expansion of the epiphyseal bone as well as an articulating layer; this 
appositional growth is accompanied by tissue resorption.  Only after puberty do the 
superficial zone cells produce a mature anisotropic articular cartilage. 
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1.2 Structure of articular cartilage 
 
There are three main types of adult cartilage: fibrocartilage, elastic cartilage and 
hyaline cartilage.  Fibrocartilage is found between tendon and bone attachments.  It 
consists of collagen fibres that form many thick bundles.  Elastic cartilage differs 
from fibrocartilage and hyaline cartilage in that it comprises a matrix containing 
elastic fibres, it occurs in the external ear, eustachian tube and epiglottis.  Hyaline 
cartilage is the most common; it occurs on the ventral surfaces of the ribs, the tracheal 
rings and at the ends of bones.  It generally appears homogeneous consisting of 
collagen fibres embedded in a meshwork within the extracellular matrix (ECM; 
(Standring and Gray, 2008). 
 
The transition from immature to mature cartilage structure occurs during adolescence, 
when closure of the growth plates occurs.  Mature chondrocytes are usually found as 
single cells within lacunae surrounded by extensive ECM; the tissue lacks neuronal 
components and vasculature.  Articular cartilage varies slightly in the mechanical 
properties and composition of the matrix among species, and among joints of the 
same individual (Hunziker, 1992, Athanasiou et al., 1991).  The main functions of 
articular cartilage are: to protect the underlying subchondral bone, provide a low-
friction gliding surface between the opposing skeletal elements and transmit load 
through to the underlying bone.  Articular cartilage is divided into four zones that are 
chiefly denoted by their cellular morphology and orientation of collagen fibrils 
(Saamanen et al., 2010, Bhosale and Richardson, 2008). 
 
1.3 Zones of articular cartilage 
 
Articular cartilage consists of four layers: superficial, middle (transitional), deep 
(radial) and calcified zones (Figure 1.2; (Buckwalter and Mankin, 1997).  The cells 
within these layers differ in morphology, orientation and cell density.  The ECM in 
the specific layers differs in water, proteoglycans (PG) and collagen concentration, as 
well as aggregate sizes, density and metabolic activity. 
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Figure 1.2: Diagram showing the zonal variation in articular cartilage 
Articular cartilage is composed of four distinct zones: surface (superficial), middle, 
deep and calcified zones. 
 
 
1.3.1 Superficial zone 
 
The superficial, surface or tangential zone is adjacent to the joint cavity and consists 
of an acellular region, the lamina splendens and a deeper cellular layer (Jurvelin et al., 
1996, Wu et al., 2008).  The cells are flattened and ellipsoid in shape and aligned 
parallel to the surface.  This zone is rich in collagen and the meshwork formed, gives 
cartilage its structure and tensile strength.  This layer is relatively low in PGs 
compared to other regions.  Quantities of fibronectin and water are highest in this 
zone and PGs and non-collagenous proteins bind to the meshwork. 
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1.3.2 Middle zone 
 
The morphology and matrix composition of the middle or transitional zone is between 
that of the superficial and radial zone.  The volume is usually twice that of the 
superficial zone.  The cells in this zone are spheroidal in shape and equally spaced, 
they occur singly or in pairs (Hunziker, 2010).  The matrix consists of larger diameter 
collagen fibrils that are randomly oriented, a higher PG concentration, but lower 
concentrations of water and collagen than the superficial layer (Buckwalter and 
Hunziker, 1999). 
 
1.3.3 Deep zone 
 
The radial or deep zone contains large spheroidal shaped cells that are aligned in 
columns perpendicular to the joint surface.  In the upper and lower regions, they are 
rich in cytoplasmic organelles such as endoplasmic reticulum and Golgi apparatus.  In 
the mid-section, they frequently contain large numbers of intermediate filaments.  
There is a gradual but marked, increase in cell size with depth, the cells occur singly 
in the upper portion, but with increasing depth usually occur in groups of three to four 
called chondrons (Hunziker, 1992, Hunziker, 2010).  This layer contains the largest 
diameter collagen fibrils that are arranged perpendicular to the joint surface and 
penetrate the calcified cartilage beneath.  The deep zone has the highest concentration 
of PGs and the lowest concentration of water (Buckwalter and Mankin, 1997).  The 
alignment of these cells within the matrix is maintained by the collagen fibre 
organisation, termed Benninghof Arcades (Oegema and Thompson, 1995, Buckwalter 
and Hunziker, 1999). 
 
1.3.4 Calcified zone 
 
The calcified cartilage zone is adjacent to the subchondral bone.  The calcified zone 
cells are smaller and fewer than those in the radial zone (Oegema and Thompson, 
1995).  The border between the calcified zone and subchondral bone is known as the 
tidemark, it represents a mineralisation front where the calcified zone and subchondral 
zone beneath, interdigitate and has a characteristically undulating appearance when 
viewed histologically.  During postnatal growth, this front advances and the matrix 
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compartment becomes actively mineralised.  It is generally believed that cell activity 
and mineralisation in this area is low or even completely absent, and that only after 
traumatic insults or during the early phases of osteoarthritis (OA), do chondrocytes 
near the tidemark become activated and induce mineralisation (Hunziker, 1992). 
 
1.4 Extracellular matrix organisation 
 
Articular cartilage can be further divided into compartments within each zone, 
reflecting differential distribution and densities of matrix constituents (Hunziker, 
2010).  The matrix comprises three regions: the pericellular, the territorial and the 
interterritorial region (Figure 1.3).  The pericellular and territorial matrices bind the 
cell membranes and matrix macromolecules.  These matrices protect the cells from 
damage during loading and deformation of the tissue.  The principle function of the 
interterritorial matrix is to provide the mechanical properties of the tissue (Buckwalter 
and Hunziker, 1999). 
 
1.4.1 Pericellular matrix 
 
The pericellular matrix is attached to the cell membrane of chondrocytes and is 
approximately 1µm thick. A chondron is made up of a chondrocyte and its 
surrounding pericellular matrix, this matrix is free of fibrillar collagens, but rich in 
PGs (Hunziker, 1992) and non-fibrillar collagens including type VI collagen 
(Buckwalter and Mankin, 1997).  Cytoplasmic projections extend from the 
chondrocytes into and through the pericellular matrix to the territorial matrix 
(Buckwalter and Hunziker, 1999). 
 
1.4.2 Territorial matrix 
 
The territorial matrix surrounds the pericellular matrix.  It is characterised by a 
basket-like arrangement of collagen fibrils that surround individual chondrocytes and 
in deeper zones, surrounds chondrons (Figure 1.3; (Hunziker, 1992, Hunziker, 2010).  
The basket arrangement may provide mechanical protection for the chondrocytes 
during loading and deformation of the tissue.  It is difficult to identify the boundary 
between the territorial and interterritorial matrices, although the fibril orientation 
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changes from the basket-like orientation to a more parallel arrangement (Buckwalter 
and Hunziker, 1999). 
 
 
 
Figure 1.3: Schematic representation of adult articular cartilage 
Diagram showing the organisation of the fibrillar components within the matrix of 
articular cartilage.  The pericellular matrix (not shown in this diagram) surrounds 
individual chondrocytes forming chondrons.  The territorial matrix contains a basket-
like arrangement of collagen fibrils and organises chondrons into distinct 
morphological entities.  The interterritorial matrix forms the bulk of the tissue 
(Buckwalter and Hunziker, 1999). 
 
 
1.4.3 Interterritorial matrix 
 
The interterritorial matrix makes up the majority of the volume of the extracellular 
space.  It is characterised by cross-banded collagen fibrils or fibres running in parallel 
(Figure 1.3). The concentration of PGs in the interfibrillar space varies according to 
the zone (Hunziker, 1992).  The collagen fibrils are the thickest of all three matrix 
regions, in the deep zone, the fibrils are large and lie perpendicular to the joint 
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surface.  As the collagen fibrils approach the joint surface, they become more oblique 
until in the superficial zone, the fibrils are smaller in diameter and are orientated 
parallel to the joint surface (Buckwalter and Hunziker, 1999). 
 
1.5  Composition of articular cartilage 
 
Articular cartilage is aneural and avascular and derives its mechanical properties from 
its matrix. Articular cartilage consists of chondrocytes, matrix, water and matrix 
macromolecules.  Cells make up approximately 1% of the constituents of articular 
cartilage in large animals, however, the percentage is higher in smaller animals 
(Stockwell, 1978).  Mature chondrocytes depend primarily on anaerobic metabolism, 
as cartilage cells obtain their nutrients from synovial capillaries in the synovial 
membrane, which is transported in the synovial fluid to the cartilage matrix.  The 
cartilage matrix is restrictive to the size and charge of molecules.  In all layers, 
chondrocytes form a complex relationship with the ECM.  Primary cilia may also 
have a role in sensing mechanical changes in the matrix (Buckwalter and Hunziker, 
1999, Farnum and Wilsman, 2011). 
 
1.5.1 The chondrocyte 
 
Chondrocytes are the only known resident cell type within articular cartilage and are 
responsible for the integrity, organisation and maintenance of the ECM around them 
(Saamanen et al., 2010).  Chondrocytes are approximately 10!m in diameter and are 
generally spheroidal in shape, with the exception of chondrocytes within the 
superficial zone that are more flattened.  Mature chondrocytes are located in lacunae 
and their cell membranes adhere directly to the pericellular matrix, which contains 
PGs, non-collagenous proteins and glycoproteins (James and Uhl, 2001).  Adult 
articular chondrocytes do not normally divide, but contribute to the maintenance and 
integrity of the cartilage through a combination of synthetic and catabolic activities 
(Cancedda et al., 2003). 
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1.5.2 The cartilage collagens 
 
The strength of articular cartilage depends on the extensive cross-linking of collagens 
and the zonal arrangement.  All collagen molecules are composed of three ! chains 
characterised by a glycine-X-Y sequence, where X is commonly proline and Y 
hydroxyproline (Cremer et al., 1998).  Several collagens are found within cartilage 
including types II, VI, IX, X and XI.  Collagen types II and XI are classed as fibrillar 
collagens.  They are closely associated and covalently bonded with collagen type IX 
and form the fibrillar meshwork characteristic of articular cartilage (Figure 1.4; (Eyre, 
1995).  Collagens found in articular cartilage are either: fibrillar (types II and XI) or 
fibril-associated (IX, XII and XIV; (Sandell, 1995). 
 
Type II collagen is the most abundant protein in the ECM, comprising approximately 
90-95% of the total and primarily provides cartilage with its tensile strength (Lin et 
al., 2006).  It polymerises to form the major component of the large cross-banded 
filaments.  It is composed of three identical ! chains, which are synthesised as 
precursors to form a procollagen molecule that is released into the extracellular space, 
there are two alternative forms of type II procollagen, type IIA and type IIB; only the 
latter is produced in mature cartilaginous tissue (Sandell et al., 1991).  The collagen 
fibrillar meshwork entraps aggregating PGs and provides a framework for the small 
PGs like decorin and fibromodulin to bind (Eyre et al., 1992). 
 
Type IX collagen is an example of a fibril-associated collagen with interrupted triple 
helices (FACIT) and the heterotrimeric molecule consists of three different ! chains 
(Figure 1.4B; !1 [IX], !2 [IX] and !3 [IX]).  It accounts for at least 10% of the 
collagen in foetal cartilage, but only around 1% of the collagenous protein in adults 
(Eyre et al., 1992, Sandell, 1995, Gelse et al., 2003).  Collagen type IX is sometimes 
also classed as a PG and is closely associated with type II and type XI collagens in 
articular cartilage. 
 
Type XI collagen is thought to lie within type II fibrils (Mendler et al., 1989) and may 
control fibrillogenesis of type II collagen (Gelse et al., 2003).  It also forms a 
heterotrimer !1 (XI), !2 (XI) and !3 (XI) (Figure 1.4C; (Eyre et al., 1992). 
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Figure 1.4: Schematic representation of the major collagen types present in 
articular cartilage 
A). Heterotypic fibril consisting of types: II, IX and XI collagen.  B). Type IX 
collagen.  C).  Type XI collagen (Duance et al., 1999). 
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In summary, type II, IX and XI collagens form a fibrillar meshwork that gives the 
tissue its form, tensile stiffness and strength.  Type II forms the backbone of the 
heteropolymeric fibrils, with type IX located along the surface of the fibrils of type II 
in an anti-parallel orientation.  Type XI is located within the fibrils where it is 
covalently linked to type II (Cremer et al., 1998, Gelse et al., 2003).  Type IX binds 
covalently to the superficial layers of filaments projecting into the matrix that can 
bind to other type IX collagens.  The type IX arrangement may also stabilise the 
extracellular framework as well as, aiding in the binding of PGs. 
 
Other collagens are present in articular cartilage but to a lesser extent.  Type VI 
collagen forms microfibrils concentrated within the pericellular matrix, it comprises 
approximately 1% of the total collagens present within articular cartilage (Poole et al., 
1992).  It is a globular collagen and is another short-helix molecule.  It does not 
appear to be covalently linked to other collagen types (Cremer et al., 1998).  This 
collagen aids in the attachment of the chondrocytes to the matrix by interacting 
indirectly, with matrix components such as collagen type II, HA, fibronectin and 
possibly with cell surface receptors (Soder et al., 2002). 
 
Type X collagen is yet another short-helix collagen that is specific to cartilage.  It is 
considerably shorter than types II, IX and XI, and is only found in small amounts in 
normal adult articular cartilage.  It may have a role in the mineralisation of cartilage, 
as its expression is restricted to the hypertrophic zone of the growth plates of growing 
animals and to the deep calcified layer of mature articular cartilages (Eyre et al., 
1992).  During OA, however, chondrocytes nearer the articular surface, including the 
superficial cells retain the ability to synthesise collagen type X (Morrison et al., 
1993). 
 
Type XII and XIV collagens are similar in structure and like type IX, are FACIT 
collagens.  Their function is poorly understood but they may act as minor interfibrillar 
proteins in cartilaginous tissue (Gelse et al., 2003). 
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1.5.3 Cartilage proteoglycans 
 
ECM macromolecules consist mainly of collagen, elastin, PGs and matrix 
glycoproteins.  PGs have a protein core to which one or more GAGs are covalently 
attached (Roughley, 2006, Knudson and Knudson, 2001).  PGs are associated with all 
tissues, although connective tissues have the most abundant concentrations due to 
their extensive ECM.  There are three classes of PGs: ECM, cell surface, and 
intracellular, however, intracellular PGs do not occur in cartilage (Hascall et al., 
1999).  The most abundant are ECM PGs, of which there are a further three types: 
large aggregating, large non-aggregating, and small interstitial. 
 
GAGs are long linear polysaccharides that are composed of repeating disaccharide 
units.  GAGs can be sulphated or non-sulphated and it is generally only the sulphated 
that are associated with PGs.  Within articular cartilage, there are four sulphated 
GAGs (chondroitin sulphate, dermatan sulphate, keratan sulphate [KS] and heparan 
sulphate) and a single non-sulphated GAG (HA).  However, the predominate GAG 
present in articular cartilage is chondroitin sulphate (Schnabel et al.) (Roughley and 
Lee, 1994, Knudson and Knudson, 2001). 
 
There are five PGs present in the ECM of articular cartilage: aggrecan, biglycan, 
decorin, fibromodulin and collagen type IX.  Most of the PGs exist as aggregates 
formed by the non-covalent association of PG with HA and link protein.  The major 
PG in cartilage is aggrecan, which is a member of the large aggregating chondroitin 
sulphate PG family (Figure 1.5 and 1.6). 
 
Aggrecan is the largest and most abundant PG comprising approximately 90% of the 
total found within articular cartilage (Lin et al., 2006).  It is highly negatively charged, 
drawing in water from outside the tissue by osmosis; this addition of water causes the 
aggrecan matrix to swell and expand, which enables cartilage to resist compressive 
loads (Kiani et al., 2002).  When the tissue is compressed water is displaced, which is 
dissipated upon removal of the compressive force by water being drawn back into the 
tissue.  This flow of water during compressive cycling is thought to aid in the flow of 
nutrients from synovial fluid to the chondrocytes (Roughley and Lee, 1994). 
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Aggrecan consists of three globular domains (G1, G2 and G3) and three extended 
domains (interglobular domain [IGD], KS and CS).  The majority of the aggrecan 
core protein lies between the G2 and G3 regions, KS and CS chains are attached 
between these domains.  The G1 and G2 domains are connected by a short IGD, 
(Knudson and Knudson, 2001, Kiani et al., 2002).  The G1 domain has the same 
structural motif as link protein, the G1 region is located at the N-terminus and 
interacts with HA and link protein (Knudson and Knudson, 2001, Kiani et al., 2002).  
This aggregation with HA is mediated through a specific protein at the N-terminus of 
their core proteins (the HA-binding domain).  Similar domains are present in other 
HA-binding molecules, such as versican, link protein, and CD44 (Hardingham et al., 
1992). 
 
Loss of aggrecan is a major feature of cartilage degradation associated with disease in 
particular, OA (Chen et al., 2003).  Chondrocytes play a vital role in the breakdown of 
aggrecans, by the production of specific proteinases (aggrecanases).  These 
proteinases include aggrecanase-1 and -2, which are members of the ADAMTS 
metalloproteinases (a disintegrin and metalloproteinase with thrombospondin motifs; 
ADAMTS-4 and ADAMTS-5).  These cleave the core of the protein of aggrecan at a 
number of sites (Handley et al., 2002). 
 
Aggrecan plays an important role in mediating chondrocyte-chondrocyte and 
chondrocyte-matrix interactions through its ability to bind HA (Kiani et al., 2002).  
HA is a large non-sulphated GAG that is synthesised at the plasma membrane via 
hyaluronan synthase (HAS) into the extracellular space and is present around all 
chondrocytes (Roughley, 2006).  HA plays an important role in the function and 
structural organisation of cartilage, cell adhesion, migration and differentiation 
mediated by cell surface receptors such as CD44 and HA-binding proteins (Lin et al., 
2006).  The interaction between aggrecan and HA is non-covalent and is strengthened 
and stabilised by link protein.  Link proteins are small glycoproteins synthesised by 
chondrocytes that have the ability to interact with HA and a single aggrecan molecule.  
The aggrecan aggregate is a densely substituted PG with a bottlebrush structure 
(Figure 1.5; (Hardingham et al., 1992); large molecules may have more than 300 
aggrecan molecules (Pitsillides, 1999).  There are two populations of PG aggregates: 
slow and fast sedimenting types.  Fast have a high CS to HA ratio and slow have a 
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low ratio.  The superficial zone contains mostly smaller slow sedimenting aggregates.  
Deeper regions contain both types.  The loss of larger aggregates is one of the earliest 
changes in OA (Buckwalter and Hunziker, 1999). 
 
 
 
 
Figure 1.5 Schematic representation of aggrecan aggregate 
Diagram of PG aggregate comprising aggrecan, HA and link protein. 
 
 
Perlecan is a large non-aggregating PG that is commonly associated with basement 
membranes; it has a very large protein core (400 kDa) and two or three heparan 
sulphate GAG chains attached to its N-terminal.  The rest of the core protein has 
several different structural domains that facilitate its specific interaction with cells and 
other specific matrix macromolecules.  It interacts with ECM proteins, growth factors 
and receptors (Melrose et al., 2006, Arikawa-Hirasawa et al., 1999) and is enriched in 
the pericellular matrix in adult articular cartilage (Knudson and Knudson, 2001). 
 
The small interstitial PGs or small leucine-rich repeat PGs (SLRPs) are ubiquitous in 
connective tissues.  They are characterised by having relatively small core proteins 
that contain leucine-rich protein domain repeats that facilitate protein-protein 
interactions and associations.  In articular cartilage they consist of decorin, biglycan, 
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fibromodulin and lumican, they are similar in structure but differ in GAG content.  
Decorin and biglycan are classified as dermatan sulphate PGs, whereas fibromodulin 
and lumican are KS PGs.  The core proteins of the SLRPs allow interaction with 
fibrillar collagens, assisting in the regulation of fibril diameter during formation and 
possibly the interaction of fibrils in the ECM.  The SLRPs also help protect the fibrils 
from proteolytic damage by preventing collagenases from gaining access to cleavage 
sites (Roughley, 2006).  These leucine-rich PGs also interact with many other 
macromolecules, such as collagen types VI, XII and XIV, fibronectin and growth 
factors including TGF-!.  The level of SLRP synthesis varies with age and may be 
affected by a variety of growth factors (Roughley, 2006). 
 
Syndecan and glypican are cell surface PGs expressed by chondrocytes.  Syndecans 
are transmembrane PGs that have a specific protein domain that anchors them in the 
plasma membrane.  Glypican is a PG that is covalently linked to the cell surface by 
phosphoinositol in the lipid layer of the plasma membrane (Knudson and Knudson, 
2001). 
 
An example of intracellular PGs is serglycin (mast cells).  Its protein core is 
composed of serine and glycine repeats that render it extremely resistant to proteolytic 
digestion.  It contains many heparan or CS GAG chains attached to the core protein, 
this PG binds powerful proteases to its GAG chains, that are specifically released into 
the ECM on mast cell degranulation in inflammation and wounding (Hascall et al., 
1999). 
 
1.5.4 Non-collagenous macromolecules 
 
There are numerous abundant proteins that are neither collagenous or PGs within 
articular cartilage, these macromolecules may help to organise and maintain the 
structure and facilitate matrix-cell signalling.  The macromolecules that will be 
discussed in more detail are: cartilage oligomeric matrix protein (COMP), cartilage 
intermediate layer protein (CILP), fibronectin, tenascin and surface zone protein 
(SZP).  This list is by no means exhaustive, but represents proteins commonly 
encountered.  These macromolecules can be grouped into structural molecules and 
molecules regulating cell function. 
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The first structural matrix macromolecule to consider is COMP, it is a cartilage-
specific pentameric protein also known as thrombospondin 5 (Lohmander et al., 
1994).  It is primarily found within the interterritorial matrix in mature articular 
cartilage, but during development it is principally located within the territorial matrix.  
It is thought to mediate chondrocyte attachment to the ECM by binding to collagens I, 
II and IX, fibronectin and aggrecan (Murray et al., 2001).  The function of COMP is 
still unclear but it is thought to be associated with endochondral ossification and the 
stabilisation of the ECM (Tseng et al., 2009).  During cartilage damage and disease, 
fragments of COMP are released into the synovial fluid and increased levels can be 
associated with the progression of OA.  It is not yet understood whether this altered 
COMP distribution is a repair response or increases the damage to cartilage (Neame et 
al., 1999, Murray et al., 2001). 
 
CILP is a 91.5 kDa glycoprotein located in the interterritorial matrix, and is prevalent 
in older tissue.  It occurs within the deeper layers of cartilage and is almost absent 
from the superficial and calcified zones; its function in cartilage is not clear (Neame et 
al., 1999). 
 
Fibronectin is a large cell matrix adhesion glycoprotein present at high concentrations 
in most ECM.  It can bind to cells via several cell surface receptors, known as 
integrins.  Integrin !5"1 is a receptor for fibronectin.  The RGD peptide (arginine-
glycine-aspartate) sequence is crucial for binding to this integrin and is believed to 
have a role in cell adhesion (Hayashi et al., 1996).  Fibronectin binds to a number of 
matrix macromolecules including collagen and GAG chains of PGs.  It is also 
considerably up-regulated in OA (Jones et al., 1987). 
 
Tenascin-C is structurally related to fibronectin and is predominantly expressed in the 
condensing mesenchyme during development (Gluhak et al., 1996), repair and 
oncogenesis.  However, studies show it is also produced by mature differentiated 
chondrocytes and incorporated into the pericellular region surrounding the 
chondrocytes (Qi and Scully, 2003).  It is a hexameric ECM glycoprotein and its 
disulphide-linked sub-units consist of a series of domains that display homology to 
other proteins, including epidermal growth factor, fibronectin and fibrinogen (Mackie 
and Ramsey, 1996).  Despite sharing structural features with fibronectin, tenascin-C 
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possesses anti-adhesion and anti-spreading properties.  Tenascin-C affects attachment 
and spreading of a number of cell types in culture.  It has been shown to interact with 
cell-surface receptors, including integrins and syndecans.  Tenascin-C can also exhibit 
pro-adhesive effects on cells such as endothelial cells.  It promotes the differentiation 
of chondrocytes from mesenchyme and perichondrium, probably via its ability to 
inhibit cell attachment and favouring a rounded cell shape (Mackie and Ramsey, 
1996). 
 
The final macromolecule to be discussed is SZP, which was first described by 
Schumacher et al (1994).  SZP is secreted by superficial zone cells of articular 
cartilage and is homologous to lubricin (Flannery et al., 1999, Schumacher et al., 
1994), which is secreted by the synovium.  It is a mucin containing glycoprotein with 
a covalently attached PG chain.  Both SZP and lubricin are boundary lubricants in 
synovial joints and reduce friction at the articular surface (Becerra et al., 2010). 
 
1.5.5 Interstitial fluid 
 
Water is the most abundant constituent of cartilage and contributes to approximately 
80% of the wet weight.  Some of the water can move freely within and out of the 
tissue, around 30% is associated with the fibrillar collagen meshwork, but the 
majority is associated with the large aggregating PGs that are highly negatively 
charged.  The interstitial fluid transports gases, small proteins, metabolites and cations 
from the synovial fluid to the chondrocytes and vice versa (Buckwalter and Mankin, 
1997). 
 
1.6 Chondrocyte-matrix interactions 
 
Chondrocytes exist singly, paired or in multiples surrounded by pericellular matrix 
and together comprise a chondron (Poole, 1997).  Within the deep zone, chondrocytes 
are stacked into columns, whilst in other zones chondrocytes were thought to be 
isolated from each other.  However, recently, horizontal pairs or multiples of 
chondrocytes have been observed within the superficial zone (Chi et al., 2004, 
Rolauffs et al., 2008, Schumacher et al., 2002) suggesting these cells are also in direct 
contact with each other.  In a recent study using atomic force and two-photon 
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excitation microscopy interconnecting tracks between superficial zone lacunae in 
normal human articular cartilage were observed (Gonzalez et al., 2007).  Chondrocyte 
attachment to the ECM appears to be mediated by matrix receptors, including 
integrins and annexins.  Cell anchorage, migration, matrix synthesis and tissue repair 
are all affected by the interaction of these molecules and the ECM in combination 
with growth factors and cytokines (Figure 1.6; (Loeser, 1993, Aszodi et al., 2003). 
 
 
 
Figure 1.6: Schematic representation of proteoglycans in articular cartilage 
This diagram highlights the interactions of the chondrocyte within its extracellular 
matrix macromolecules (Knudson and Knudson, 2001). 
 
 
The interaction between chondrocytes and the ECM is partly mediated by integrins, 
whose cytoplasmic domains are attached to the cytoskeleton.  Signalling of integrins 
is bidirectional; the extracellular domain of integrins can become more adhesive for 
the ligands, or alternatively from the ‘outside-in’, the attachment of integrins to their 
ligands results in a cellular response (van der Kraan et al., 2002).  Chondrocytes are 
known to attach to a number of proteins including fibronectin, vitronectin, and 
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collagen types I, II, V, IX and XI and studies have suggested that integrins mediate 
attachments to these proteins. 
 
Integrins are heterodimeric proteins that are composed of ! and " subunits; each 
subunit has an extracellular and cytoplasmic domain (Reid et al., 2000).  Binding of 
integrins with ligands within the ECM can induce cellular responses and promote 
cytoskeletal reorganisation (Kim et al., 2003).  The most abundant integrin expressed 
on chondrocytes is !5"1, the fibronectin receptor (Salter et al., 1992, van der Kraan et 
al., 2002).  Fibronectin receptors have been shown to be mechanoreceptors and 
involved in the differentiation of chondrocytes (Reid et al., 2000). 
 
Annexins are another group of transmembrane molecules that act as receptors for the 
ECM; annexin II, V and VI have all been observed in articular cartilage (Reid et al., 
2000).  Anchorin CII (the cartilage-derived annexin V) is the most abundant annexin 
within articular cartilage and has various functions including anti-inflammatory 
responses, signal transduction, and cell-matrix interaction and plays a vital role in 
cartilage metabolism.  Anchorin CII has affinity for collagen types II and X and is 
expressed mainly by superficial zone chondrocytes (van der Kraan et al., 2002, Durr 
et al., 1993). 
 
Another well-documented ECM receptor is CD44, which is a polymorphic 
glycoprotein.  CD44 is a cell adhesion molecule and receptor for HA, fibronectin and 
collagen (Salter et al., 1992).  CD44 mediated binding of HA is essential for cartilage 
homeostasis.  When HA adherence to CD44 is restricted, it results in degradation of 
the cartilage ECM (Bosch et al., 2002, Knudson and Knudson, 2004). 
 
1.7 Age-related changes in articular cartilage 
 
The formation of superficial fibrillations is the most apparent age-related morphologic 
change in articular cartilage (Buckwalter and Lane, 1996, Martin and Buckwalter, 
2003).  These changes are rare in adolescents and young adults and it may not be 
possible to distinguish age-related superficial fibrillation from early stages of OA.  
Evidence suggests that most cases of superficial fibrillation do not progress to the 
deeper layers of the cartilage even after decades.  Changes in the mechanical 
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properties of articular cartilage have been observed with aging (Barbero et al., 2003); 
cells accumulate intracytoplasmic filaments and may lose some of their endoplasmic 
reticulum, there is also a reduction in cartilage hydration and cell number.  In 
addition, the mitotic and synthetic activities of cells decline.  The water content 
generally decreases with age and both the PGs and collagens that form the primary 
components of the articular cartilage matrix macromolecular framework undergo age-
related changes (Buckwalter et al., 1993, Roughley and Lee, 1994).  Aggrecans 
become smaller and more variable in size with age.  The KS content within aggrecan 
increases and the CS content decreases.  As a result of the decrease in aggrecan size 
there is a reduction in the size of PG aggregates.  Proteolytic degradation results in 
fragments within the matrix that can bind to HA where they can inhibit aggregation of 
fully functional molecules, HA decreases in size and increases in concentration 
(Thonar et al., 1986).  Link proteins also become less effective with age as they 
undergo ongoing proteolytic alterations.  Age-related changes may also occur in small 
PGs.  Cartilage collagens also undergo changes with age: more cross-linking, increase 
in fibril diameter and variability, decrease in type XI in relation to type II collagen, 
large collagens with high amounts of cross-linking may become less flexible and 
make the cartilage more rigid (Barbero et al., 2003). 
 
1.8 Articular cartilage degradation and disease 
 
Articular cartilage commonly survives for seven or more decades of adult life without 
overt signs of degeneration (Roughley and Lee, 1994).  The superficial zone of 
articular cartilage plays a vital role in the healthy joint.  It provides a smooth surface 
with low friction.  It also withstands high tensile stresses and distributes the load over 
the surface of the joint, thereby protecting the underlying cartilage.  The superficial 
layer, however, is often the first region to show signs of damage during disease or 
following trauma.  Damage to this layer exposes the deeper cartilage to damaging 
stresses of loading during joint movement (Aydelotte et al., 1992).  Trauma to joints 
commonly affects younger individuals following sporting activities but can occur at 
any age and all components of the joint including the articular cartilage are eventually 
affected. 
 
 23 
Damage to articular cartilage ultimately leads to OA.  This is the commonest disease 
affecting articular cartilage and most often occurs in the knee, hip and shoulder joints, 
but any synovial joint can be affected.  Symptoms include joint pain, restriction of 
movement, deformity and variable degrees of inflammation (Buckwalter and Mankin, 
1997).  The clinical observation first reported by Hunter in 1743 (Hunter, 1743) that 
articular cartilage once damaged would not repair still stands today.  OA is the single 
most expensive disease in the developed world, as it progresses over a series of 
decades (Mollenhauer and Erdmann, 2002).  OA resulting from joint injury is referred 
to as secondary OA.  More commonly, OA develops in the absence of any known 
joint degeneration and is referred to as, primary or idiopathic OA and may result from 
several other factors such as obesity, joint instability, overuse, genetics or anatomical 
abnormalities (Carossino et al., 2007, Buckwalter and Martin, 2006). 
 
Lesions in articular cartilage are often referred to as partial or full thickness-defects.  
Partial thickness or chondral defects are contained within the cartilaginous regions 
and do not extend to the calcified cartilage.  Full-thickness or osteochondral defects 
extend down to the vascularised subchondral bone and, are thus exposed to the bone 
marrow pool of stem cells that fill the defect in an attempt to repair. The newly 
formed tissue is fibrocartilaginous and does not integrate well with the native tissue 
and is a poor substitute for hyaline cartilage (Redman et al., 2005, Hunziker, 1999, 
Cancedda et al., 2003).  In OA, fraying or fibrillation of the superficial zone extends 
into the middle zone of the articular cartilage.  There is a reduction in PGs in the 
fibrillated regions and clusters of chondrocytes are often evident as the tissue attempts 
to repair.  As the fissures extend deeper they eventually reach the subchondral bone, 
this is often accompanied by an increase in matrix synthesis and duplication in the 
tidemark.  The continued degradation results in further loss of the superficial zone 
cells, which are responsible for cell regeneration (Rosenberg, 1992).  Accompanying 
fibrillation is an increase in water content along with a shortening of GAG chains and 
decrease in PG aggregation and concentration of aggrecans.  All these factors disrupt 
the organised arrangement of the matrix and increase the permeability of the tissue.  
This disruption is followed by degradation of the matrix constituents including type 
IX and XI collagens; this increases the stresses on the remaining collagen-fibril 
network and chondrocytes.  Type X collagen is normally associated with calcified 
cartilage, however, terminal differentiation of chondrocytes has been associated with 
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the progression of OA and can be characterised by the expression of type X collagen, 
resulting in increased matrix degradation and loss of type II collagen (van der Kraan 
et al., 2001).  With the increased fibrillation there is an elevation in enzymatic 
degradation of the matrix, further decreasing the volume of cartilage eventually 
resulting in total loss of cartilage and presence of necrotic eburnated bone.  Cracks 
with vascular invasions may also be evident with fibrocartilage pockets (Frenkel and 
Di Cesare, 1999).  In some cases, the unsuccessful repair response leads to the 
formation of osteophytes.  Fragments of cartilage can also detach from the articular 
surface and become trapped within the joint space causing obstruction and 
inflammation as well as further structural damage (Nelson et al., 2010). 
 
1.9 Repair mechanisms of articular cartilage 
 
The most suitable treatment for end-stage OA, particularly in the knee joint is 
prosthetic replacement.  This surgical procedure is suitable for aged individuals with a 
sedentary lifestyle, however, is not ideal for patients under 45 years of age (Bhosale 
and Richardson, 2008).  In younger individuals, a variety of methods have been used 
to repair defects and stimulate the formation of new articular cartilage, these include: 
penetration of the subchondral bone, lavage, mosaicplasty, soft-tissue grafts, cells 
transplantation and osteotomy.  All of these methods are highly variable in their 
results and do not produce tissue comparable to articular cartilage.  Many factors need 
to be considered when selecting a repair method for cartilage defects, such as the size 
of the defect and age of the patient (Bhosale and Richardson, 2008). 
 
The original and still the most widely used method that surgeons adopt for cartilage 
repair involves penetration of the subchondral bone.  This method includes procedures 
such as: abrasion athroplasty, Pridie drilling and microfracture and mimics 
osteochondral defects, penetrating the bone marrow pool of stem cells.  Abrasion 
athroplasty uses a burr to induce bleeding from the underlying bone, producing fibrin 
blood clots that are then infiltrated with stem cells (Yen et al., 2008, Nelson et al., 
2010).  Pridie drilling and microfracture function in a similar way, they encourage the 
formation of fibrin blood clotting and mainly serve to give symptomatic relieve to 
patients.  Microfracture may be an improvement on drilling as there is no over-heating 
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or burning of the subchondral bone (Bhosale and Richardson, 2008, Redman et al., 
2005). 
 
Joint debridement involves the arthroscopic removal of damaged cartilage and is most 
effective when combined with arthroscopic lavage; a process involving irrigating the 
joint space and removing debris.  These are common methods to alleviate pain but are 
not known to have any biological repair response (Nelson et al., 2010).  Osteotomy is 
a technique that accompanies debridement and lavage.  It is generally conducted on 
joints with unilateral arthritic damage and redistributes the joint load reducing contact 
pressures on the cartilage surface.  This procedure involves incising bone in order to 
change joint alignment. 
 
Mosaicplasty is widely used to treat both chondral and osteochondral defects, during 
this process osteochondral plugs are harvested form low weight-bearing areas within 
the knee joint, harvested plugs are inserted into the defects.  There is a lack of 
integration with the native tissue and questionable viability of the chondrocytes within 
the plugs (Hangody et al., 1997).  This method is limited by the shortage of 
autologous cartilage available to harvest, so is restricted to small size defects.  This 
method also requires damaging an equal amount of healthy tissue as it is replacing, 
which subsequently is subject to degradation (Chiang and Jiang, 2009).  
Osteochondral allografts can be used for the treatment of focal, chondral or full 
thickness defects and is well documented in the knee (Gomoll et al., 2011).  However, 
this technique is not well documented in cases of advanced OA.  Cartilage only 
allografts can be used for small chondral defects, where plugs or culture-expanded 
chondrocytes are inserted into the defect(s), this method has less post-operative 
complications associated with it as there are no immunological responses (Nelson et 
al., 2010). 
 
During recent years, considerable research has been directed towards facilitating the 
biological repair of articular cartilage defects.  Methods are diverse involving: tissue 
engineering, scaffolds, stem cells, or gene therapy or a combination of these 
(Hunziker, 2009).  Cells are embedded within a matrix or scaffold, and are derived 
from a number of locations including expanded autologous chondrocytes, bone 
marrow stem cells, or allogenic stem cells.  Autologous chondrocyte implantation 
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(ACI) was the first procedure to utilise ‘tissue engineering’ in articular cartilage.  
During the procedure, a small plug of cartilage is harvested and expanded in culture; 
the expanded cells are reintroduced into the chondral defect during a second operation 
under a periosteal flap.  This technique was first developed by Chesterman and Smith 
(1968), where chondrocytes were placed in humeral defects of Dutch rabbits and 
adapted by Bentley and Greer (1971).  This procedure was further developed by 
Brittberg in the clinic (Brittberg et al., 1994).  ACI has also been adapted using 
mesenchymal stem cells to replace chondrocytes (Brittberg, 2010, Bhosale and 
Richardson, 2008).  Alternatively, cells can be seeded into scaffolds or matrices as in 
matrix-induced autologous chondrocyte implantation (Broadus et al.), where 
chondrocytes or stem cells are contained within a collagen scaffold, a procedure that 
avoids the need for a periosteal flap. 
 
Scaffolds provide a three dimensional environment in which cells can be embedded.  
Collagen or HA are the most common materials used for scaffolds as they are natural 
constituents of cartilage.  However, synthetic scaffolds such as polyglycolic and 
polylactic acid based scaffolds are also used (Oliveira et al., 2007, Cancedda et al., 
2003).  These synthetic scaffolds eliminate immune responses.  These procedures, 
however, all demand a large number of cells, requiring extended time in culture and 
ultimately dedifferentiation. 
 
1.10 Resident mesenchymal progenitor cells in synovial joint tissues 
 
Stem cells can be defined as any cell that retains a high capacity for self-renewal 
throughout adult life.  They characteristically divide to produce a daughter cell that is 
a stem cell or a precursor cell; these precursor cells proliferate before differentiating 
and are otherwise known as transit amplifying cells (Jones and Watt, 1993, Raff, 
2003). 
 
Stem cells within synovial joints are mesodermal in origin and are often referred to as 
mesenchymal stem cells (MSCs).  MSCs have been located in virtually all tissues and 
organs (Saamanen et al., 2010) and are known to home to injured or diseased tissues.  
However, the mechanisms that orchestrate this migration is not certain, (Chamberlain 
et al., 2007).  Adult MSCs principally maintain tissues by serving as a cellular reserve 
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for tissue remodelling and renewal and are maintained at specific sites in ‘stem cell 
niches’.  These niches have been observed in tendons, bone marrow and nodes of 
Ranvier at the periphery of articular cartilage (Karlsson et al., 2009, Saamanen et al., 
2010, Walker et al., 2009).  The regulation and survival of stem cells requires 
interaction with the microenvironment via cell contact, cell signalling pathways such 
as Notch, extracellular proteins and cell surface receptors (Walker et al., 2009, Jones 
and Wagers, 2008). 
 
Unlike hematopoietic stem cells (HSCs), there is no single marker to identify MSCs.  
This cell type appears to be heterogeneous with most being progenitors rather than 
true stem cells, but all are highly clonogenic and possess the potential to differentiate 
into multiple mesenchymal tissues (Pittenger et al., 1999, Saamanen et al., 2010).  
The International Society of Cellular Therapy recommended that MSCs fulfil 
minimum criteria including: adhesion to plastic, expression of surface markers CD73, 
CD90, CD105 and tripotent differentiation capacity to a chondrogenic, osteogenic and 
adipogenic phenotype (Horwitz et al., 2005).  As well as the cell surface markers 
listed above, numerous publications have listed multiple MSC markers, including 
CD44, CD49e, CD90, CD105 and CD166 (Diaz-Romero et al., 2005), however none 
are specific to this cell type (Chamberlain et al., 2007).  Stem cells can be identified 
within a small side-population using fluorescently activated cell sorting (FACS).  The 
weakly fluorescent cells within this side-population express high levels of an ABC 
transporter and actively efflux Hoechst dye from the cells (Goodell et al., 1996, Raff, 
2003).  This technique was first applied to isolate HSCs in the mouse but is now 
routinely used to select MSCs and other stem cells.  Side-population cells have been 
identified in synovial cells and articular chondrocytes (Yamane and Reddi, 2007, 
Grogan et al., 2009, de la Fuente et al., 2004, Hattori et al., 2007). 
 
1.11 Stem cells in articular cartilage 
 
Adult articular cartilage was thought to be devoid of stem cells or progenitors but 
recent work has demonstrated their presence in vivo, and in vitro studies have 
demonstrated the presence of stem cell markers and plasticity in culture (Barbero et 
al., 2003, Fickert et al., 2004, Dowthwaite et al., 2004, Hayes et al., 2001, Alsalameh 
et al., 2004, de la Fuente et al., 2004). 
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In vivo, chondrocytes demonstrate little or no capacity for self-repair; this is most 
likely due to absence of vascularisation, limited number of progenitors and restricted 
mobility of the cells.  However, in culture, chondrocytes are able to proliferate and 
gradually dedifferentiate to a fibroblast-like precursor indicated by loss of synthesis of 
aggrecan and type-II collagen expression.  These dedifferentiated cells regain their 
phenotype when placed in three-dimensional culture such as agarose, micromass or 
pellet culture (Benya and Shaffer, 1982, Tallheden et al., 2003, Raff, 2003).  
Dedifferentiated monolayer chondrocytes have demonstrated plasticity by 
differentiating to chondrogenic, osteogenic and adipogenic phenotypes and display 
similar characteristics to MSCs (Tallheden et al., 2003, Barbero et al., 2003, Williams 
et al., 2010, Fickert et al., 2004, de la Fuente et al., 2004). 
 
It is generally accepted that articular cartilage grows by apposition and that the 
progenitor cells are located at the articular surface during development and maturation 
(Hayes et al., 2003, Williams et al., 2009).  In the skeletally immature South 
American opossum, BrDU highlighted slow-cycling cells within the superficial zone 
of articular cartilage, a characteristic expected of chondroprogenitors or a stem cell 
population (Hayes et al., 2001).  These chondroprogenitors were isolated in our 
laboratory by Dowthwaite et al (2004) and were found to express the cell fate marker, 
Notch1 and preferentially adhered to fibronectin.  When cultured, this subpopulation 
of cells from the superficial zone exhibited a high colony forming efficiency.  This 
study also demonstrated the expression of integrins !1 and "5 (CD29 and CD49e 
respectively) throughout the depth of immature bovine cartilage.  However, labelling 
was must abundant within the superficial zone (Dowthwaite et al., 2004).  Msx1, a 
transcription factor associated with bone formation has been located within immature 
bovine articular cartilage (unpublished observations) and has recently been associated 
with OA chondrocytes (Karlsson et al., 2010). 
 
Recently, other stem cell markers have also been identified within articular 
chondrocytes including CD105 and CD166, the majority of human chondrocytes in 
vitro express CD105 with a minority expressing CD166 (Alsalameh et al., 2004, 
Williams et al., 2010, Fickert et al., 2004, de la Fuente et al., 2004, Grogan et al., 
2009).  CD44 and CD90 are also characterised as MSC markers and are located 
within articular cartilage (Diaz-Romero et al., 2005, Diaz-Romero et al., 2008).  
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CD117 is also a MSC marker and has been associated with cells within the synovial 
joint but as yet has not be identified within articular cartilage (Gimeno et al., 2005). 
 
1.11.1 Differentiation markers 
 
The Notch phenotype was originally identified in drosophila by Morgan and 
colleagues (Morgan, 1917).  It is a heterodimer transmembrane protein comprising a 
large extracellular domain with multiple epidermal growth factor (EGF) repeats, and a 
relatively small transmembrane domain (Carlson and Conboy, 2007).  Notch is 
located in many tissues including muscle, neurons, skin, bone marrow, and cartilage 
(Carlson and Conboy, 2007, Chiba, 2006). 
 
The Notch signalling cascade is initiated by cell-cell contact of the Notch receptor 
with one of its ligands (Gering and Patient, 2010).  In mammals, four Notch 
homologues (Notch 1-4) interact with five transmembrane ligands (Delta-like1, Delta-
like3, Delta-like4, Jagged1 and Jagged2) (Gering and Patient, 2010).  The DSL 
(Delta/Serrate/LAG2) domain-containing proteins, Delta, Jagged1, and Jagged2, are 
ligands for Notch1 and 3 receptors (Shimizu et al., 2000).  Cells expressing Delta or 
Jagged proteins in their cell membranes activate neighbouring cells.  This activation 
results in intramolecular cleavage of the precursor protein (S1 cleavage) to form a 
heterodimer, composed of an extracellular and transmembrane domain on the cell 
membrane.  When attached to one of these ligands, Notch undergoes a conformational 
change that enables it to be cleaved by a protease (S2 cleavage); where the 
extracellular domain is separated from the transmembrane subunit.  The 
transmembrane domain is then also cleaved (S3 cleavage) allowing translocation of 
the NICD (Notch intracellular domain) to the nucleus.  The cleaved portion enters the 
nucleus and binds to a dormant transcription factor of the CSL (CBF1, Su [H], Lag-1) 
family, converting the complex from a transcriptional repressor to a transcriptional 
activator and subsequent upregulation of downstream targets such as HES (Figure 1.7; 
(Chiba, 2006, Gering and Patient, 2010, Mumm and Kopan, 2000). 
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Figure 1.7: Diagram of Notch signalling pathway 
Notch is activated and attaches to a ligand resulting in S2 cleavage.  The 
transmembrane domain is further cleaved by !-secretase during S3 cleavage to release 
the NICD, which translocates to the nucleus, resulting in upregulation of downstream 
targets (Borggrefe and Oswald, 2009). 
 
 
Notch is also involved in lateral inhibition, where within a group of equivalent cells 
expressing both ligand and receptor, one cell differentiates and blocks neighbouring 
cells from adopting the same fate, by activating the notch receptor on the surrounding 
cells.  Thus, Notch signalling controls cell fate by inhibiting or promoting 
differentiation (Mumm and Kopan, 2000, Gering and Patient, 2010). 
 
Notch signalling was thought to be mono-directional although recent work by 
Hiratochi et al (2007) has disputed this.  In this study, neuronal stem cells were 
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cultured with Delta1 expressing COS7 cells and the rate of neuronal development was 
lower than controls.  Conversely, when neuronal stem cells were cultured with 
Notch1-expressing COS7 cells, the rate of neuronal development was significantly 
higher than controls.  These results suggest that Delta1 expressing cells activate Notch 
signalling on neuronal stem cells, which help maintain an undifferentiated state.  
These data imply that Delta1 plays a role in bi-directional signalling (Hiratochi et al., 
2007). 
 
Notch signalling is involved in cell fate determination during differentiation, 
proliferation and apoptosis (Carlson and Conboy, 2007, Artavanis-Tsakonas et al., 
1999).  Notch expression has been observed within articular cartilage, where Notch1 
was restricted to the superficial zone during development and in immature animals 
(Hayes et al., 2003, Dowthwaite et al., 2004, Hiraoka et al., 2006, Grogan et al., 
2009).  Ligands, Delta1, Jagged1 and Jagged2 have also been located within articular 
cartilage (Hayes et al., 2003).  Notch1 has also recently been demonstrated in equine 
chondroprogenitors and bone marrow stromal cells (McCarthy et al., 2011). 
 
Msx genes are a small family of homeobox-containing genes that encode transcription 
factors, they are related to the Drosophila muscle segment homeobox (msh)-like gene 
family.  They are expressed in a variety of tissues during development and are 
essential in cranial-facial formation, and the development of mammary glands, teeth 
and limbs (Bensoussan-Trigano et al., 2011, Blin-Wakkach et al., 2001). 
 
The presence of Msx1 and 2 within the limb bud mesenchyme are essential for normal 
limb development (Bensoussan-Trigano et al., 2011).  In chick limb buds, high 
expression of Msx1 and 2 correlates with functional epithelial-mesenchymal 
interactions (Brown et al., 1997).  Msx1 is thought to prevent differentiation and, 
hence, promote proliferation.  It has been shown to inhibit MyoD gene expression in 
differentiating muscle exhibiting a negative effect on differentiation; this has been 
supported by forced expression of Msx1 in myogenic precursors (Blin-Wakkach et 
al., 2001, Hu et al., 2001).  Msx genes are associated with inhibiting chondrogenic 
and osteogenic differentiation in vitro and are general inhibitors of mesenchymal and 
epithelial progenitor cell differentiation in vivo and in vitro.  This inhibition is 
correlated with an upregulation in cyclin D1 activity and, therefore, preventing these 
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cells from exiting the cell cycle and undergoing terminal differentiation, therefore 
Msx does not actively promote proliferation but blocks differentiation by preventing 
cells from exiting the cell cycle (Hu et al., 2001).  In mature tissue, Msx expression is 
restricted to stem cells including mammary epithelium and basal epithelium of the 
dermis and in pathology, it can be observed within tumours and cancer cell lines 
(Sarapura et al., 1997, Hu et al., 2001). 
 
1.11.2 Stem cell markers 
 
Integrins were first described by Hynes in 1987 and are heterodimeric glycoproteins 
consisting of ! and " subunits (Hynes, 1987), each of which has an extracellular and 
cytoplasmic domain.  Integrins mediate cell-cell and cell-matrix interactions and 
regulate many processes including matrix assembly, adhesion, migration and 
differentiation (Aszodi et al., 2003). Both ! and " subunits have relatively small 
cytoplasmic tails that interact with the cytoskeletal proteins mediating changes in cell 
shape (Hynes, 1987, Loeser, 1993, Durr et al., 1993, Loeser et al., 1995, Loeser, 
2002). 
 
Salter et al (1992) investigated the expression of integrins within articular cartilage.  
The fibronectin receptors "1 (CD29) and !5 (CD49e) were found to be the most 
abundant.  Integrins !1 and !3 were also observed in this study, however their 
expression was weaker and much less consistent (Salter et al., 1992).  CD29 mediates 
cell adhesion to collagen types I, II and fibronectin and these interactions are thought 
to play a role in cartilage formation (Enomoto et al., 1993, Loeser et al., 1995).  More 
recently, CD29 and CD49e expression has been further demonstrated in cultured 
chondrocytes and intact articular cartilage, as well as MSCs (de la Fuente et al., 2004, 
Dowthwaite et al., 2004, Williams et al., 2010).  In immature bovine cartilage, these 
integrins were predominantly expressed within superficial and middle zone cells, and 
cells from both zones demonstrated a high affinity for fibronectin.  However, only 
superficial zone cells were able to form colonies (Dowthwaite et al., 2004).  
Expression was also observed in normal human chondrocytes where the majority of 
cells expressed CD29 and a subset expressed CD49e.  However, when 
chondroprogenitors were expanded in culture all expressed CD49e (Williams et al., 
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2010).  The presence of CD29 and CD49e within the superficial zone, 
chondroprogenitors and within MSCs suggests that these integrins may identify a 
resident progenitor within articular cartilage. 
 
CD44 is a polymorphic transmembrane protein present in many tissues (Salter et al., 
1996).  The amino terminus has a sequence that is homologous with link protein and 
aggrecan.  There are several isoforms; the common forms are hematopoietic (CD44H) 
and epithelial (CD44E).  CD44E is similar to CD44H but has an additional 135 amino 
acids within its extracellular domain (Salter et al., 1996).  CD44H is the major 
isoform expressed by chondrocytes, however, smaller amounts of other isoforms do 
occur in articular cartilage. 
 
Within cartilage, CD44 is the primary HA receptor, mediating both cell-cell and cell-
matrix interactions.  At the cell surface CD44 may regulate the pericellular matrix 
structure via HA (Knudson and Knudson, 2004).  In addition to interacting with HA, 
CD44 also binds other extracellular proteins including fibronectin and collagen types 
I and VI (Aguiar et al., 1999, Ostergaard et al., 1997, Noonan et al., 1996).  CD44 has 
the capacity to function as a HA receptor at the chondrocyte cell surface (Akmal et 
al., 2005) but can also mediate internalisation and degradation of HA (Chow et al., 
1995, Aguiar et al., 1999, Nishida et al., 2000).  In a study by Ostergaard et al (1997), 
CD44 in normal and OA cartilage, was predominantly located within the superficial 
zone of normal articular cartilage.  Within OA cartilage, CD44 was only observed 
within the deep zone (Ostergaard et al., 1997, Tibesku et al., 2005). 
 
CD90 otherwise known as thymocyte differentiation antigen 1 (Thy-1), is a 
glycosylphosphatidylinositol (GPI)-anchored cell surface protein associated with lipid 
rafts in the outer leaflet of the plasma membrane.  It is expressed in various cell types 
including fibroblasts, endothelial cells and stem cells (Rege and Hagood, 2006, 
Haeryfar et al., 2005).  The processes behind CD90 signalling remain unclear, as the 
GPI-anchored glycoprotein lacks the transmembrane or cytoplasmic sequences 
generally required for signal transduction (Haeryfar et al., 2005).  It is, however, 
expressed by HSCs, MSCs and a small sub-population of articular chondrocytes 
(Fickert et al., 2004, de la Fuente et al., 2004, Grogan et al., 2009, Diaz-Romero et al., 
2005). 
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In vitro, CD90 appears to be associated with proliferating chondrocytes (Diaz-
Romero et al., 2005).  CD90 is also involved with regulation of the cytoskeleton and 
cellular adhesion (Kasahara and Sanai, 2000, Frame et al., 2002).  It is suggested that 
CD90 expression in vitro, could induce re-differentiation of dedifferentiated 
chondrocytes (Diaz-Romero et al., 2005). 
 
CD105 (endoglin) was first described by antibody SN6, that recognised a small 
population of bone marrow cells and was thought to be a marker of pluripotent stem 
cells (Haruta and Seon, 1986).  Further studies by Gougos & Letarte, confirmed that 
the cell surface marker was an antigen of precursor cells (Gougos and Letarte, 1988b, 
Gougos and Letarte, 1988a).  CD105 was later found to be expressed during 
angiogenesis and on endothelial cells (Duff et al., 2003). 
 
CD105 is a 180 kDa homodimeric transmembrane glycoprotein.  It has a large 
extracellular region, a hydrophobic transmembrane region and a short cytoplasmic 
tail.  CD105 binds TGF-!1, TGF-!3, activin-A, BMP-2 and BMP-7 in the presence of 
ligand binding receptors types I and II.  CD105 is not a true receptor; it is an 
accessory protein that interacts with the ligand binding receptor of multiple members 
of the TGF-! superfamily kinase receptor complexes (Barbara et al., 1999, Bellon et 
al., 1993, Arufe et al., 2009, Guerrero-Esteo et al., 2002).  Among these receptors, the 
serine-threonine kinase receptor types I and II are necessary for all tested biological 
responses to TGF-! (Rius et al., 1998, Lastres et al., 1996).  CD105 contains the RGD 
sequence on an exposed part of the extracellular domain.  The RGD peptide is a key 
recognition structure found on ECM proteins, such as fibronectin and is recognised by 
cell surface integrins (Gougos and Letarte, 1990).  Molecular cloning of the human 
endoglin cDNA demonstrated the existence of at least two different isoforms, a short 
and long isoform (S-endoglin and L-endoglin).  L-endoglin is the predominant 
isoform; both differ in their cytoplasmic domains (Bellon et al., 1993, Rius et al., 
1998, Lastres et al., 1996). 
 
TGF! regulates several processes, including regulation of cellular proliferation, 
differentiation, migration, morphogenesis, cellular adhesion, ECM formation and can 
stimulate the expression of CD105 (Rius et al., 1998, Lastres et al., 1996).  Another 
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role for CD105 on MSCs may be in mediating TGF-! signalling during chondrogenic 
differentiation.  All TGF-! isoforms are capable of inducing MSCs towards a 
chondrogenic lineage (Barry et al., 1999).  Indeed, a study by Parker and colleagues 
demonstrated that CD105 was expressed on human articular and non-articular 
chondrocytes at high concentrations and that it forms higher order complexes with 
receptor I and receptor II on the cell surface.  The protein also forms a heteromeric 
complex with betaglycan in human chondrocytes (Parker et al., 2003).  In many cells, 
CD105 suppresses TGF-! signalling.  The marker is significantly reduced in 
differentiated MSCs including chondrogenic differentiation and is thought to 
characterise the differentiation status of MSCs derived from umbilical cord blood (Jin 
et al., 2009).  TGF-! family members have recently been reported to control 
differentiation of MSCs and CD105 may play a functional role during stem cell 
differentiation, however, this has yet to be shown (Jin et al., 2009). 
 
CD117 (c-kit) is a transmembrane protein of the type III subfamily of tyrosine kinases 
(Miettinen and Lasota, 2005).  The extracellular region consists of five 
immunoglobulin-like domains, it has a transmembrane and juxtamembrane domain 
and an intracellular region consisting of two tyrosine kinase domains, connected by a 
kinase insert (Reilly, 2002).  CD117 binds stem cell factor (SCF) which results in 
phosphorylation, activating several intracellular signalling molecules including 
transcription factors, that determine various cell responses such as: cell migration, 
proliferation, differentiation and adhesion (Hansen et al., 2005).  CD117 has been 
observed in chronic inflammatory joint diseases, such as rheumatoid arthritis and OA.  
CD117 has been detected in articular cartilage, synovium, HSCs and MSCs (de la 
Fuente et al., 2004, Romanov et al., 2005, Gimeno et al., 2005). 
 
Activated leukocyte cell adhesion molecule (ALCAM; CD166) was first discovered 
on thymic epithelial cells and activated leukocytes by Bowen and colleagues (Bowen 
et al., 1996) and is a member of the immunoglobulin superfamily of cell adhesion 
molecules.  It has five extracellular immunoglobulin domains, a hydrophobic 
transmembrane domain and a short cytoplasmic tail (Swart, 2002, Bowen et al., 1996, 
Bruder et al., 1998, Skonier et al., 1996) and is highly conserved across multiple 
species. 
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CD166 mediates homophilic (CD166-CD166) and heterophilic (CD166-CD6) cell 
adhesion (Swart, 2002).  Nelissen and co-workers demonstrated that CD166 
homophilic cell adhesion is regulated through actin cytoskeleton dependent clustering 
of CD166 at the cell surface, this clustering is essential to obtain stable adhesive 
interactions (Nelissen et al., 2000, van Kempen et al., 2001, Arai et al., 2002).  It is 
also suggested that CD166 may maintain stem cells or prevent differentiation 
(Ohneda et al., 2001).  The majority of published data concern homophilic 
interactions of CD166, which may suggest that this is predominant over the 
heterophilic interaction (Swart, 2002). 
 
CD166 expression has recently been observed in a number of other tissues including 
fibroblasts, neurones, synovium, cartilage and MSCs (Joo et al., 2000, Nelissen et al., 
2000, Alsalameh et al., 2004, Pretzel et al., 2011).  Pretzel et al (2011) were the first 
group to describe the localisation within human articular cartilage.  CD166 was 
mainly located within the superficial and middle zones of OA and normal cartilage 
suggesting that it is a marker of chondroprogenitors (Pretzel et al., 2011). 
 
The use of specific markers to isolate chondroprogenitors will allow for further 
characterisation, including a more in-depth understanding of the mechanisms of 
proliferation and differentiation within articular cartilage.  This has the potential to 
lead to an improved understanding of the role of these markers and, as such, may 
provide us with a more beneficial cell type that could significantly contribute to the 
field of articular cartilage repair. 
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Aims of the project 
 
 
Articular cartilage grows by apposition from the joint surface indicating the presence 
of a resident progenitor population within the superficial zone of immature tissue.  
Stem cells are required for tissue engineering; however, specific isolation of these 
cells has proved problematic.  This study attempts to discover if known stem cell 
markers are expressed by chondroprogenitors and, will assess, if the expression is 
context dependent upon methods of isolation and culture. 
 
The aim of this study is to identify the location of potential stem cell markers (CD29, 
CD44, CD49e, CD90, CD105, CD117 and CD166) and differentiation markers 
(Notch1, Delta1, Jagged1, Jagged2 and Msx1) in immature bovine articular cartilage.  
The study will further investigate marker expression within isolated and monolayer 
cultured chondrocytes to determine whether subpopulations of stem cells are present 
within superficial zone chondrocytes. 
 
This will be achieved by: 
• histological analysis by immunofluorescence of cell surface markers and 
differentiation markers; 
• isolation of superficial zone chondrocytes and analysis of marker expression 
by flow cytometry; 
• overnight culture of superficial zone chondrocytes and analysis of marker 
expression by flow cytometry; 
• overnight culture of superficial, middle and deep zone chondrocytes and 
comparative analysis of marker expression by flow cytometry; and 
• extended monolayer culture for 14 days, with cells analysed for marker 
expression by flow cytometry at days 3, 7 and 14. 
 
  
 
 
 
 
 
 
 
 
CHAPTER 2: 
IMMUNOHISTOCHEMICAL ANALYSIS OF STEM 
CELL AND DEVELOPMENTAL MARKERS 
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2.1 Introduction 
 
Articular cartilage relies on the interaction and organisation of its constituents to 
provide a lubricated, wear-resistant and friction-reducing surface that is resilient and 
slightly compressible on loading.  The tissue comprises a single cell type, the 
chondrocyte, which accounts for 1-5% of the total volume of the mature tissue.  A 
specialised ECM surrounds the chondrocytes.  This matrix differs throughout the 
depth of tissue and around the cell periphery (Walsh et al., 2003). 
 
The tissue is divided into four distinct cellular zones: superficial, middle, deep and 
calcified.  The chondrocytes in each layer differ morphologically and in mechanical 
properties.  The superficial zone is covered by the lamina splendens, an acellular layer 
of type II collagen with fibrils arranged tangentially to the direction of shear stress 
that acts as a gliding surface.  The superficial zone consists of flattened, disc-like 
chondrocytes that are aligned parallel to the joint surface. The transitional zone is 
thicker than the superficial zone and contains chondrocytes that are spherical in shape 
and collagen fibres that are randomly oriented.  In most joints, the chondrocytes of the 
deep or radial zone also consist of spherical cells but in this zone they are arranged in 
columns perpendicular to the joint surface.  The radially arranged collagen fibres 
extend into the calcified zone reinforcing the attachment between cartilage and bone 
(Hu and Athanasiou, 2003). 
 
Animal models are widely used to develop and evaluate tissue-engineering techniques 
intended for human applications.  These models are capable of yielding results that 
are often transferable to human tissue.  The use of a large animal model is likely to 
more closely resemble the cartilage of a human compared with a small animal model 
(Reinholz et al., 2004) and skeletally immature tissue allows for the opportunity to 
study tissue that is still developing and in which stem cell numbers may be higher.  
Immature tissue is also much thicker and more cellular than mature tissue (Figure 2.1) 
enabling more cells to be isolated from each joint (Stockwell, 1967).  Large animal 
tissue, such as bovine, of immature and mature animals is also readily available. 
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There is a seven-fold reduction in cellularity during maturation from birth to adult 
human articular cartilage, which equates to a 60% decrease over seven decades 
(Stockwell, 1967, da Silva et al., 2008).  The density of bovine articular cartilage is 
comparable with human tissue as the mature tissue is of a similar thickness (1.68mm 
compared to 2.26mm in human) and similar cell density (2.0 compared to 1.4 cells x 
10
4
 mm
3
; (Stockwell, 1979). It should be noted that in this study all work will be 
carried out using an immature (approximately 7 days old) bovine model. 
 
 
Figure 2.1: Image illustrating the difference in thickness, cellularity and 
organisation between immature (approximately 7 days old) and mature (18 months 
old) bovine articular cartilage (image kindly donated by Dr. I.M. Khan). 
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It has been shown that maturing articular cartilage grows by appositional growth from 
the articular surface therefore; a population of progenitor cells must reside within the 
tissue (Hayes et al., 2001).  Progenitor cells have been reported within the surface 
zone of articular cartilage after isolation by adhesion to fibronectin in vitro 
(Dowthwaite et al., 2004).  In addition, the surface zone has been centrally implicated 
in the regulation of tissue development and growth, factors that support the 
appositional growth model (Archer, 1994, Hayes et al., 2001). 
 
Friedenstein and colleagues first identified MSCs in bone marrow in the 1970s 
(Friedenstein et al., 1976) cited in (Chung and Burdick, 2009) and more recently, 
MSCs have been shown to differentiate into several cell types including adipocytes, 
osteoblasts and chondrocytes (Caplan, 1991, Both et al., 2007, Kastrinaki et al., 
2008). 
 
MSCs can be characterised by the expression of particular cell-surface antigens 
including CD29, CD44, CD49e, CD90, CD105, CD117 and CD166 (Barry et al., 
1999, Buhring et al., 2007, Majumdar et al., 2000, Romanov et al., 2005).  Diaz-
Romero and colleagues demonstrated a similarity in the cell surface marker 
expression of dedifferentiated normal human chondrocytes and MSCs.  This study 
used a number of the above markers to discriminate between differentiated and 
dedifferentiated chondrocytes (Diaz-Romero et al., 2005). Other studies demonstrated 
that a small subpopulation of CD105/CD166 expressing cells was present within 
human articular cartilage that could be differentiated into chondrocytes, adipocytes 
and osteoblasts (Alsalameh et al., 2004).  CD90 has been identified within monolayer-
expanded chondrocytes (Diaz-Romero et al., 2005, Diaz-Romero et al., 2008) but has 
not been identified within articular cartilage in vivo.  In addition, it has been suggested 
that CD90 expression is associated with proliferating cells and that the highest levels 
of expression are observed during the cell’s proliferation phase (Diaz-Romero et al., 
2005, Chen et al., 1999).  CD166 is widely expressed on hematopoietic and non-
haematopoietic cells such as neuronal cells, mesenchymal stem cells, endothelial cells 
and bone marrow stromal cells (Nelissen et al., 2000).  CD166 may support not only 
haematopoietic development but also inhibit stem cell differentiation (Ohneda et al., 
2001). 
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Another potential stem cell marker is Notch1, Notch and its transmembrane ligands 
are cell surface proteins that regulate cell differentiation during development 
(Artavanis-Tsakonas et al., 1999, Hayes et al., 2003).  Indeed, the presence of Notch1 
has been demonstrated primarily in the surface zone of immature bovine articular 
cartilage (Dowthwaite et al., 2004).  Additionally, normal human tissue contains a 
small number of Notch1 positive cells that are not located primarily at the tissue 
surface (Hiraoka et al., 2006).  The same study demonstrated an increased frequency 
of Notch1 expression in OA tissue (Hiraoka et al., 2006).  
 
Msx1 is also interesting, as it is expressed by cells during embryogenesis.  In mature 
tissue, Msx gene expression is generally associated with multipotent progenitor cells, 
although has also been reported within mammary and uterine tissue stem cells and 
within differentiated pituitary cells (Sarapura et al., 1997, Hu et al., 2001).  Msx1 has 
been implicated in craniofacial, optic, limb and cardiac development.  It has been 
proposed that Msx genes maintain cells in a proliferative state by blocking exit from 
the cell cycle, whilst not actively promoting proliferation (Hu et al., 2001). 
 
The aim of this study is to identify the location of potential MSC markers (CD29, 
CD44, CD49e, CD90, CD105, CD117 and CD166) and developmental markers 
(Notch1, Delta1, Jagged1, Jagged2 and Msx1) in immature bovine articular cartilage. 
 42 
2.2 Materials and Methods  
 
 
2.2.1 Tissue isolation 
 
Immature (approximately 7 days old) bovine limbs (removed at the carpal joint, 
Figure 2.2) were obtained from F. Drury & Sons abattoir, Swindon.  The limbs were 
cleaned in detergent, skinned and incised at the level of the metacarpophalangeal joint 
on day of slaughter.  Full-depth explants 0.5-1.0 cm
2
 were taken using fine dissection 
from the lateral and medial condyles and condylar ridges from a minimum of three 
animals for each antibody tested (Figure 2.3). 
 
 
 
 
Figure 2.2: Diagram of bovine skeleton  
Diagram illustrating the structure of the bovine limb, in particular, the forelimb carpal 
and fetlock (metacarpophalangeal) joint (adapted from Agripedia, 2009). 
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Figure 2.3: Gross morphology of the metacarpophalangeal joint demonstrating 
explant removal 
Gross morphology of the metacarpophalangeal joint (A & B), the open joint (C), 
sample excision from the condyles (D) and the excised full-depth explants (E). 
 
 
2.2.2 Tissue processing 
 
Fixation should prevent antigen elution and degradation as well as preserve the 
position of the antigen, whether nuclear, cytoplasmic or membrane-bound, and 
preserve as much antigenic secondary and tertiary structure as possible for detection 
by antibodies (Farmilo and Stead, 2009).  For this study, two predominant fixation 
methods were used, 2% paraformaldehyde (PFA) and 95% ethanol (ETOH). 
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Cryosections 
 
Tissue was snap frozen by precipitate immersion in a pre-cooled n-hexane (Sigma-
Aldrich, UK)/dry ice bath.  Explants that weren’t used immediately were stored at 
-80°C until required.  Frozen, unfixed tissue was embedded in OCT embedding media 
(R.A. Lamb, UK).  Tissue was sectioned at a thickness of 10µm using a conventional 
cryomicrotome (cryostat; Bright OT5000, UK) and mounted on Histobond slides 
(R.A. Lamb).  Slides not used immediately were stored at -80°C until required. 
 
Paraffin wax sections 
 
Tissue was fixed in 2% PFA or 95% ETOH overnight at 4ºC, and embedded in 
paraffin wax at 60ºC paraffin wax for 1-hour x2.  The embedded explants were 
sectioned at a thickness of 10µm using a conventional microtome (Leitz 1512, UK) 
and mounted on Histobond slides.  Tissue was dewaxed by two washes in xylene (two 
minutes each) and rehydrated in descending concentrations of alcohol (2x 100%, 95% 
and 70%) the incubation time in each solution was 2 minutes.  Finally the tissue was 
washed in water for 5 minutes and the sections stained with relevant antibodies. 
 
2.2.3 Immunofluorescence optimisation 
 
Primary and secondary antibody concentrations (Tables 2.1 and 2.2 respectively) were 
optimised by titration.  Secondary antibodies were titrated firstly using the primary 
antibody of interest.  If more than one primary antibody was used for a particular 
secondary antibody, the primary antibody that demonstrated the most extensive 
cellular labelling throughout the tissue was used.  Jagged2 was used to optimise rabbit 
anti-goat/donkey anti-goat; Jagged1 was used for goat anti-rabbit; bTan20 was used 
for goat anti-rat; and CD166 was used for rabbit anti-mouse secondary antibody 
(Table 2.2).  BTan20 is an antibody that recognises the intracellular domain of 
Notch1.  Primary antibodies were titrated at 2.5, 5, 10 and 15µg ml-1 using optimised 
secondary antibody concentrations (Table 2.1). 
 
Background fluorescence can be a problem in articular cartilage to reduce this, 
primary and secondary antibodies were tested after optimisation with and without the 
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addition of blocking serum, and secondary antibodies were tested with and without 
bovine serum. 
 
An enzymatic pre-treatment is often necessary in cartilage as large amounts of 
glycosaminoglycans and proteoglycans present in the tissue result in masking of 
antigens.  Each antibody was tested on tissue fixed with 2% PFA and 95% ETOH 
(CD44, CD90, CD105, CD117, CD166 and Notch1 were also tested with acetone 
fixed tissue).  Cryosections and paraffin wax sections were used and epitopes 
unmasked by hyaluronidase and chondroitinase digest (enzymatic pre-treatment was 
carried out for CD44, CD90, CD105, CD117, CD166 and Notch1). 
 
2.2.4 Immunofluorescence of bovine articular cartilage 
 
Immunofluorescence detection (of wax or frozen sections) of primary antibodies was 
used to detect the presence of stem cell and developmental markers within articular 
cartilage.  All washes and incubations were performed at room temperature and in a 
humidified chamber unless otherwise stated.  All antibodies and immunoglobulin-
matched (IgG-matched) controls were prepared in phosphate buffered saline (PBS; 
Sigma-Aldrich) containing 0.1% Tween 20 (polyethylenesorbitan monolaurate; 
Sigma-Aldrich) and 5% normal blocking serum (for each primary antibody the serum 
was from the species in which the secondary antibody was raised). 
 
Wax sections were de-waxed and rehydrated in two washes of xylene and decreasing 
series of alcohol (2 x 100%, 95% and 70%), the incubation time in each solution was 
2 minutes.  Finally, the sections were rinsed in running water for 5 minutes. 
 
Cryosections were hydrated for 5 minutes in PBS.  Tissue was fixed in fresh 2% PFA, 
95% ETOH or acetone for 2 minutes at 4°C.  Both paraffin wax sections and 
cryosections were circled with a water repellent marker (Dako pen; Dako, UK), 
washed 3 times in PBS/0.1% Tween 20 (PBS/T) and blocked in relevant sera for 30 
minutes.  Excess serum was removed by blotting the slides before incubating the 
sections with relevant primary antibodies for 1 hour.  The tissue was washed 3 times 
in PBS/T and primary antibodies were detected using fluorescein iso-thiocyanate 
(FITC, Sigma-Aldrich) or Alexafluor 488 (Invitrogen, UK) conjugated secondary 
 46 
antibodies.  The secondary antibody was pre-incubated firstly with 5% bovine serum 
for 1 hour before applying the solution to the sections.  Secondary antibodies were 
centrifuged at 16,000xg for 10 minutes to remove any precipitated protein (if present), 
before adding to sections.  Finally, sections were washed 3 times in PBS/T and 
coverslips mounted with Vectorshield containing 4’,6-Diamidino-2-phenylindole 
(DAPI; Vector laboratories, UK). 
 
Antigen unmasking 
 
Sections were digested with hyaluronidase and chondroitinase (carried out for CD44, 
CD90, CD105, CD117, CD166 and Notch1).  Sections were fixed as previously 
described, washed thrice in PBS/T and then washed in Tris-acetate buffer (Sigma-
Aldrich; pH6.5).  Chondroitinase ABC (Sigma-Aldrich; 0.25 IU ml
-1
) and 
hyaluronidase (Sigma-Aldrich; 2 IU ml
-1
) solutions were prepared in Tris-acetate 
buffer, added to sections and incubated for 1 hour at 37°C.  Sections were washed for 
5 minutes in PBS then blocked with relevant sera.  Primary and secondary antibodies 
were applied as described previously. 
 
Control sections were processed as above omitting primary antibody and incubating 
the sections with IgG-matched controls or PBS/T.  Sections were also incubated with 
PBS/T alone to detect autofluorescence within the tissue. 
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Antigen recognised Clone Name Source IgG 
Delta1 F-15 Santa Cruz Biotechnology, Inc. UK Goat 
Jagged1 H-66 Santa Cruz Biotechnology, Inc. Rabbit 
Jagged2  N-19 Santa Cruz Biotechnology, Inc. Goat 
Msx1 N-20 Santa Cruz Biotechnology, Inc. Goat 
Notch1 C-20 Santa Cruz Biotechnology, Inc. Goat 
Notch1 BTan20 DSHB, USA Rat 
CD29 TDM29 Millipore, UK Mouse 
CD44 IM7 Biolegend, UK Rat 
CD49e SAM-1 Millipore Mouse 
CD90 CT-TH1 Invitrogen, UK Mouse 
CD105 SN6 Ancell, USA Mouse 
CD117 104D2 Invitrogen Mouse 
CD166 3A6 Ancell Mouse 
 
Table 2.1: Table of primary antibodies used 
The antibodies above were tested at concentrations 2.5, 5, 10 and 15 µg ml
-1
. 
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Primary 
Antibody 
Secondary 
Antibody 
Source 
Secondary 
Antibody Dilution 
Manufacture 
Recommended 
Concentration
/Dilution 
Rabbit anti-goat 
FITC 
Sigma-
Aldrich 
1:50, 1:100, 1:200 
& 1:400 
Minimum of 
1:160 
Rabbit anti-goat 
Texas Red 
Vector 
Laboratories 
1:100 & 1:150 
5-20 µg ml
-1
 
(1:300-1:75) 
Anti-
Jagged2 & 
IgG 
Donkey anti-goat 
Alexafluor 488 
Invitrogen 1:200 & 1:400 
1-10 µg ml
-1
 
(1:2000-1:200) 
Goat anti-rabbit 
FITC 
Sigma-
Aldrich 
1:100 & 1:200 
Minimum of 
1:80 
Anti-
Jagged1 & 
IgG 
Goat anti-rabbit 
Texas Red 
Vector 
Laboratories 
1:100, 1:150 & 
1:250 
5-20 µg ml
-1
 
(1:300-1:75) 
Anti-
BTan20 & 
IgG 
Goat anti-rat 
FITC 
Sigma-
Aldrich 
1:100 & 1:200 1:32 
Anti-
CD166 & 
IgG 
Rabbit anti-mouse 
FITC 
Sigma-
Aldrich 
1:30, 1:50, 1:100, 
1:200 & 1:400 
1:200 
 
Table 2.2: Table of secondary antibody concentrations used for optimisation 
The primary antibodies shown above were titrated at concentrations 2.5, 5, 10 & 15 
µg ml
-1
 and each concentration was tested against the range of secondary antibody 
dilutions shown.  The mid-range value of the secondary antibodies was determined by 
the manufacturers instructions or immunofluorescence carried out by co-workers. 
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2.3 Results 
 
 
2.3.2 Immunofluorescence optimisation 
 
Immunofluorescence optimisation is important to maximise the signal to noise ratio.  
Many factors have to be taken into account including tissue preparation and fixation, 
antibody concentration and antigen unmasking.  In this study, cryosections were used 
to optimise all antibodies using paraformaldehyde and alcohol fixation.  The 
optimised antibody concentrations were then tested on paraffin wax sections; CD29, 
CD49e and bTan20 were not tested on wax sections, as previous work in the 
laboratory had demonstrated valid conditions for immunofluorescence using frozen 
and wax sections and found them to be comparable (personal communication with Dr. 
Rebecca Williams).  CD44, CD90, CD105, CD117, CD166, Notch1, Delta1, Jagged1, 
Jagged2 and Msx1 antibodies were all tested using wax and frozen sections, the 
cellular labelling did not differ between wax and frozen sections.  However, in 
general more matrix autofluorescence was observed with wax sections. 
 
All CD (cluster of differentiation) markers with the exception of CD29 were localised 
to the superficial zone of the tissue using paraformaldehyde and alcohol fixation.  To 
determine whether this was an artefact of tissue preparation, the remaining CD 
markers were tested on wax sections and comparable results were observed with both 
fixations.  CD44, CD90, CD105, CD117 and CD166 were also tested using acetone 
fixation.  In addition, wax and frozen sections were treated with antigen unmasking.  
The cellular labelling did not alter with fixation or when pre-treated with enzymes. 
 
Notch1, Delta1, Jagged1, Jagged2 and Msx1 were all observed throughout the tissue 
but not all cells were labelled.  Antibody optimisation was carried out with the 
developmental markers, Notch1, its ligands and Msx1 but cellular labelling did not 
differ between fixations or tissue embedding procedures.  Notch1 was also tested with 
acetone fixation and with antigen unmasking of both frozen and wax sections.   
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Following titration of the antibodies, background fluorescence was further reduced by 
the addition of blocking serum to the primary and secondary antibodies and pre-
incubating the secondary antibody in bovine serum.  Optimal antibody concentrations 
are shown in Tables 2.3 and 2.4. 
 
 
Secondary 
Antibody 
Optimal 
Dilution 
Secondary 
Antibody 
Optimal 
Dilution 
Rabbit anti-goat 
Texas Red 
1:150 
Goat anti-rabbit 
Texas Red 
1:150 
Rabbit anti-goat 
FITC 
1:200 
Goat anti-rabbit 
FITC 
1:200 
Donkey anti-goat 
Alexafluor 488 
1:400 
Rabbit anti-
mouse FITC 
1:400 
Goat anti-rat 
FITC 
1:200   
 
Table 2.3: Table of secondary antibody optimal concentrations 
The secondary antibodies were titrated using primary antibodies with the most 
cellular labelling: Jagged2 (goat), bTan20 (rat), Jagged1 (rabbit) and CD166 (mouse).  
The optimal concentrations are shown in this table. 
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Name 
(Isotype) 
Optimal 
Dilution 
Name 
(Isotype) 
Optimal 
Dilution 
Name 
(Isotype) 
Optimal 
Dilution 
Delta (goat) 10 µg ml
-1
 
BTan20 
(rat) 
10 µg ml
-1
 
CD90 
(mouse) 
10 µg ml
-1
 
Jagged1 
(rabbit) 
10 µg ml
-1
 
CD29 
(mouse) 
5 µg ml
-1
 
CD105 
(mouse) 
10 µg ml
-1
 
Jagged2 
(goat) 
10 µg ml
-1
 CD44 (rat) 10 µg ml
-1
 
CD117 
(mouse) 
10 µg ml
-1
 
Msx1 (goat) 5 µg ml
-1
 
CD49e 
(mouse) 
10 µg ml
-1
 
CD166 
(mouse) 
10 µg ml
-1
 
Notch1 
(goat) 
10 µg ml
-1
     
 
Table 2.4: Table of primary antibody optimal concentrations 
Following secondary antibody optimisation, the primary antibodies were titrated with 
concentrations 2.5, 5, 10 & 15 µg ml
-1
.  The remaining goat polyclonal antibodies 
were titrated with the optimum concentration of secondary antibodies. 
 
 
2.3.3 Immunofluorescence of bovine articular cartilage 
 
Results shown are representative of labelling seen with each antibody and each 
antibody was tested at least in triplicate. 
 
All antibodies produced improved results when the primary antibody was incubated 
with 5% blocking serum and when the secondary antibody was pre-incubated with 5% 
bovine serum. 
 
The results for each antibody and optimal fixatives are summarised in Table 2.5. 
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CD29 
 
CD29 expression was most intense within the superficial zone of the tissue (Figure 
2.4A) but was abundant throughout, It was also observed within the cytoplasm in 
addition to the cell membrane.  The extent of the labelling did not vary with titration 
of the primary or secondary antibody.  However, the least amount of background 
fluorescence was observed at 5 µg ml
-1
.  The degree of labelling did not differ with 
either fixative (95% ETOH or 2% PFA).  The antibody had already been tested on 
wax embedded tissue by co-workers and was not repeated in this study, as the results 
were comparable to frozen sections.  Images shown were of cryosections fixed in 
paraformaldehyde (Figure 2.4). 
 
CD44 
 
CD44 expression was observed in a small number of cells in the most superficial 1-2 
cell layers of the superficial zone (Figure 2.5A and C), no labelling was apparent in 
the rest of the tissue.  Cells expressing the antigen were brightly labelled.  There was 
no difference between 95% ETOH, 2% PFA or acetone fixation.  Cryosections and 
wax embedded sections produced results that were comparable, however, wax 
sections produced a higher degree of autofluorescence.  As the expression was limited 
to the superfical zone, the tissue was also digested with hyaluronidase and 
chondroitinase to ensure the restricted CD44 expression was not due to epitope 
masking.  The enzymatic digest produced equivalent results.  Labelling appeared 
superior with ethanol preserved tissue, images shown are of alcohol fixed 
cryosections digested with hyaluronidase and chondroitinase (Figure 2.5). 
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Figure 2.4: CD29 expression in full-depth immature articular cartilage 
A and B:  Low power images of full-depth tissue, A: surface and middle zones, B: 
middle and deep zones including a cartilage canal (transverse section [TS]).  CD29 
was distributed evenly throughout the depth of the tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
 54 
 
Figure 2.5: CD44 expression in full-depth immature articular cartilage 
A and B:  Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD44 was only evident within the most superficial layer 
of cells within the tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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CD49e 
 
CD49e staining was carried out using cryosections only.  Co-workers had previously 
demonstrated comparable results between wax embedded tissue and frozen sections.  
Sections were fixed in 95% ETOH or 2% PFA, paraformaldehyde producing superior 
results.  Some very weak labelling was observed throughout the tissue, but intense 
labelling was only seen in the superficial 1-3 cell layers.  Images shown are of 
paraformaldehyde fixed cryosections (Figure 2.6). 
 
CD90 
 
CD90 was not detected by immunofluorescence and only background labelling 
equivalent to the controls was observed.  Cryosections and paraffin wax embedded 
sections were tested with this antibody using the fixatives: 95% ETOH, 2%PFA or 
acetone.  The antibody was also tested after hyaluronidase and chondroitinase digest 
but the results did not differ.  Images shown are of alcohol fixed cryosections (Figure 
2.7). 
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Figure 2.6: CD49e expression in full-depth immature articular cartilage 
A and B:  Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD49e was only observed within the upper 1-3 layers of 
the superficial zone. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Figure 2.7: CD90 expression in full-depth immature articular cartilage 
A and B:  Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD90 was not detected by immunofluorescence in the 
tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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CD105 
 
CD105 expression was observed at the articular surface within the upper 1-3 cell 
layers and the majority of cells in this region were labelled.  This antibody was tested 
on cryosections and paraffin wax embedded tissue and fixed with acetone, 2% PFA or 
95% ETOH.  Sections were also treated with a hyaluronidase and chondroitinase 
digest.  The antibody produced optimal results with frozen sections fixed in 2% PFA 
(Figure 2.8).  Enzymatic digestion of the tissue had no effect on labelling. 
 
CD117 
 
CD117 expression was not detected by immunofluorescence and was identical to the 
controls.  Cryosections and paraffin wax embedded sections were tested with this 
antibody using the fixatives: 95% ETOH, 2%PFA or acetone. The antibody was also 
tried after hyaluronidase and chondroitinase digest but the results did not differ.  
Images shown are of alcohol fixed cryosections digested with hyaluronidase and 
chondroitinase (Figure 2.9). 
 
CD166 
 
CD166 expression was confined to the superficial 1-2 cell layers of cartilage.  Almost 
all of the cells within this superficial region expressed CD166, unlike CD44, CD49e 
and CD105.  The antibody was tested on cryosections and paraffin wax sections and 
tissue fixed with 95% ETOH, 2% PFA or acetone.  The antibody was also tried after 
unmasking with hyaluronidase and chondroitinase.  Optimal results were obtained 
with cryosections fixed in paraformaldehyde (Figure 2.10).  Enzymatic digestion of 
the tissue had no effect on labelling. 
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Figure 2.8: CD105 expression in full-depth immature articular cartilage 
A and B:  Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD105 expression was only observed within the upper 1-3 
cell layers of the superficial zone. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm. 
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Figure 2.9: CD117 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD117 expression was not detected by 
immunofluorescence in the tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Figure 2.10: CD166 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  CD166 labelling was only evident within the upper 1-2 
cell layers of the tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Notch1 
 
C20 labelling for Notch1 was present throughout the tissue but was prevalent in the 
superficial and deep zones.  The antibody was tested on cryosections and paraffin wax 
sections.  The tissue was fixed in 95% ETOH, 2% PFA or acetone.  The antibody was 
also tested after hyaluronidase and chondroitinase treatment, which had no effect on 
detection.  Notch1 was detected on cryosections and paraffin wax sections although 
more background fluorescence was observed with wax sections.  There was no 
difference between any of the fixatives and the images shown are of cryosections 
fixed in paraformaldehyde (Figure 2.11). 
 
BTan20 binds to the intracellular region of Notch1, the labelling for Notch1 was 
comparable to C20 labelling, expression was primarily observed within the superficial 
and deep zones with a limited number of cells expressing the antigen within the 
middle zone.  This antibody was only tested on cryosections that were fixed in 95% 
ETOH or 2% PFA.  Paraformaldehyde fixed sections produced better labelling 
(Figure 2.12). 
 
Two antibodies for Notch1 were used that bind to different regions of the protein, to 
further test the specificity of the antibodies.  The distribution of labelling was 
comparable with both antibodies however; C20 demonstrated more intense cellular 
expression. 
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Figure 2.11: Notch1 (C20) expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Notch1 (C20) expression was observed throughout the 
tissue but predominantly in the superficial and deep zones. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Figure 2.12: Notch1 (bTan20) expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Notch1 (bTan20) expression was observed throughout the 
tissue but predominantly in the superficial and deep zones. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Delta1 
 
Delta1 labelling was observed throughout the tissue.  Labelling was most extensive 
within the superficial and deep zones of the tissue.  Delta1 was detected on frozen and 
wax sections, fixed in 95% ETOH or 2% PFA.  Paraformaldehyde fixed frozen 
sections produced superior results and images shown are of this fixative (Figure 2.13). 
 
Jagged1 
 
Jagged1 labelling was observed primarily in the superficial and deep zones of the 
tissue although some weak labelling was present in the middle zone.  The antibody 
was tested on frozen and wax sections, fixed in 95% ETOH or 2% PFA.  
Paraformaldehyde fixed frozen sections produced optimal results and images shown 
are of sections treated with this fixative (Figure 2.14). 
 
Jagged2 
 
Jagged2 labelling was observed throughout the tissue with intense expression 
observed in the deep zone.  Jagged2 was detected with paraffin sections and 
cryosections although more background fluorescence was observed with wax 
sections.  Labelling was seen with both fixatives (PFA and ETOH); however, the 
labelling was superior with paraformaldehyde fixed sections.  Images shown are of 
cryosections fixed with paraformaldehyde (Figure 2.15). 
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Figure 2.13: Delta1 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Intense Delta1 labelling was observed in the superficial 
and deep zones of the tissue with weaker expression in the middle zone. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively.  
Scale bars = 20µm 
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Figure 2.14: Jagged1 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Jagged1 expression was observed in the superficial and 
deep zones of the tissue with weaker expression in the middle zone. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Figure 2.15: Jagged2 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Jagged2 expression was observed throughout the tissue. 
C, D and E: High power images (TS) of surface, middle and deep zones respectively. 
Scale bars = 20µm 
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Msx1 
 
Msx1 labelling was observed throughout the depth of tissue, although not all cells 
were labelled.  Msx1 was detected on cryosections and paraffin wax sections, fixed in 
95% ETOH or 2% PFA.  Paraformaldehyde fixed wax sections produced superior 
results and images shown are of sections treated with this fixative (Figure 2.16).  
 
Controls 
 
Controls were processed by omitting primary antibody and, instead, incubating the 
sections with appropriate species-specific IgG or PBS/T.  Sections were also 
incubated with PBS/T alone to detect autofluorescence within the tissue.  Controls 
were all negative (Figure 2.17). 
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Figure 2.16: Msx1 expression in full-depth immature articular cartilage 
A and B: Low power images (TS) of full-depth tissue, A: surface and middle zones, 
B: middle and deep zones.  Msx1 expression was observed throughout the tissue 
zones but not all cells were labelled. 
C, D and E: High power images (TS) of surface, middle (including cartilage canal) 
and deep zones respectively.  Scale bars = 20µm 
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Figure 2.17: Control images in full-depth immature articular cartilage 
Low power images (TS) of full-depth tissue, all controls were negative: 
A and B: Mouse IgG control; C and D: Rat IgG control; 
E and F: Rabbit IgG control; G and H: Goat IgG control. 
A, C, E and G: surface and middle zones, B, D, F and H: middle and deep zones. 
Scale bars = 20µm 
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Antigen recognised Optimum Fixative 
Zones in which labelling 
was present 
CD29 
95% ethanol or 
2% PFA 
All zones 
CD44 95% ethanol Superficial 
CD49e 2% PFA Superficial 
CD90 
95% ethanol or 
2% PFA 
No labelling 
CD105 2% PFA Superficial 
CD117 
95% ethanol or 
2% PFA 
No labelling 
CD166 2% PFA Superficial 
Notch1 (C-20) 
95% ethanol or 
2% PFA 
Mainly superficial and deep 
Notch1 (bTan20) 2% PFA Mainly superficial and deep 
Delta 2% PFA Mainly superficial and deep 
Jagged1 2% PFA Mainly superficial and deep 
Jagged2 2% PFA All zones 
Msx1 2% PFA All zones 
 
Table 2.5: Summary of results 
The table summarises the optimal conditions and results for each primary antibody 
used. 
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2.4 Discussion 
 
 
In this study, all cell surface markers tested, except CD90 and CD117 were located 
within the superficial zone of articular cartilage.  CD29 was also expressed in the 
middle and deep zones.  The developmental markers: Notch1, Delta1, Jagged1, 
Jagged2 and Msx1 were located throughout the tissue but not all cells were labelled.  
To determine whether the restricted expression of CD44, CD49e, CD105 and CD166 
and absence of CD90 and CD117 were not due to sample preparation and that optimal 
conditions for antibody binding were achieved, tissue was embedded in paraffin wax 
or snap-frozen, and a selection of fixation methods were used including: 
paraformaldehyde; alcohol and acetone.  Acetone fixation was only used to test 
CD44, CD90, CD117, CD105, CD166 and Notch1.  CD29 and CD49e were not tested 
as colleagues had already tested these and they were found to be comparable to PFA 
and ETOH fixation. 
 
Wax embedding results in superior preservation of the tissue architecture compared 
with freezing.  The processing of wax embedded tissue can lead to reduced immuno-
reactivity and when combined with formaldehyde fixation can result in increased 
tissue autofluorescence.  Frozen sections generally display inferior morphological 
tissue preservation compared with wax sections but produce improved 
immunofluorescent labelling, as epitopes are better preserved (Farmilo and Stead, 
2009, Hayes et al., 2008).  Due to the inherent autofluorescence generally observed in 
articular cartilage, both frozen and wax embedded sections were used to obtain 
optimal results.  Autofluorescence associated with adult human articular cartilage 
(Pretzel et al., 2011) were not as apparent using immature bovine articular cartilage 
and changes in fixation did not significantly affect the labelling observed in the tissue 
sections. 
 
When CD44, CD90, CD105, CD117, and CD166 were pre-treated with hyaluronidase 
and chondroitinase no difference in expression was observed.  In a similar study, 
Ostergaard et al (1997) also found no difference between enzymatically treated or 
untreated human tissue.  This is in contrast to other studies where incubation with 
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protease K showed improved results in formaldehyde-fixed wax sections of rat and 
human articular cartilage (Ozbey et al., 2010, Pretzel et al., 2011). 
 
Of the cell surface markers tested, CD29 was the most abundant, which is comparable 
with previous studies (Salter et al., 1992, Dowthwaite et al., 2004).  In Dowthwaite et 
al (2004) CD49e was expressed in the majority of cells at the cell surface but the 
intensity and number of chondrocytes labelled decreased with tissue depth, using flow 
cytometry, 79% of superficial zone cells expressed CD49e compared to 5% and 2.5% 
of middle and deep zones chondrocytes respectively.  The zonal distribution shown in 
the Dowthwaite study is comparable to expression observed in this Chapter, where 
very weak labelling was seen throughout the tissue but intense CD49e labelling was 
only detected within the upper 1-2 cell layers of the superficial zone. 
 
CD166 was present within the majority of the upper 1-2 cell layers of the superficial 
zone.  CD105 was also only located within the superficial zone but at a much lower 
cell intensity and fewer cells were labelled.  In studies using adult rat articular 
cartilage, CD105 and CD166 expression were observed throughout the tissue depth, 
however intense CD105 labelling was observed in the superficial zone (Ozbey et al., 
2010).  In a second study, the distribution of CD166 in normal and OA human 
articular cartilage was restricted to the superficial and middle zone chondrocytes 
(Pretzel et al., 2011).  The variations in zonal distribution of CD105 and CD166 
expression observed in these studies may be due to differences in maturity of tissue or 
species.  Differences in integrin expression between mature and foetal chondrocytes 
has previously been reported by Salter et al (1995) in human knees. 
 
CD44 is the primary HA receptor, mediating both cell-cell and cell-matrix interaction 
(Knudson and Knudson, 2004).  The reports of CD44 expression in articular cartilage 
vary in their zonal distribution, Bosch et al. (2002) described CD44 expression in the 
middle and deep zones but not in the superficial zone, whilst Ostergaard et al (1997) 
identified CD44 within the superficial zone and decreased expression in the middle 
and deep zone chondrocytes.  In this study, CD44 was located in the superficial zone 
only.  The restricted expression observed in the present study may be an artefact of 
tissue preparation causing receptors to be masked.  However, enzymatic pre-treatment 
did not result in increased detection, so this is unlikely to be a factor.  Variations in 
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expression of CD44 between this study and previous ones may be due to the 
immaturity of the tissue and isotropic organisation.  Although CD44 is the 
predominant HA receptor in articular cartilage it is not the only receptor.  CD44 is 
known to interact with other extracellular proteins such as fibronectin and this protein 
has been demonstrated within the superficial and middle zones of immature cartilage 
(Dowthwaite et al., 2004).  Fibronectin adherent superficial zone cells exhibit a 
greater colony forming efficiency and thus enriches for chondroprogenitors. 
 
CD90 and CD117 were not observed with any of the variations in fixation or enzyme 
pre-treatment.  CD90 has not been reported within matrix-intact articular cartilage.  
Colonies (>32 cells) taken from fibronectin-adherent chondrocytes from human and 
equine articular cartilage and expanded in monolayer have been shown to express 
CD90 (Williams et al., 2010, McCarthy et al., 2011).  CD90 expression has also been 
shown in full-depth chondrocytes cultured for 14 days in monolayer (Diaz-Romero et 
al., 2005).  CD117 has not previously been identified within articular cartilage but has 
been observed in isolated chondrocytes at low levels (de la Fuente et al., 2004).  It is a 
multipotent marker identified in mesenchymal stem cells and within synovial 
membranes from normal and OA patients (Hermida-Gomez et al., 2011, Gimeno et 
al., 2005).  CD90 and CD117 are expressed in multipotent cells and may be 
characteristic of chondrocytes that have dedifferentiated in monolayer culture; this 
will be investigated further in Chapter 3. 
 
The differentiation markers Notch1, Delta1, Jagged1 and Jagged2 were all observed 
throughout the tissue.  Notch1 expression was most intense at the surface and deep 
zones.  This pattern of superficial and deep zone expression was also observed with 
Delta1 and Jagged1 antibodies.  Jagged2 expression was most intense within the deep 
zone. 
 
Notch1 expression shown in this study is comparable to observations obtained by 
Dowthwaite and co-workers in immature bovine articular cartilage (Dowthwaite et al., 
2004).  Notch1 and its ligands have been studied during development in both chick 
and the mammalian model.  In chick, the expression of Notch1, Delta1, Jagged1 and 
Jagged2 is widespread within the developing anlagen although as development 
progresses becomes restricted to the superficial fibrocartilage (Williams et al., 2009).  
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During mouse development, Hayes et al (2003) observed Notch1 expression at the 
articular surface up to birth but was later restricted to the deeper zones.  Jagged2 was 
present throughout the developing tissue before birth and Delta1 was predominantly 
present within the epiphyseal and not the articular cartilage, Jagged1 was not detected.  
Postnatal, Jagged2 and Jagged1 were observed weakly in the deeper and middle 
layers respectively but then increased their distribution throughout the tissue, only 
absent from the first 1-2 layers of cells.  Delta1 was present in the surface 2-3 cell 
layers and in some middle and deep zone cells (Hayes et al., 2003). 
 
A number of studies have investigated Notch1 and its ligands within mature articular 
cartilage, the majority reported Notch1 expression throughout the depth of human 
(Hiraoka et al., 2006, Ustunel et al., 2008) or rat (Ozbey et al., 2010) articular 
cartilage.  However, Notch1 expression has also been described at a greater density 
within the superficial zone or restricted to this zone in mature human articular 
cartilage (Grogan et al., 2009, Karlsson et al., 2007), which is similar to results 
observed in this study using immature bovine articular cartilage.  Karlsson et al 
(2007) also reported that Jagged1 and Jagged2 were localised to a small number of 
cells within the superficial zone of human articular cartilage, but Delta1 was detected 
throughout the full thickness, except for the deepest layers.  However, Ustunel and 
colleagues observed Delta1 and Jagged1 expression throughout human articular 
cartilage, with Delta1 and Jagged1 expression most intense within the superficial zone 
and deep zone respectively (Ustunel et al., 2008).  The distribution of Delta1 and 
Jagged1 expression demonstrated by Ustunel et al (2008) are similar to results shown 
in this study, with Jagged1 and Delta1 expression most intense within the superficial 
zone of articular cartilage. 
 
Msx1 was observed throughout the tissue but not all cells were labelled.  Msx1 has 
not been detected in adult articular cartilage, but has been identified within the 
developing limb (Foerst-Potts and Sadler, 1997).  Msx1 down regulation is associated 
with terminal differentiation of several cell types including cartilage and muscle.  In 
muscle, Msx1-forced expression results in a highly proliferative transformed 
phenotype and blocks myogenic terminal differentiation through the inhibition of 
MyoD.  Thus, Msx1 is thought to prevent differentiation and enhance proliferation.  
Msx1 is also able to decrease Cbfa1, essential for osteoblast differentiation, mice 
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lacking this factor exhibit an absence of bone formation (Blin-Wakkach et al., 2001).  
The presence of Msx1 throughout immature bovine articular cartilage could be a 
result of proliferation occurring within the progenitor and transit amplifier 
populations. 
 
It is clear from the results shown that the superficial zone is important for growth as 
all markers tested, with the exception of CD90 and CD117, were expressed in the 
superficial zone, with CD44, CD49e, CD105 and CD166 localised to this region.  
Indeed, Hunziker et al (2007) investigated the hypothesis of appositional growth in 
immature rabbits.  Post-partum the articular cartilage was isotropic in chondrocytic 
organisation.  Two months after birth, the depth of the tissue and cell density had 
decreased and the cells were slightly more spatially oriented.  The rabbit is sexually 
mature at three months and exhibited an anisotropic structure with a further decrease 
in tissue depth, characteristic of adult articular cartilage.  This study demonstrated that 
articular cartilage grows by a process of appositional growth from the superficial zone 
and tissue resorption with the articular cartilage acting as a surface growth plate.  The 
immature cartilage is gradually resorbed and eliminated and only post puberty are the 
precursor cells within the superficial zone reprogrammed to produce mature-type 
articular cartilage (Hunziker et al., 2007, Hunziker, 2010). 
 
Results here, and in several previous studies have described the presence of 
progenitor cells at the articular surface of developing or immature joints (Williams et 
al., 2009, Dowthwaite et al., 2004, Hayes et al., 2003).  The superficial zone of 
immature bovine articular cartilage has already been shown to express increased 
levels of Notch1 (Dowthwaite et al., 2004), the Dowthwaite study also demonstrated 
that superficial and middle zone cells had a high affinity to fibronectin, but only the 
superficial zone cells formed colonies.  Chondroprogenitor colonies from adult human 
tissue were also shown to express Notch1 whereas full-depth colonies did not 
(Ustunel et al., 2008).  Further evidence was provided by Hayes et al (2001) where a 
proportion of the superficial zone exhibited an extended cell cycle time when treated 
with BrDu.  BrDu is incorporated at S-phase of cell division, cells in the transitional 
zone labelled after 4-6 days, the superficial zone cells labelled after 10 days.  The 
slow cycling time of the superficial zone cells is characteristic of a progenitor or stem 
cell population (Hayes et al., 2001). 
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This study demonstrates that the stem cell markers, CD44, CD49e, CD105 and 
CD166 are all localised to the articular cartilage superficial zone cells, with CD29 and 
the differentiation markers Notch1, Delta1, Jagged1, Jagged2 and Msx1 expressed 
throughout the tissue.  The restricted expression of these stem cell markers 
predominantly to the superficial zone in immature bovine articular cartilage is akin to 
results observed by previous investigators (Dowthwaite et al., 2004, Hayes et al., 
2003, Williams et al., 2009) and supports appositional growth.  Variations in the 
distribution of markers observed in this study and other studies may be due to 
maturity of tissue or to species-specific differences.  These data suggest the presence 
of a stem cell-like population that resides within the superficial zone of immature 
bovine articular cartilage.  These markers can be used to isolate these stem cell-like 
cells from the total population.  The expression of these markers within superficial 
zone cells will be further investigated in vitro in Chapter 3. 
 
  
 
 
 
 
 
 
 
 
CHAPTER 3: 
QUANTITATIVE STUDY OF CELL SURFACE 
MARKERS IN ARTICULAR CHONDROCYTES 
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3.1 Introduction 
 
 
In the previous Chapter, stem cell markers were predominantly expressed within the 
superficial zone of immature bovine articular cartilage sections.  In brief, CD44, 
CD49e, CD105 and CD166 were restricted to the superficial zone; CD29 and the 
differentiation markers Notch1, its ligands and Msx1 were located throughout the 
depth of the cartilage; CD90 and CD117 were not detected.  The results in this study 
are consistent with previous observations where progenitors are thought to reside 
within the superficial zone (Dowthwaite et al., 2004, Hayes et al., 2003, Williams et 
al., 2009). 
 
Following on from this whole tissue work, we investigated the expression of the stem 
cell markers in vitro to determine the effects of cell isolation on expression.  Previous 
work by other groups has shown that following short periods in monolayer culture, 
some human articular chondrocytes expressed CD29, CD44, CD49e and low levels of 
CD90, CD105 and CD166 (Diaz-Romero et al., 2005, Diaz-Romero et al., 2008, 
Bocelli-Tyndall et al., 2006).  In one study, a sub-population of CD105/CD166 
expressing cells after expansion and dedifferentiation were able to differentiate into 
chondrocytes, osteoblasts and adipocytes (Alsalameh et al., 2004) suggesting these 
markers could be used to isolate MSCs. 
 
Few studies have been carried out in bovine tissue, however, Dowthwaite et al (2004) 
showed that in isolated immature bovine chondrocytes, superficial, middle and deep 
zone cells expressed CD29.  The same study showed CD49e was predominantly 
expressed by superficial zone cells (79%) compared with middle (5%) and deep 
(2.5%) zone cells.  It is evident from a study by Grogan et al (2009) that although 
72%, 35% and 29% Notch1 labelled cells were observed within the superficial, 
middle and deep zones respectively, expression decreased following 24 hours in 
monolayer culture to 4.7% of the total population (Grogan et al., 2009).  Differences 
in zonal expression of Notch1 were also observed in immature bovine tissue 
(Dowthwaite et al., 2004).  Notch1 labelling was predominantly within the superficial 
2-3 cell layers; following chondrocyte isolation, 86% of the isolated surface zone cells 
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were Notch1-positive compared with 10% and 34% from the middle and deep zone, 
respectively (Dowthwaite et al., 2004).  Notch1, Delta1 and Jagged1 labelling was 
observed in human chondrocytes cultured in monolayer, however the expression of 
these markers was more intense in progenitor populations.  Jagged2 was only 
observed in normal chondrocytes (Ustunel et al., 2008).  From these studies, it is 
evident that there could be differences in marker expression between in vivo and in 
vitro chondrocytes and this is an important factor to consider when using these stem 
cell markers as a means of isolating progenitor/MSC populations. 
 
The majority of studies investigating antigen expression of isolated or cultured 
chondrocytes use flow cytometry; this method enables rapid analysis and 
quantification of a large number of cells.  A single cell suspension is injected into the 
machine and enters the flow cell (Figure 3.1A).  Essentially, the flow cell consists of a 
central core containing the cell sample surrounded by an outer core of sheath fluid.  
The pressure of the sheath fluid against the cell sample in the narrowing flow cell 
creates a laminar sheath flow that carries the cells upward in single file through the 
centre of the flow cell where they are interrogated by one or more lasers, this is 
known as hydrodynamic focusing.  Hydrodynamic focussing is essential to obtain 
information from each cell entering the flow cell.  Light scattered in a forward 
direction, is collected by a lens known as the forward scatter channel.  Forward 
scattered light is indicative of cell size and can distinguish between viable cells and 
cellular debris.  Light deflected from cell organelles is detected perpendicular to the 
laser and is measured by the side scatter channel, which provides information 
regarding the granular content or cytoplasmic complexity of a cell (Figure 3.1B).  
Flow cytometers use a number of fluorescence channels to detect light emitted, 
known as photomultiplier tubes, the specificity of detection is controlled by optical 
filters that only permit the passage of specific band widths of light (Rahman, 2006, 
Carter and Ormerod, 2005). 
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Figure 3.1: Flow cell within flow cytometer 
Cells are hydrodynamically focussed within the flow cell to produce a stream of 
single cells for interrogation by one or more lasers (A).  Light scattered in a forward 
direction is detected by the forward scatter channel and is indicative of particle size.  
The side scatter channel provides information about the granular content or 
cytoplasmic complexity of each cell (B) 
 
 
The purpose of this Chapter is to quantify the expression of stem cell markers (CD29, 
CD44, CD49e, CD90, CD105, CD117 and CD166) and developmental or 
differentiation markers (Notch1, Delta1, Jagged1, Jagged2 and Msx1) within the 
superficial zone of immature bovine articular cartilage using flow cytometry; and also 
to determine whether sub-populations of stem cells are present within superficial zone 
chondrocytes.  When data are combined with Chapter 2, these data will highlight any 
differences in expression between tissue sections and isolated cells. 
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3.2 Materials and Methods 
 
 
3.2.1 Tissue isolation and digestion 
 
Immature bovine limbs were cleaned and skinned as described in Chapter 2.  
Following the removal of the skin, the metacarpophalangeal joint was opened under 
sterile conditions and superficial zone explants were dissected from the joints.  The 
explants were dissected using a #10 scalpel blade from the lateral and medial 
condyles as well as the condylar ridges. Superficial zone explants were removed using 
fine dissection, these explants were thin and translucent. In a small number of the 
joints, middle and deep zone explants were also excised.  Middle zone explants were 
excised from directly below the removed superficial zone, removing approximately 
half of the remaining depth of tissue.  The remaining cartilage was termed the deep 
zone and was removed from directly beneath the excised middle zone.  This technique 
does not allow for accurate identification of the three zones but is a rapid and 
consistent procedure for separation of the tissue into regions.  Articular cartilage from 
two to three joints were used from different animals for each experiment and all 
experiments were carried out in at least triplicate.  
 
Explants from each region were placed into separate wells of a 6-well tissue culture 
plate (Corning Life Sciences; Fisher Scientific, UK) with 10% media (Dulbecco’s 
Modified Eagle Medium containing Hams F12 and glutamine (DMEM/F12 + 
Glutamax; Gibco; Invitrogen, UK).  The media were supplemented with 10% foetal 
bovine serum (FBS; Gibco), 50!g ml
-1
 gentamicin (Gibco), 50µg ml-1 ascorbic acid 
(Sigma-Aldrich) and 0.5g glucose (Sigma-Aldrich).  When dissection was complete, 
the supplemented media (media+) were removed from the wells and the finely diced 
explants were transferred, using a #23 scalpel, to zone specific tubes containing 1% 
pronase (Roche diagnostic Ltd. UK) prepared in 10ml media+ (for each joint).  
Superficial and middle zone explants were enzymatically digested in 1% pronase for 
15 minutes at 37°C followed by collagenase (Sigma-Aldrich; 300 IU; prepared with 
10 media+ [for each joint]) for 3 hours at 37°C.  Deep zone explants were treated with 
1% pronase in media+ for 1 hour at 37°C followed by collagenase (900 
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hours at 37°C.  The enzymatic digestion was carried out on a rotating platform to 
ensure uniform digestion of the tissue.  The resultant cell suspension was filtered 
through a 40µm cell strainer (Falcon, BD Biosciences) and the filtered cell suspension 
was centrifuged for 5 minutes at 400xg.  The supernatant was removed and the cell 
pellet re-suspended in media+.  The cells were counted using a haemocytometer and 
an average cell count calculated.  Ten µl cell suspension was added to one chamber of 
the slide and four counts performed and an average recorded.  Cell number was 
determined using the following calculation: 
Cells per ml = average cell count x dilution factor x 10
4
 
Total number of cells = Cells ml
-1
 x total volume of cells (ml) 
 
Cells were re-suspended at 1.0 x 10
6 
cells ml
-1
 and 5 x 10
6
 cells were transferred to 
each 175cm
2
 flask (Corning Life Sciences) with the addition of a further 15ml of 
media+ (20ml total).  The cells were cultured overnight in a humidified incubator at 
37°C containing 5% CO2.  Some of the cells were immunolabelled following the cell 
count to determine if cell surface expression was present immediately following 
enzymatic digestion, an average of 6 x 10
6
, 5 x 10
6
 and 18 x 10
6
 cells were obtained 
from the superficial, middle and deep zones respectively. 
 
 
3.2.2 Bone marrow extraction 
 
Bone marrow contains populations of cells that are able to differentiate along 
mesenchymal lineages.  These MSCs can be characterised by their adherence to 
plastic, efficacy to form colonies and the expression of a number of cell surface 
antigens including CD29, CD44, CD49e, CD90, CD105, CD117 and CD166.  MSCs 
are negative for hematopoietic lineage markers CD4, CD14 and CD45 (Flores-Torales 
et al., 2010, Bocelli-Tyndall et al., 2006, Lee et al., 2009, Romanov et al., 2005).  
Notch1 has also been identified as a MSC marker (Hiraoka et al., 2006).  These MSCs 
would provide a positive control for the stem cell and differentiation markers used in 
the current study. 
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Bone marrow was isolated from immature bovine metacarpi.  The limb was washed 
as previously described and all soft tissue removed using a #23 scalpel before 
bisecting with a band saw under sterile conditions.  Sawing produces a small amount 
of bone debris, which can contaminate the marrow.  Bone debris was removed using a 
sterile spatula ensuring minimum contamination of the bone marrow. 
 
The bone marrow was removed using a second sterile spatula into a sterile 100mm 
diameter culture dish (Corning Life Sciences).  Under sterile conditions, 10ml DMEM 
containing 0.05mg ml
-1
 gentamicin (media+G) was added to the culture dish, the 
marrow was vigorously mixed using a pipette to disperse the tissue.  The suspension 
was transferred to a 50ml tube (Corning Life Sciences), the culture dish was washed a 
further two times with 10ml media+G to remove as many cells as possible from the 
dish.  The tube containing the cell suspension was gently inverted, allowing the fat to 
float to the top of the tube.  The cell suspension beneath the fat was then strained 
(approximately 20ml) into a fresh sterile 50ml tube through a 40µm cell strainer.  Any 
cells remaining in the first tube were rinsed with a further 20ml of media+G and the 
separation by inversion and straining repeated.  The cell suspension was centrifuged 
at 300xg for 5 minutes and the pellet re-suspended in 20ml media+G containing 10% 
FBS; the cell suspension was transferred to two 75cm
2
 flasks (Corning Life Sciences), 
and a further 10ml 10% media+G added to each flask.  The cells were incubated at 
37°C with 5% CO2 for four days. 
 
After four days, the media containing all non-adherent cells was extracted and the 
adherent cells washed twice in media+G.  After seven days in culture, the media were 
supplemented with 5ng ml
-1
 fibroblast growth factor (FGF2), changing the media 
every second day.  The bone marrow stromal cells were maintained until required for 
flow cytometry analysis when 0.5-1.0 x 10
6
 cells were used per antibody (dilutions 
shown in Table 3.1 and 3.2). 
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Antigen 
recognised 
Clone 
Name 
Conjugated 
fluorophore 
Source IgG 
CD29  TDM29 FITC Millipore, UK Mouse 
CD44  IM7 FITC 
BD Biosciences, 
UK 
Rat 
CD49e  SAM-1 R-PE Millipore, UK Mouse 
CD90  CT-TH1 FITC Invitrogen, UK Rat 
CD105  SN6 APC* Invitrogen, UK Mouse 
CD117  104D2 APC Invitrogen, UK Mouse 
CD166  3A6 R-PE** Ancell, USA Mouse 
 
Table 3.1: Conjugated primary antibodies used 
The table shows the range of directly conjugated antibodies used; these antibodies 
were all used at 10µg ml
-1
. 
*APC = Allophycocynanin 
**R-PE = R-Phycoerythrin 
 
 
3.2.3 Direct immunofluorescence for flow cytometry 
 
All centrifugation steps were performed at 400xg for 3 minutes unless otherwise 
stated.  Plated cells were washed with 10ml PBS.  Accutase (10ml; Sigma-Aldrich) 
was added to the cells and incubated at 37°C for 5-10 minutes or until the cells 
became rounded and were beginning to detach from the flask.  Detached cells were 
transferred to 50ml tubes.  The flasks were washed with 10ml PBS to ensure all cells 
had been obtained and the liquid aspirated to the relevant 50ml tube.  The cells were 
centrifuged and supernatant removed. 
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Cells were re-suspended in 1ml PBS containing 0.1% BSA (PBS/BSA) and counted 
using a haemocytometer as described previously.  Cells were re-suspended at 1 x 10
6
 
cells ml
-1
 and 1ml of the cell suspension was transferred to 1.5ml tubes, the cells were 
centrifuged and the supernatant aspirated.  Conjugated primary antibody or IgG-
matched control was added to each tube (dilutions shown in Table 3.1), re-suspended 
and incubated for 45 minutes at 4˚C (in the dark).  Following incubation the cells 
were centrifuged, and washed twice in PBS/BSA with a centrifuge step between each 
wash.  Finally, cells were re-suspended in 0.5ml PBS/BSA filtered through 30µm 
filters (Celltrics; Partec, UK) into 12mm FACS tubes (Falcon, BD Biosciences, UK) 
and viewed on a BD FACS Canto flow cytometer (BD Biosciences). 
 
 
3.2.4 Indirect immunofluorescence for flow cytometry 
 
All centrifugation steps were performed at 400xg for 3 minutes unless otherwise 
stated.  Non-conjugated antibodies were tested using fixed and live cells with the 
exception of anti-Msx1, which was only tested using fixed cells.  Msx1 is only 
present within the nucleus of the cell and antibody binding requires a compromised 
plasma membrane and, therefore, would not be detected in viable cells.  Cells were 
fixed using 2% PFA; this method was found to be the superior fixation method of 
tissue sections and is a common and reliable fixative for cell analysis using flow 
cytometry.  For live cells, all antibodies and controls were prepared in PBS/BSA and 
5% normal blocking serum.  Antibodies and controls added to fixed cells were 
prepared in PBS/T and 5% normal blocking serum (dilutions shown in Table 3.2). 
 
Plated cells were washed in 10 ml PBS and detached using Accutase and centrifuged 
as described previously.  To fix the cells, 1ml cold 2% PFA was added and the cells 
incubated for 2 minutes before centrifuging.  Secondary antibody was prepared in 
advance with bovine serum (10!g ml
-1
), incubating for 1 hour at 4°C.  Following 
fixation, the cells were re-suspended in 1ml PBS/T and counted using a 
haemocytometer. 
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Relevant blocking serum was added to the tube containing the cells.  The sample was 
mixed by pipetting and the mixture incubated for 15 minutes at 4°C.  The cell 
suspension was transferred to 1.5ml tubes and centrifuged.  Primary antibody or IgG-
matched controls were added to each tube, re-suspended and the cells incubated for 
30 minutes at 4°C.  Following incubation, the cells were washed three times in 
PBS/T, centrifuged between each wash, supernatant removed and re-suspended in 
PBS/T.  Secondary antibody was added to each tube (dilutions shown in Table 3.2), 
re-suspended and incubated for 30 minutes at 4˚C in the dark.  Following incubation, 
the cells were centrifuged and washed twice in PBS/T.  Finally, the cells were re-
suspended in 1ml PBS and passed through a 30µm filter to remove cell aggregates 
and examined on a BD FACS Canto flow cytometer. 
 
For labelling of live cells, all reagents and wash steps were carried out in PBS/BSA. 
 
Control samples were processed as described, omitting primary antibody and, instead, 
incubating the cells with appropriate IgG-matched controls, PBS/T (fixed cells) or 
PBS/BSA (live cells). 
 
Antigen 
recognised 
Clone 
name 
IgG 
Secondary 
antibody 
Dilution 
Blocking 
serum 
Delta  F-15 Goat 
Rabbit anti goat 
FITC 
1:200 Rabbit 
Jagged1  H-66 Rabbit 
Goat anti-rabbit 
FITC 
1:100 Goat 
Jagged2  N-19 Goat 
Rabbit anti goat 
FITC 
1:200 Rabbit 
Msx1  N-20 Goat 
Rabbit anti goat 
FITC 
1:200 Rabbit 
Notch1  C-20 Goat 
Rabbit anti goat 
FITC 
1:200 Rabbit 
 
Table 3.2: Non-conjugated primary antibodies used 
The table shows the range of non-conjugated antibodies used, all were used at 5 µg 
ml
-1
; the concentrations of secondary antibody are shown in the table. 
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3.2.5 Flow cytometry analysis 
 
Flow cytometry was performed using a BD Canto dual laser bench top flow 
cytometer, equipped with 633nm and 488nm lasers and BD FACS Diva software 
(v 5.0.3).  Single colour analysis was performed using primary antibodies conjugated 
to FITC, PE or APC, excitation and emission spectra for these fluorophores can be 
seen in Figure 3.2. 
 
 
 
 
Figure 3.2:  Fluorophore spectra 
Spectra illustrating the excitation spectra (dotted lines) and emission spectra (solid 
filled histogram) of FITC (green) PE (yellow) and APC (red).  The highlighted 
rectangular area on each graph demonstrates the band pass filter used for each 
fluorophore (adapted from BD Biosciences 2011). 
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Cells were analysed initially for forward scatter (FSC) and side scatter (SSC).  FSC is 
a measure of relative cell size and SSC a measure of relative granularity or 
internal/cytoplasmic complexity.  Density dot-plots were used to show the distribution 
of cells using the FSC and SSC parameters, voltages were adjusted so that all the cells 
were aligned optimally (Figure 3.3 A).  An area of concentrated pixels (cells) was 
selected using a gate (Figure 3.3 A), which enables a sub-population to be analysed 
independently.  This is an important step in flow cytometry analysis as it reduces the 
contamination from dead cells and cell doublets.  Dead cells can be especially 
adhesive, non-specifically binding antibody, leading to false positives.  An increased 
level of fluorescence is also observed with cell doublets.  It must be noted that during 
the processing of each sample the whole, un-gated population was also analysed to 
ensure no sub-populations or labelled cells were omitted. 
 
 
 
Figure 3.3: Diagram illustrating gating and voltage adjustments 
The dot-plot illustrates a typical position of the cell population and gating used (A). 
Highest density cells are displayed as red pixels and lowest density cells are displayed 
as blue pixels.  The cells were positioned away from the axes and cell debris.  The 
gated population from the negative control sample was set so that the median 
fluorescence was close to the second logarithmic decade (grey line; B), the 
distribution of labelled cells (blue) was then overlaid and compared. 
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To illustrate antibody labelling, single parameter histograms were used to display 
relative fluorescence intensity on the x-axis and the cell count of the y-axis.  The 
voltages were adjusted for individual fluorophores so that the negative controls were 
set to the second logarithmic (log) decade (Figure 3.3 B).  If voltages are not set 
correctly, control samples can be set too low to analyse or conversely immunolabelled 
cells could be above the level of detection by the flow cytometer.  Instrument settings 
were adjusted using either IgG-matched controls or unstained cell samples.  Labelling 
of cells was assessed by percentage shift or fluorescent intensity of fluorescently 
labelled cells compared to control cells. 
 
Results were tested for statistical significance using a paired, one-tailed t-test where 
the geometric mean fluorescent intensity (MFI) of control cells was compared with 
that of the immunolabelled cells.  To compare MFI ratios between freshly isolated 
cells and cells cultured in monolayer overnight, statistical significance was tested 
using an unpaired, two-tailed Student’s t-test. 
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3.3 Results 
 
 
3.3.1 Immunofluorescence 
 
For this study, we used Accutase to detach the chondrocytes cultured overnight.  
Accutase contains proteolytic and collagenolytic enzymes and is routinely used for 
analysis of cell surface markers by flow cytometry.  Previous studies have used 
trypsin/EDTA (ethylenediaminetetraacetic acid) to detach chondrocytes from plastic, 
however, a small decrease in expression of cell surface markers was observed 
compared to detachment with EDTA. 
 
All data were acquired using BD FACS Diva software but all further analysis was 
completed using FlowJo (version 9.2, Tree Star, Inc., Oregon, USA) from data stored 
in FCS 3.0 format.  Gating of cells based on size and granularity (FSC and SSC) was 
set manually and gated cells analysed for fluorescence intensity.  Where bimodal 
distributions of fluorescent intensity were present, the results were displayed as 
percentage labelled and MFI.  The percentage labelled were defined by placing a 
delineator at the limit of the control sample fluorescence (between 0.5 and 1.0%), any 
cells above this level were designated as positively labelled.  Where fluorescent 
labelling of cells was displayed as a unimodal distribution the MFI only was 
displayed, as the test sample distribution often overlaps that of the control. 
 
Results shown are representative of labelling seen for each antibody, with the typical 
or central distributions shown.  Each antibody was tested at least in triplicate from at 
least three animals and controls comprised unlabelled cells or IgG-matched controls.  
Secondary antibodies used with non-conjugated primary antibodies, were pre-
incubated with bovine serum as this resulted in lower levels of autofluorescence. 
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3.3.2 Freshly isolated superficial zone chondrocytes 
 
Cells were isolated using pronase and collagenase and immediately labelled with the 
relevant conjugated or non-conjugated primary antibody, 1.0 x 10
6
 cells were used for 
each antibody. 
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3.3.3 Immunofluorescence with conjugated antibodies 
 
CD29 (Integrin !1) 
 
All cells incubated with CD29 antibody exhibited increased MFI relative to controls 
(5.52 fold; Table 3.3). Gated cells, labelled with CD29 were plotted against a control 
sample and the distributions compared (Figure 3.4B).  The geometric mean of CD29 
was significantly different to the control cells (P= 0.0296). 
 
 
 
Figure 3.4: CD29 FITC expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 99% 
of the total population.  The gated control (grey line) and CD29 (blue) labelled cells 
were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD29 FITC MFI ratio 
Sample 1 120.00 785.00 6.54 
Sample 2 80.90 415.00 5.13 
Sample 3 83.00 406.00 4.89 
  Mean 5.52 
 
Table 3.3: CD29 FITC expression from freshly isolated surface cells 
Table contains the MFI for each cell sample acquired and the MFI ratio between test 
and control.  The highlighted region indicates the sample represented in the histogram 
(Figure 3.4B). 
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CD44 (Hyaluronan receptor) 
 
When cells were incubated with CD44 a small increase in MFI relative to the controls 
was observed (1.1 fold; Figure 3.5B and Table 3.4).  This increase in fluorescence 
was shown to be statistically different to the control (P = 0.0368). 
 
 
 
Figure 3.5: CD44 FITC expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
98.9% of the total population.  The gated control (grey line) and CD44 (green) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD44 FITC MFI ratio 
Sample 1 67.20 69.40 1.03 
Sample 2 120.00 140.00 1.17 
Sample 3 80.90 89.80 1.11 
Sample 4 83.00 91.80 1.11 
  Mean 1.10 
 
Table 3.4: CD44 FITC expression from freshly isolated surface cells 
Table contains the geometric fluorescence intensity for each sample acquired and the 
MFI ratio.  The highlighted region indicates the sample represented in the histogram 
(Figure 3.5B). 
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CD49e (Integrin !5) 
 
The distribution of the fluorescent intensity between CD49e and control cells was not 
statistically different (P = 0.1781; Figure 3.6 and Table 3.5). 
 
 
 
Figure 3.6: CD49e PE expression from freshly isolated surface cells 
Gated cells, excluding clumped cells and debris (A) comprised 94.9% of the total 
population analysed.  The gated control (grey line) and CD49e (pink) labelled cells 
were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD49e PE MFI ratio 
Sample 1 68.70 69.30 1.01 
Sample 2 69.60 74.00 1.06 
Sample 3 79.30 79.80 1.01 
  Mean 1.03 
 
Table 3.5: CD49e PE expression from freshly isolated surface cells 
Table contains the MFI values for each sample recorded and the MFI ratio of CD49e 
labelled versus control cells.  The highlighted region indicates the values for the 
histogram shown (Figure 3.6B). 
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CD90 (Thy-1) 
 
Gated cells, labelled with CD90 were plotted against a control sample and the 
distributions compared (Figure 3.7B).  Cells labelled with CD90 exhibited increased 
MFI compared with controls (1.23 fold; Figure 3.7B and Table 3.6).  The MFI of 
CD90 was significantly different to the control cells (P= 0.0237). 
 
 
 
Figure 3.7: CD90 FITC expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 99% 
of the total population.  The gated control (grey line) and CD90 (orange) labelled cells 
were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD90 FITC MFI ratio 
Sample 1 120.00 152.00 1.27 
Sample 2 80.90 99.20 1.23 
Sample 3 83.00 99.00 1.19 
  Mean 1.23 
 
 
Table 3.6: CD90 FITC expression from freshly isolated surface cells 
Table contains the geometric mean values for each sample tested and the MFI ratio.  
The highlighted region indicates the sample represented in the histogram (Figure 
3.7B). 
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CD105 (Endoglin) 
 
The distribution of the fluorescent intensity of both CD105 labelled and control cells 
were not statistically different (P = 0.0558; Figure 3.8B and Table 3.7). 
 
 
 
Figure 3.8: CD105 APC expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
96.4% of the total population.  The gated control (grey line) and CD105 APC (pink) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  CD105 Control CD105 APC MFI ratio 
Sample 1 55.60 60.70 1.09 
Sample 2 73.00 98.90 1.35 
Sample 3 73.30 99.20 1.35 
  Mean 1.27 
 
 
Table 3.7: CD105 APC expression from freshly isolated surface cells 
Table contains the MFI values for each sample acquired and the MFI ratio between 
labelled cells and control.  The highlighted region indicates the sample represented in 
the histogram (Figure 3.8B). 
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CD117 (c-kit) 
 
The fluorescent intensity of CD117 labelled cells was equivalent to that of the control 
cells (Figure 3.9 and Table 3.8).  The geometric means were not shown to be 
statistically different (P = 0.0763). 
 
 
 
Figure 3.9: CD117 APC expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
96.2% of the total population.  The gated control (grey line) and CD117 (green) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  CD117 Control CD117 APC MFI ratio 
Sample 1 55.60 61.40 1.10 
Sample 2 73.00 109.00 1.49 
Sample 3 73.30 128.00 1.75 
  Mean 1.45 
 
 
Table 3.8: CD117 APC expression from freshly isolated surface cells 
Table contains the geometric mean values for each sample recorded and the MFI ratio 
of labelled cells compared to controls.  The highlighted region indicates the sample 
represented in the histogram (Figure 3.9B). 
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CD166 (ALCAM) 
 
The fluorescent intensity of CD166 labelled cells was equivalent to that of the control 
(Figure 3.10B).  Small increases in the geometric mean were seen with CD166 (Table 
3.9) but these were shown not to be significantly different to the control (P = 0.0633) 
 
 
 
Figure 3.10: CD166 PE expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
98.3% of the total population.  The gated control (grey line) and CD166 (green) 
labelled cells were then analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD166 PE MFI ratio 
Sample 1 84.30 91.20 1.08 
Sample 2 67.10 69.00 1.03 
Sample 3 88.70 99.50 1.12 
  Mean 1.08 
 
Table 3.9: CD166 PE expression from freshly isolated surface cells 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.10B). 
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3.3.4 Immunofluorescence with non-conjugated antibodies 
 
Notch1 
 
All fixed cells incubated with Notch1 antibody exhibited increased MFI relative to 
controls (3.57 fold); a small increase was observed with live cells (Figure 3.11 and 
Table 3.10).  The MFI of Notch1 labelled cells was significantly different to the 
control cells (live P= 0.0110, fixed P = 0.0047). 
 
 
 
Figure 3.11: Notch1 expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Notch1 (blue) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Notch1 
MFI 
ratio    Control Notch1 
MFI 
ratio 
Sample 1 127.00 141.00 1.11  Sample 1 191.00 720.00 3.77 
Sample 2 146.00 167.00 1.14  Sample 2 168.00 544.00 3.24 
Sample 3 101.00 125.00 1.24  Sample 3 178.00 658.00 3.70 
  Mean 1.16    Mean 3.57 
 
Table 3.10: Notch1 expression from freshly isolated surface cells 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms above (Figure 3.11). 
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Delta1 
 
There was an increase in the overall fluorescent intensity of fixed cells labelled with 
the Delta1 antibody.  The distribution of fluorescent intensity of Delta1 and control 
cells appeared to be similar with live cells, however, there was a small difference in 
MFI (Figure 3.12 and Table 3.11).  The MFI of Delta1 labelled cells was significantly 
different to the control cells (live P= 0.0009, fixed P = 0.0060). 
 
 
 
Figure 3.12: Delta1 expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Delta1 (green) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Delta 
MFI 
ratio    Control Delta 
MFI 
ratio 
Sample 1 127.00 135.00 1.06  Sample 1 191.00 539.00 2.82 
Sample 2 146.00 154.00 1.05  Sample 2 168.00 674.00 4.01 
Sample 3 101.00 108.00 1.07  Sample 3 178.00 660.00 3.71 
  Mean 1.06    Mean 3.51 
 
Table 3.11: Delta1 expression from freshly isolated surface cells 
The table contains the geometric mean values for each sample and the MFI ratio 
between labelled and control cells.  The highlighted regions indicate the values used 
in the histograms (Figure 3.12). 
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Jagged1 
 
Jagged1 labelling was not observed with live cells, however, all fixed cells labelled 
with Jagged1 exhibited increased MFI relative to controls (2.97 fold; Figure 3.13 and 
Table 3.12).  The geometric mean of fixed Jagged1 cells was significantly different to 
the control cells (P = 0.0138), however, live labelled cells were not statistically 
different to the controls (P= 0.1572). 
 
 
 
Figure 3.13: Jagged1 expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Jagged1 (green) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Jagged1 
MFI 
ratio    Control Jagged1 
MFI 
ratio 
Sample 1 125.00 111.00 0.89  Sample 1 187.00 455.00 2.43 
Sample 2 136.00 136.00 1.00  Sample 2 164.00 563.00 3.43 
Sample 3 157.00 154.00 0.98  Sample 3 241.00 736.00 3.05 
  Mean 0.96    Mean 2.97 
 
Table 3.12: Jagged1 expression from freshly isolated surface cells 
The table contains the MFI values for each sample carried out as well as the MFI ratio 
for both live and fixed cells. The highlighted regions are shown in the histograms 
above (Figure 3.13). 
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Jagged2 
 
All fixed cells labelled with Jagged2 antibody exhibited increased MFI relative to 
controls (2.21 fold; Table 3.13), however, no difference was observed between live 
cells and their controls. Gated cells, labelled with Jagged2 were plotted against a 
control sample and the distributions compared (Figure 3.14A and B).  The geometric 
mean of fixed Jagged2 cells was significantly different to the control cells (P= 
0.0076) the live cells were not statistically different to the controls (P= 0.0784). 
 
 
 
Figure 3.14: Jagged2 expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Jagged2 (orange) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Jagged2 
MFI 
ratio    Control Jagged2 
MFI 
ratio 
Sample 1 127.00 132.00 1.04  Sample 1 191.00 356.00 1.86 
Sample 2 146.00 148.00 1.01  Sample 2 168.00 390.00 2.32 
Sample 3 101.00 102.00 1.01  Sample 3 178.00 435.00 2.44 
  Mean 1.02    Mean 2.21 
 
Table 3.13: Jagged2 expression from freshly isolated surface cells 
The table contains the geometric mean values for each sample acquired and the MFI 
ratio between test and control.  The highlighted regions indicate the samples used in 
the histograms (Figure 3.14). 
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Msx1 
 
All cells incubated with Msx1 antibody exhibited increased MFI relative to controls 
(4.75 fold; Figure 3.15 and Table 3.14).  The geometric mean of Msx1 was 
significantly different to the control cells (P= 0.0264). 
 
 
 
Figure 3.15: Msx1 expression from freshly isolated surface cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Msx1 (blue) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Fixed cells 
  Control Msx1 MFI ratio 
Sample 1 191.00 672.00 3.52 
Sample 2 168.00 704.00 4.19 
Sample 3 178.00 1164.00 6.54 
  Mean 4.75 
 
Table 3.14: Msx1 expression from freshly isolated surface cells 
The table contains the geometric mean values for each sample recorded and their MFI 
ratio.  The highlighted region is shown in the histogram above (Figure 3.15). 
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3.3.5 Chondrocytes cultured in monolayer for 24 hours 
Following enzymatic digestion, 5 x 10
6
 cells were transferred to each 175cm
2
 flask 
and incubated for 24 hours in 20ml media+.  Cells were then labelled with the 
relevant conjugated or non-conjugated primary antibody, 1.0 x 10
6
 cells were used for 
each antibody. 
 
 
3.3.6 Immunofluorescence with conjugated antibodies 
 
CD29 (Integrin !1) 
 
All cells labelled with CD29 antibody exhibited increased MFI relative to controls 
(12.74 fold).  Gated cells, labelled with CD29 were plotted against a control sample 
and the distributions compared (Figure 3.16B).  The geometric mean of CD29 was 
significantly different to the control cells (P= 0.0056). 
 
 
 
Figure 3.16: CD29 FITC expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
94.2% of the total population.  The gated control (grey line) and CD29 (blue) labelled 
cells were analysed for fluorescent intensity (B). 
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Geometric mean values 
  Control CD29 FITC MFI ratio 
Sample 1 95.10 1271.00 13.36 
Sample 2 104.00 1485.00 14.28 
Sample 3 99.30 1049.00 10.56 
  Mean 12.74 
 
Table 3.15: CD29 FITC expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.16B). 
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CD44 (Hyaluronan receptor) 
 
A sub-population was observed when cells were immunolabelled with CD44 resulting 
in a bimodal distribution (Figure 3.17B).  There was a MFI increase of 37.25 fold 
between labelled and unlabelled cells (Figure 3.17B and Table 3.16).  The MFI of 
CD44 labelled cells (+ve) was significantly different to the negative population (-ve; 
P= 0.0164), the mean percentage of cells expressing CD44 was 47.00%. 
 
 
 
Figure 3.17: CD44 FITC expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
94.7% of the total population.  The gated control (grey line) and CD44 (green) 
labelled cells were analysed for fluorescent intensity (B).  The bimodal distribution 
was divided into unlabelled cells (-ve) and labelled cells (+ve). 
 
Geometric mean values 
  
CD44 
Control 
CD44 
-ve 
CD44 
+ve 
MFI ratio 
+ve/-ve 
MFI ratio 
-ve/control 
% 
+ve 
Sample 1 86.00 95.80 2743.00 28.63 1.11 27.20 
Sample 2 95.10 110.00 4437.00 40.34 1.16 58.30 
Sample 3 104.00 125.00 5346.00 42.77 1.20 55.50 
   Mean 37.25 1.16 47.00 
 
Table 3.16: CD44 FITC expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratios between 
CD44+ve and CD44-ve, and CD44-ve and control cells.  The highlighted region 
indicates the sample represented in the histogram (Figure 3.17B). 
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CD49e (Integrin !5) 
 
All cells incubated with CD49e antibody exhibited increased geometric mean relative 
to controls (1.71 fold; Figure 3.18B and Table 3.17).  The geometric mean of CD49e 
was significantly different to the control cells (P= 0.0052). 
 
 
 
Figure 3.18: CD49e PE expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
90.3% of the total population.  The gated control (grey line) and CD49e (pink) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD49e PE MFI ratio 
Sample 1 108.00 172.00 1.59 
Sample 2 54.20 105.00 1.94 
Sample 3 54.20 101.00 1.86 
Sample 4 54.20 79.10 1.46 
  Mean 1.71 
 
Table 3.17: CD49e PE expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.18B). 
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CD90 (Thy-1) 
 
All cells incubated with CD90 antibody exhibited a small increase in MFI relative to 
controls (1.32 fold; Figure 3.19 and Table 3.18). Gated cells, labelled with CD90 
were plotted against a control sample and the distributions compared (Figure 3.19B).  
The geometric mean of CD90 was significantly different to the control cells (P= 
0.0007). 
 
 
 
Figure 3.19: CD90 FITC expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 93% 
of the total population.  The gated control (grey line) and CD90 (orange) labelled cells 
were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD90 FITC MFI ratio 
Sample 1 86.00 120.00 1.40 
Sample 2 95.10 118.00 1.24 
Sample 3 104.00 138.00 1.33 
Sample 4 99.30 131.00 1.32 
  Mean 1.32 
 
Table 3.18: CD90 FITC expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.19B). 
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CD105 (Endoglin) 
 
Cells incubated with CD105 antibody exhibited increased MFI relative to controls 
(1.74 fold; Figure 3.20 and Table 3.19).  The geometric mean of CD105 was 
significantly different to the control cells (P = 0.0048). 
 
 
 
Figure 3.20: CD105 APC expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
90.8% of the total population.  The gated control (grey line) and CD105 (pink) 
labelled cells were then analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD105 APC MFI ratio 
Sample 1 55.90 100.00 1.79 
Sample 2 90.80 160.00 1.76 
Sample 3 102.00 192.00 1.88 
Sample 4 90.10 138.00 1.53 
  Mean 1.74 
 
Table 3.19: CD105 APC expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
labelled and control cells.  The highlighted region indicates the sample represented in 
the histogram (Figure 3.20B). 
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CD117 (c-kit) 
 
All cells incubated with CD117 antibody exhibited a small increase in MFI relative to 
controls (2.10 fold; Figure 3.21 and Table 3.20). Gated cells, labelled with CD117 
were plotted against a control sample and the distributions compared (Figure 3.21B).  
The geometric mean of CD117 was significantly different to the control cells (P= 
0.0035). 
 
 
 
Figure 3.21: CD117 APC expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
90.8% of the total population.  The gated control (grey line) and CD29 (green) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD117 APC MFI ratio 
Sample 1 55.90 113.00 2.02 
Sample 2 71.90 180.00 2.50 
Sample 3 71.90 145.00 2.02 
Sample 4 71.90 135.00 1.88 
  Mean 2.10 
 
Table 3.20: CD117 APC expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.21B). 
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CD166 (ALCAM) 
 
All cells incubated with CD166 antibody exhibited increased MFI relative to controls 
(3.83 fold; Figure 3.22B and Table 3.21).  The geometric mean of CD29 was 
significantly different to the control cells (P= 0.0125). 
 
 
 
Figure 3.22: CD166 PE expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris (A) this gate accounted for 
93.2% of the total population.  The gated control (grey line) and CD166 (green) 
labelled cells were analysed for fluorescent intensity (B). 
 
Geometric mean values 
  Control CD166 PE MFI ratio 
Sample 1 126.00 368.00 2.92 
Sample 2 119.00 524.00 4.40 
Sample 3 134.00 557.00 4.16 
  Mean 3.83 
 
Table 3.21: CD166 PE expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in the 
histogram (Figure 3.22B). 
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3.3.7 Immunofluorescence with non-conjugated antibodies 
 
Notch1 
 
The fluorescent intensity of both fixed and live cells labelled with Notch1 was not 
statistically different to the controls (fixed; P = 0.2963 and live P= 0.0518; Figure 
3.23 and Table 3.22). 
 
 
 
Figure 3.23: Notch1 expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Notch1 (blue) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Notch1 
MFI 
ratio    Control Notch1 
MFI 
ratio 
Sample 1 117.00 116.00 0.99  Sample 1 126.00 261.00 2.07 
Sample 2 110.00 119.00 1.08  Sample 2 270.00 201.00 0.74 
Sample 3 198.00 205.00 1.04  Sample 3 187.00 180.00 0.96 
Sample 4 133.00 138.00 1.04  Sample 4 114.00 158.00 1.39 
  Mean 1.04    Mean 1.29 
 
Table 3.22: Notch1 expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms (Figure 3.23). 
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Delta1 
 
Delta1 expression was not observed with live or fixed cells, (Figure 3.24 and Table 
3.23).  The geometric mean of Delta1 cells was not significantly different to the 
control cells (fixed; P = 0.4721 and live; P= 0.1039). 
 
 
 
Figure 3.24: Delta1 expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Delta (green) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Delta 
MFI 
ratio    Control Delta 
MFI 
ratio 
Sample 1 102.00 118.00 1.16  Sample 1 126.00 156.00 1.24 
Sample 2 110.00 117.00 1.06  Sample 2 270.00 181.00 0.67 
Sample 3 198.00 199.00 1.01  Sample 3 187.00 175.00 0.94 
  Mean 1.08  Sample 4 114.00 196.00 1.72 
       Mean 1.14 
 
Table 3.23: Delta1 expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms above (Figure 3.24). 
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Jagged1 
 
Jagged1 expression was not observed with live cells, however, all fixed cells labelled 
with Jagged1 exhibited increased MFI relative to controls (3.73 fold; Figure 3.25 and 
Table 3.24).  The geometric mean of fixed Jagged1 cells was significantly different to 
the control cells (P = 0.0467); the live cells were not statistically different (P= 
0.0635). 
 
 
 
Figure 3.25: Jagged1 expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Jagged1 (green) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Jagged1 
MFI 
ratio    Control Jagged1 
MFI 
ratio 
Sample 1 207.00 218.00 1.05  Sample 1 2707.00 7055.00 2.61 
Sample 2 227.00 239.00 1.05  Sample 2 513.00 2469.00 4.81 
Sample 3 197.00 231.00 1.17  Sample 3 574.00 2160.00 3.76 
  Mean 1.09    Mean 3.73 
 
Table 3.24: Jagged1 expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms above (Figure 3.25). 
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Jagged2 
 
Jagged2 expression was not observed with live or fixed cells, (Figure 3.26 and Table 
3.25).  The geometric mean of Jagged2 cells was not significantly different to the 
control cells (fixed; P = 0.4863 and live; P= 0.2643). 
 
 
 
Figure 3.26: Jagged2 expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Jagged2 (orange) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Live cells  Fixed cells 
  Control Jagged2  
MFI 
ratio    Control Jagged2  
MFI 
ratio 
Sample 1 102.00 106.00 1.04  Sample 1 126.00 137.00 1.09 
Sample 2 110.00 106.00 0.96  Sample 2 270.00 220.00 0.81 
Sample 3 133.00 141.00 1.06  Sample 3 187.00 177.00 0.95 
  Mean 1.02  Sample 4 114.00 160.00 1.40 
       Mean 1.06 
 
Table 3.25: Jagged2 expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms above (Figure 3.26). 
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Msx1 
 
Msx1 expression was not observed.  The geometric mean of Msx1 labelled cells was 
not statistically different to the control cells (P = 0.4796; Figure 3.27 and Table 3.26). 
 
 
 
Figure 3.27: Msx1 expression from cells plated in monolayer overnight 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and Notch1 (blue) labelled cells were analysed for fluorescent intensity. 
 
Geometric mean values 
Fixed cells 
  Control Msx1 MFI ratio 
Sample 1 270.00 175.00 0.65 
Sample 2 187.00 169.00 0.90 
Sample 3 114.00 217.00 1.90 
  Mean 1.15 
 
Table 3.26: Msx1 expression from cells plated in monolayer overnight 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted regions indicate the samples represented in the 
histograms above (Figure 3.27). 
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3.3.8 Expression of freshly isolated cells compared with cells cultured for 24 hours 
(conjugated antibodies) 
 
When the mean MFI of cells cultured for 24 hours was compared to freshly isolated 
cells an increase was observed with CD29 (P = 0.0042), CD44 (P = 0.0002), CD49e 
(P = 0.0037), CD105 (P = 0.0090), CD117 (P = 0.0331) and CD166 (P = 0.0039) 
(Figure 3.28). 
 
 
 
Figure 3.28: Histogram of mean MFI of conjugated antibodies 
The graph illustrates the mean MFI of cells immunolabelled immediately following 
enzymatic digestion and cells cultured for 24 hours in monolayer.  Significant 
differences in MFI between the time points are represented by * (P < 0.05), ** (P < 
0.01) or *** (P < 0.001). 
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3.3.9 Expression of freshly isolated cells compared with cells cultured for 24 hours 
(non-conjugated antibodies) 
 
When the mean MFI of cells cultured for 24 hours was compared to freshly isolated 
cells a decrease was observed with fixed cells Notch1 (P = 0.0017), Delta1 (P = 
0.0020), Jagged2 (P = 0.0028) and Msx1 (P = 0.0222) (Figure 3.29).  The only 
significant difference with live cells was seen between the Notch1 time points, with a 
decrease in the mean MFI when cells cultured for 24 hours were compared to freshly 
isolated cells (P = 0.0243). 
 
 
 
Figure 3.29: Histogram of mean MFI of non-conjugated antibodies 
The graph illustrates the mean MFI of cells immunolabelled immediately following 
enzymatic digestion and cells immunolabelled following 24-hour culture in 
monolayer.  Each of the time points was tested on live and fixed cells.  Significant 
differences in MFI between the time points are represented by * (P < 0.05) or ** (P < 
0.01). 
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3.3.10 Zonal variation in cell surface marker expression 
 
As a number of the markers were not expressed when tested immediately following 
digestion, zonal variation was investigated after the cells were incubated for 24 hours 
in monolayer culture.  Developmental markers; Notch1, Delta1, Jagged1, Jagged2 and 
Msx1 and the cell surface receptor CD29 were not tested for zonal variation as 
immunolabelling in tissue found they were expressed in all zones (Chapter 2). 
 
The zonal variation experiments were only carried out once as a preliminary study so 
statistical analysis has not been carried out on any differences observed between 
zones. 
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CD44 (Hyaluronan receptor) 
 
When cells from each zone were labelled with CD44 antibody a sub-population of 
cells expressed the marker, resulting in a bimodal distribution (Figure 3.30).  Each 
zone differed in the percentage of CD44 labelled cells (surface = 25.2%, middle = 
42.3% and deep = 25.4%) and the MFI ratio between labelled (+ve) and unlabelled 
cells (-ve; surface = 26.19 fold, middle = 30.5 fold and deep = 9.31 fold). 
 
 
 
Figure 3.30: CD44 FITC expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD44 (green) labelled cells were analysed for fluorescent intensity.  The bimodal 
distribution was divided into unlabelled cells (-ve) and labelled cells (+ve). 
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CD49e (Integrin !5) 
 
Cells from all zones labelled with CD49e antibody, exhibited increased geometric 
mean relative to controls (surface = 1.60 fold; middle = 1.61 fold and deep = 1.40 
fold; Figure 3.31). 
 
 
 
Figure 3.31: CD49e PE expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD49e (pink) labelled cells were analysed for fluorescent intensity. 
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CD90 (Thy-1) 
 
All cells labelled with CD90 antibody exhibited a small increase in MFI relative to 
controls (surface = 1.40 fold; middle = 1.41 fold and deep = 1.35 fold; Figure 3.32).  
 
 
 
Figure 3.32: CD90 FITC expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD90 (orange) labelled cells were analysed for fluorescent intensity. 
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CD105 (Endoglin) 
 
Cells from each zone labelled with CD105 antibody exhibited increased MFI relative 
to controls (surface = 1.79 fold; middle = 2.11 fold and deep = 1.57 fold; Figure 
3.33). 
 
 
 
Figure 3.33: CD105 APC expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD105 (pink) labelled cells were analysed for fluorescent intensity. 
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CD117 (c-kit) 
 
Cells from all three zones labelled with CD117 antibody exhibited increased 
geometric mean relative to controls (surface = 2.01 fold; middle = 3.29 fold and deep 
= 1.57 fold; Figure 3.34). 
 
 
 
Figure 3.34: CD117 APC expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD117 (green) labelled cells were analysed for fluorescent intensity. 
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CD166 (ALCAM) 
 
When surface zone cells were incubated with CD166 antibody a subpopulation of 
immunolabelled cells was identified equating to 43.1% of the total population (Figure 
3.35 +ve) with a 9.66 fold increase in MFI compared with the negative cells (-ve).  
Middle and deep zones cells exhibited an increased MFI relative to controls but the 
distribution was unimodal (middle = 3.99 fold and deep = 10.32 fold; Figure 3.35). 
 
 
 
Figure 3.35: CD166 PE expression from surface, middle and deep zone cells 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and CD166 (green) labelled cells were analysed for fluorescent intensity.  The 
bimodal distribution of the surface zone cells was divided into unlabelled cells (-ve) 
and labelled cells (+ve). 
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3.3.11 Immunofluorescence with bone marrow stromal cells 
 
A number of the markers used have been reported in bone marrow stromal cells 
(BMSCs).  The cells were photographed after 6 days in monolayer culture when 
colonies are evident (Figure 3.36; A and B) and then again when the cells are 
confluent after 19 days in culture and prior to detachment with Accutase (Figure 3.36; 
C and D). 
 
 
 
Figure 3.36: Bone marrow stromal cells in monolayer culture 
Images of bone marrow stromal cells, initially forming colonies (A; low power, B; 
high power) then expanding to confluence (C; low power and D; high power). 
Scale Bars = 100µm. 
 
128 
3.3.12 Immunofluorescence of BMSCs with conjugated antibodies 
 
Gated cells were labelled, plotted against controls and the distributions compared 
(Figure 3.37).  BMSCs labelled with CD29, CD44 and CD166 displayed high 
expression levels with increases in MFI of 25.84, 104.69 and 74.74 fold respectively.  
Expression was also observed with CD49e (2.06 fold).  The remaining markers were 
only present at low levels (CD90; 1.09 fold, CD105 = 1.21 fold; and CD117 = 1.19 
fold). 
 
 
 
Figure 3.37: Cell surface marker expression from BMSCs plated in monolayer 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and immunolabelled cells (coloured) were analysed for fluorescent intensity. 
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3.3.13 Immunofluorescence of BMSCs with non-conjugated antibodies 
 
Gated cells were labelled, plotted against controls and the distributions compared 
(Figure 3.38).  Msx1 MFI was similar to the control (1.03 fold); the remaining, 
transmembrane markers (Notch1, Delta1, Jagged1 and Jagged2) were all expressed 
with marked increases in MFI relative to controls of 8.55, 4.48, 2.76 and 3.06 fold 
respectively. 
 
 
 
Figure 3.38: Non-conjugated antibody expression from BMSCs plated in monolayer 
Cells were gated, excluding clumped cells and debris.  The gated control (grey line) 
and immunolabelled cells (coloured) were analysed for fluorescent intensity. 
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3.4 Discussion 
 
 
In this Chapter, experiments were carried out using chondrocytes isolated from the 
superficial zone.  Cells isolated from the middle and deep zones were also used for 
comparison.  Chondrocytes were immunolabelled immediately following cell 
isolation or following 24 hours in monolayer culture. 
 
Freshly isolated cells were analysed using flow cytometry and the expression of cell 
surface markers (CD29, CD44, CD49e, CD90, CD105, CD117 and CD166) and 
developmental markers (Notch1, Delta1, Jagged1, Jagged2 and Msx1) studied.  Cells 
were analysed immediately following digestion in an attempt to quantify expression 
levels observed in vivo.  During enzymatic digestion, cell surface markers or 
transmembrane receptors may be cleaved resulting in reduced expression or absence 
of these markers (Diaz-Romero et al., 2005).  To determine the effects of enzymatic 
digestion, cells were also cultured for 24 hours in monolayer to enable receptor re-
expression, thus allowing us to determine the effects of pronase and collagenase 
digestion on marker expression. 
 
Following enzymatic digestion, all cells expressed CD29, comparable to data 
obtained from tissue sections in this study.  Data also correlate with labelling 
observed by Dowthwaite and colleagues, where CD29 was observed in the majority 
of bovine chondrocytes immunolabelled shortly after isolation (Dowthwaite et al., 
2004).  The high levels of CD29 expression demonstrate that this marker was either 
unaffected by the initial enzymatic digestion, or, that it was rapidly re-expressed by 
cells following digestion. 
 
Small increases in the expression of CD44 and CD90 were observed in freshly 
isolated superficial zone chondrocytes relative to controls.  The expression levels of 
CD44 were very low, varying from observations in tissue, where a small number of 
bright labelled cells were identified at the articular surface, this may suggest that the 
CD44 epitope is affected by the cell isolation procedure.  CD90 was not detected in 
tissue; the variation in expression observed in isolated cells may be due to improved 
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epitope detection in cell suspension or increased sensitivity of flow cytometry 
compared to fluorescent microscopy.  The expression of CD90 was comparable to 
labelling observed in freshly isolated human OA chondrocytes where a small number 
of cells expressed CD90 (Fickert et al., 2004). 
 
CD49e, CD105, CD117 and CD166 were not detected in freshly isolated cells.  The 
absence of expression observed with these markers in isolated cells compared to 
tissue could be due to loss of receptors during enzymatic digestion.  In a previous 
study using immature bovine chondrocytes, cells were incubated in media for a short 
time following cell isolation prior to immunolabelling.  The majority of these cells 
expressed CD49e, providing further evidence of the effects of pronase or collagenase 
on cell surface marker expression (Dowthwaite et al., 2004).  The effects of pronase 
and collagenase on receptor antigen presence were investigated by Diaz-Romero and 
colleagues (2005).  Freshly isolated cells were further incubated with pronase or 
collagenase and then immunolabelled for a selection of cell surface markers including 
CD44, CD49e, CD90, CD105 and CD166.  CD44 and CD49e were not affected by 
collagenase but CD105 was almost undetectable following collagenase incubation.  
Pronase had a much greater effect on cell surface expression, with CD44, CD49e, 
CD90, CD105 and CD166 expression all reduced or exhibiting very low detectability.  
The results from this latter study suggest that absence or low expression levels of cell 
surface markers in freshly isolated cells could be the result of the enzymatic treatment 
rather than reflecting the normal expression levels in cells.  Another study, using 
normal and OA human articular cartilage also commented on the variation in marker 
expression between cells in tissue and cells in monolayer culture.  These differences 
in marker expression may be due to enzymatic digestion, either by cleavage of 
epitopes or by preferential selection of cells during cell isolation, resulting in a 
reduction or loss of cell expressing these markers (Grogan et al., 2009). 
 
Expression of developmental markers investigated in this study show that cells fixed 
after incubation with pronase and collagenase labelled for Notch1, Delta1, Jagged1, 
Jagged2 and Msx1.  Labelling observed with freshly isolated fixed cells was 
comparable to that observed in tissue, suggesting that cell isolation by enzymatic 
digestion preserves epitopes for these particular markers.   In contrast, live freshly 
isolated cells showed a different labelling pattern.  Statistical differences were 
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observed with Notch1 and Delta1 compared to controls, however, these very small 
consistent increases in mean fluorescence were not thought to be biologically 
relevant, as the increases were very minor and mirrored that of the control cells.  No 
expression of Jagged1 or Jagged2 was observed with live cells.  As Notch1 and its 
ligands are transmembrane receptors, the epitopes are likely to be inaccessible in live 
non-permeabilised cells.  Msx1 was not tested on live cells, as this is a nuclear 
transcription factor.  The latter surface markers have not previously been described in 
freshly isolated chondrocytes. 
 
Following 24 hours in culture in monolayer, the expression of the majority of cell 
surface markers differed to that observed in freshly isolated cells.  All cells continued 
to express CD29 but the fluorescent intensity was greater than in freshly isolated 
cells, demonstrating that this marker is maintained in early monolayer culture and 
increases its expression.  There was also a significant increase in the expression of 
CD49e.  These increases in fluorescent intensity of CD29 and CD49e have previously 
been reported in immature and adult bovine as well as normal human chondrocytes 
(Dowthwaite et al., 2004, Reid et al., 2000, Diaz-Romero et al., 2005, Diaz-Romero et 
al., 2008).  CD29 and CD49e are integrins and, are thus, associated with cell-cell and 
cell-matrix interactions, therefore, increases in expression observed following 24 
hours in monolayer culture may be related to cell adhesion or matrix assembly 
(Aszodi et al., 2003). 
 
In contrast to freshly isolated cells, CD44 was observed in live chondrocytes cultured 
for 24 hours, the distribution was bimodal indicative of a sub-population of CD44 
expressing cells.  A previous study has reported a similar result (Diaz-Romero et al., 
2005, Diaz-Romero et al., 2008).  The bimodal distribution of CD44 expression 
observed following 24 hours in culture is most likely due to a subset of chondrocytes 
initiating adhesion to the plastic (Knudson and Knudson, 2004). 
 
The expression levels of the remaining cell surface markers (CD105, CD117 and 
CD166) were all low, indicating weak labelling, this contrasted with freshly isolated 
cells that did not label for these markers.  Unlike the current study, Diaz-Romero and 
co-workers (2005) observed unimodal distributions with all cell surface markers, 
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indicative of a homogeneous population with uniform expression rather than a subset 
of cells displaying differential expression. 
 
The expression levels of CD90 following 24 hours in monolayer culture were very 
low, which were similar to results observed after enzymatic digestion.  These results 
are comparable to studies using normal human chondrocytes (Diaz-Romero et al., 
2005).  CD166 expression was detected after 24 hours, again comparable to previous 
studies in human cells (Diaz-Romero et al., 2005, Diaz-Romero et al., 2008, 
Giovannini et al., 2010).  The increase in expression of CD105 and CD166 compared 
to freshly isolated cells indicates that these markers are probably cleaved during 
enzymatic cell isolation. 
 
The expression of developmental markers differed after 24 hours in monolayer to that 
observed in freshly isolated cells.  All developmental markers tested on live cells 
following 24 hours in culture were identical to control cells, indicating no expression.  
An increase in expression of Jagged1 was observed with fixed cells.  Notch1, Delta1, 
Jagged2 and Msx1 were all absent in fixed cells suggesting that morphological 
changes occur within 24 hours of monolayer culture altering levels of transmembrane 
receptors that are not otherwise affected by enzymatic digestion. 
 
Other studies have demonstrated immunolabelling for Notch1 and its ligands 
following short periods in monolayer culture. Notch1 was observed in the majority of 
cells three hours after digestion (Dowthwaite et al., 2004).  Notch1, Jagged1 and 
Delta1 were observed in monolayer cultures of chondroprogenitors, characterised by 
initial differential adhesion to fibronectin then expansion of clonal populations, 
however, these studies were in long-term cultures (Williams et al., 2010, Ustunel et 
al., 2008).  Labelling was also observed with full-depth human chondrocytes, 
however, to a much lesser extent (Williams et al., 2010, Ustunel et al., 2008, Hiraoka 
et al., 2006).  Approximately 5% of human chondrocytes at passage one expressed 
Notch1 (Hiraoka et al., 2006, Grogan et al., 2009).  Again, these data demonstrate 
how culture conditions and time points in culture can affect marker expression. 
 
As a number of the markers in this study were reduced or absent following enzymatic 
digestion, zonal variation was tested after cells were cultured in monolayer for 24 
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hours as a negative control to ascertain the effects of this short time in culture.  Zonal 
studies were not carried out with markers that were observed throughout the tissue in 
the previous Chapter (such as CD29, Notch1, Delta1, Jagged1, Jagged2 and Msx1).  
Of the markers analysed, bimodal distributions were observed with CD44 in cells 
from all zones.  It is interesting to note that superficial and deep zone cells appeared 
to express less CD44 than middle zone cells.  However, in tissue sections it was the 
superficial zone only that labelled for the receptor.  In previous studies the 
distribution of CD44 has been shown to vary within normal human articular cartilage, 
one study reported CD44 within the middle and deep zones only (Bosch et al., 2002) 
and another found CD44 restricted to the superficial and middle zones (Ostergaard et 
al., 1997).  The difference between these studies may be due to the integrity of the 
tissue collected as ‘normal cartilage’.  Bosch et al (2002) harvested tissue from 
patients undergoing joint surgery but classed this as normal, Ostergaard and 
colleagues also investigated the expression of CD44 within OA cartilage and found 
the cell marker was restricted to the deep zone (Ostergaard et al., 1997). 
 
Very little difference in expression was observed with CD49e, CD90 or CD105 but in 
all, the surface and middle zone expressed similar levels, with lower median 
fluorescent intensities in the deep zone cells.  It is also worth mentioning that with all 
stem cell markers, the middle zone cells always demonstrated greater median 
fluorescent intensity than the surface zone cells.  This pattern was also seen with 
CD117 with the highest MFI observed within the middle zone cells followed by 
surface and lowest seen with deep zone cells.  The only exception was with CD166 
where the highest levels of expression were observed within the deep zone.  These 
results are interesting as similar patterns in expression were observed with CD49e, 
CD90, CD105 and CD117.  The labelling observed with the latter markers is likely to 
be due to cell adhesion and possible rapid dedifferentiation of middle and deep zone 
cells to a less differentiated phenotype.  CD166 labelling within superficial zones 
demonstrated a partial sub-population; this was not observed previously and may be 
due to a subset of cells that have not yet re-expressed the marker following enzymatic 
digestion.  It is interesting to note that CD166 labelling was most abundant in deep 
zone cells.  CD166 is associated with cell adhesion by clustering of CD166 at the cell 
surface and deep zone cells are known to adhere to plastic more rapidly than 
superficial zone cells (Siczkowski and Watt, 1990). 
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Dowthwaite and colleagues observed evidence for rapid dedifferentiation of 
chondrocytes in monolayer culture where the cell expression of CD29 and CD49e 
were observed at 4 and 72 hours in monolayer culture.  After 4 hours in culture, 
CD49e was observed in the majority of surface zone cells but was present in very few 
middle or deep zone cells.  After 72 hours, the superficial zone expression percentage 
had decreased to around 45% and the middle and deep zone cell expression had 
increased to around the same percentage (35-45%).  CD29 was more uniformly 
distributed with 88%, 67% and 62% of cells expressing the cell surface marker in 
surface, middle or deep zone cells respectively.  There was a decline in expression of 
CD29 after 72 hours (Dowthwaite et al., 2004).  The results from the Dowthwaite 
study demonstrate similar changes in expression as observed in the current study. 
 
In summary, these data demonstrate differences between freshly isolated cells and 
those cultured in monolayer for 24 hours.  The data also highlight the differences in 
expression of these markers from the native tissue.  The differences observed in 
expression from native tissue to cells cultured overnight may be explained by the 
increased sensitivity of flow cytometry compared to fluorescence microscopy.  
However, this conclusion is unlikely as some of the markers produced greater 
intensity labelling within the middle and deep zones, but in tissue they were not 
observed in these regions.  The evidence from this study and others, however, seems 
to suggest that the differences observed, are likely due to isolation and adhesion of the 
cells to plastic.  Zonal differences between tissue and cells were also observed, 
however; these are thought to be a result of culturing and not masked epitopes within 
the tissue. 
 
To conclude, these data demonstrate that enzymatic digestion typically results in a 
reduction or loss of cell surface markers and, that, subsequent culture for 24 hours in 
monolayer, does not produce cell labelling equivalent to that observed in tissue.  The 
differences in cell labelling from tissue, to cells cultured for 24 hours in monolayer, 
suggest a phenotypic change in the cultured cells.  The next Chapter will investigate 
the expression of the stem cell markers on superficial zone chondrocytes during 
monolayer culture, to determine whether the variation in labelling continues. 
 
  
 
 
 
 
 
 
 
 
CHAPTER 4: 
COMPARATIVE ANALYSIS OF STEM CELL 
MARKERS IN PRIMARY MONOLAYER CULTURE 
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4.1 Introduction 
 
 
It is well known that articular chondrocytes dedifferentiate in monolayer culture.  
Cells re-enter the cell cycle, proliferate and become fibroblastic.  There is a shift from 
expression of typical markers of differentiated collagens (types II, IX and XI) to 
markers of dedifferentiation (collagen types I and III; (Benya and Shaffer, 1982, 
Archer et al., 1990, Darling and Athanasiou, 2005).  In a recent study, a decline in 
collagen type II was observed after two weeks in monolayer culture, which decreased 
with further culture and as, expected, chondrocytes changed from a polygonal 
morphology to elongated fibroblast-like phenotype in this time period (Diaz-Romero 
et al., 2005).  Many studies have been conducted on dedifferentiation in monolayer 
culture, however, few studies have investigated the effects of dedifferentiation on cell 
surface marker expression during primary culture of articular chondrocytes 
particularly in immature bovine articular chondrocytes. 
 
Mesenchymal stem cell markers are routinely used to assess progenitor characteristics 
in expanded chondrocyte cultures combining cell surface expression with 
differentiation of these cells along specific lineages, typically osteogenic, adipogenic 
or re-differentiation to a chondrogenic phenotype (Barbero et al., 2003, de la Fuente 
et al., 2004, Tallheden et al., 2003).  Many of these studies are conducted using 
human articular chondrocytes.  Here, large tissue samples are often difficult to obtain 
and cartilage is often from diseased or aged individuals that have relatively low 
cellularity.  As a small number of cells are often removed from patients, these cells 
have to be expanded over a series of weeks if not months to enable enough cells for 
analysis resulting in dedifferentiation. 
 
Alsalameh and colleagues identified a sub-population of human articular 
chondrocytes in primary culture that immunolabelled for both CD105 and CD166.  
These dual-labelled cells expressed aggrecan and type I collagen but not type II 
collagen.  On selection and further expansion these dual-labelled cells were shown to 
undergo adipogenesis and osteogenesis and when placed in pellets re-expressed 
collagen type II (Alsalameh et al., 2004).  A recent study reported less than 10% of 
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cells expressed CD166 but around 50% expressed CD105 after 3 weeks in monolayer 
and that the immunolabelling was considerably lower than that observed in the tissue.  
These results demonstrate the profound changes that occur in marker expression in 
monolayer cells.  Changes could be due to enzymatic digestion initially, down 
regulation of protein expression in monolayer culture, or preferential loss of cells 
expressing these markers during the cell isolation process (Grogan et al., 2009). 
 
In an earlier study, human chondrocytes were plated in monolayer and analysed at 14 
days or allowed to dedifferentiate further and analysed at 4 weeks (Diaz-Romero et 
al., 2005).  Cells that had been plated down in monolayer for 14 days demonstrated a 
marked increase in levels of expression for CD44, CD49e, CD90, CD105 and CD166 
compared to levels observed at 24 hours, with the greatest increase observed with 
CD90 (Diaz-Romero et al., 2005).  However, a more recent study by the same group 
reported that CD105 expression remained low throughout monolayer culture (Diaz-
Romero et al., 2008).  Expression of all markers following 24 hours or 14 days 
incubation exhibited a unimodal distribution of expression, indicative of a 
homogeneous population with uniform expression rather than a subset of cells 
displaying differential expression (Diaz-Romero et al., 2005, Diaz-Romero et al., 
2008).  In a further study, human chondrocytes were expanded for 2 to 18 weeks in 
monolayer culture, equating to 10 to 20 population doublings.  The majority of the 
cells tested at 10 or 20 population doublings expressed CD29, suggesting the 
expression of this integrin is relatively constant throughout monolayer culture.  The 
majority of cells were also positive for CD44 and CD90 with lower levels of 
expression observed for CD49e, CD105 and CD166.  This group also demonstrated 
CD117 expression was very low throughout the culture period (de la Fuente et al., 
2004). 
 
Diaz-Romero and colleagues suggest that several markers including CD44, CD49e, 
CD90, CD105 and CD166 can be used to distinguish between differentiated and 
dedifferentiated chondrocytes, demonstrating a phenotypic plasticity of human 
articular chondrocytes.  However, the expression of these markers, which are also 
expressed by BMSCs, may suggest a subpopulation of progenitor cells within 
articular cartilage that are enriched during cell isolation and subsequent in vitro 
culture (Diaz-Romero et al., 2005, Diaz-Romero et al., 2008).  The aforementioned 
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studies demonstrate differences in cell surface marker expression between tissue, 
isolated cells and passaged chondrocytes.  However, these studies do not investigate 
marker changes during early, or, primary monolayer culture. 
 
As discussed, stem cell markers have been identified in immature chondrocytes but 
variations have been observed with time in culture and between species.  At present, 
little evidence exists that focuses on the expression of these stem cell markers in 
immature chondrocytes.  This Chapter aims to investigate changes that may occur in 
the cell surface markers: CD29, CD44, CD49e, CD90, CD105, CD117 and CD166 at 
time points during primary monolayer culture up to and including 14 days. 
 
 139 
4.2 Materials and Methods 
 
 
3.2.1 Tissue isolation and digestion 
 
Superficial zone chondrocytes were harvested from immature bovine limbs as 
described in Chapter 3.  Articular cartilage from two to three joints were used from 
different animals for each experiment and all experiments were carried out in at least 
triplicate.  Cells were transferred to 75cm
2
 flasks (8 x 10
4
 cells cm
2
) with 10ml of 
media+ .  The cells were cultured for 3, 7 or 14 days in a humidified incubator at 
37°C containing 5% CO2.  The media were changed three times a week. 
 
 
3.2.3 Direct immunofluorescence for flow cytometry 
 
Following 3, 7 or 14 days in monolayer culture, plated cells were washed with 5ml 
PBS.  Accutase (5ml) was added to the cells and incubated at 37°C for 5-10 minutes 
or until the cells became rounded and were beginning to detach from the flask.  
Detached cells were transferred to a 50ml tube.  The flasks were washed with 5ml 
PBS to ensure all cells had been obtained and the liquid aspirated to the 50ml tube.  
The cells were centrifuged at 400xg and supernatant removed. 
 
All centrifugation steps were performed at 400xg for 3 minutes unless otherwise 
stated.  Cells were re-suspended in 1ml PBS/BSA and counted using a 
haemocytometer as described previously.  Cells were re-suspended at 2 x 10
6
 cells 
ml
-1
 and 1ml of the cell suspension was transferred to 1.5ml tubes.  The cells were 
centrifuged and the supernatant aspirated.  Cells were immunolabelled using 
CD29FITC, CD44FITC, CD49ePE, CD90FITC or CD105APC, CD117APC and 
CD166 PE as described in Chapter 3.  Following immunolabelling, cells were viewed 
on a BD FACS Canto flow cytometer. 
 
Control samples were processed as described, omitting primary antibody and, instead, 
incubating the cells with appropriate IgG-matched controls, or PBS/BSA. 
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Cells were analysed initially for forward scatter (FSC) and side scatter (SSC).  
Controls were set to the second log decade where possible.  Labelling of cells was 
assessed by percentage shift or fluorescent intensity of fluorescently labelled cells 
compared to control cells. 
 
Results were tested for statistical significance using a paired, one-tailed t-test where 
the geometric mean fluorescent intensity (MFI) of control cells was compared with 
that of the immunolabelled cells.  MFI ratios were also compared between each time 
point in culture (day 3, 7 and 14); statistical significance was tested using an unpaired, 
two-tailed t-test. 
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4.3 Results 
 
 
4.3.1 Flow cytometry analysis 
 
All data were analysed using FlowJo and gated as described in Chapter 3.  As with 
Chapter 3, bimodal distributions were displayed as percentage labelled and MFI, 
unimodal distributions were represented as MFI only. 
 
Results shown are representative of labelling seen for each antibody, with the typical 
or central distributions shown.  Each antibody was tested at least in triplicate and 
controls consisted of unlabelled cells or IgG-matched controls. 
 
 
4.3.2 Superficial zone chondrocytes at days 3, 7 and 14 in monolayer culture 
 
Cells were isolated using pronase and collagenase and cultured in monolayer for 3, 7 
or 14 days.  At each time point, the cells were detached using Accutase and labelled 
with the relevant conjugated primary antibody, 0.5-1.0 x 10
6
 cells were used to test 
each antibody. 
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CD29 (Integrin !1) 
 
All cells incubated with CD29 antibody exhibited increased MFI relative to controls 
(day 3 = 17.64 fold; day 7 = 26.94 fold; and day 14 = 13.88 fold; Table 4.1; Figure 
4.1).  The geometric mean of CD29 was significantly different to the control cells at 
each time point (day 3; P= 0.0043, day7; P 0.0017 and day 14; P = 0.0171). 
 
 
 
Figure 4.1: CD29 FITC expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD29 (blue) labelled cells were analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD29 FITC MFI ratio 
Sample 1 138.00 2493.00 18.07 
Sample 2 113.00 1987.00 17.58 
Sample 3 107.00 1848.00 17.27 
  Mean 17.64 
 
Day 7 
  Control CD29 FITC MFI ratio 
Sample 1 119.00 3336.00 28.03 
Sample 2 110.00 2735.00 24.86 
Sample 3 109.00 3044.00 27.93 
  Mean 26.94 
 
Day 14 
  CD29 Control CD29 FITC MFI ratio 
Sample 1 122.00 1802.00 14.7705 
Sample 2 95.10 1309.00 13.7645 
Sample 3 195.00 2554.00 13.0974 
  Mean 13.88 
 
 
Table 4.1: CD29 FITC expression from surface cells cultured for 3, 7 or 14 days 
Table contains the MFI for each cell sample acquired and the MFI ratio between test 
and control.  The highlighted region indicates the sample represented in each 
histogram (Figure 4.1). 
 
 
During monolayer culture, all cells continue to express CD29.  The expression levels 
increase from day 3 to day 7 and decrease from 7 to 14 days in culture; these changes 
in geometric mean were shown to be significantly different (days 3 to 7; P = 0.0009, 
days 7 to14; P = 0.0003).  To test whether CD29 expression was returning to levels 
observed at day 3, the MFI at day 3 and day 14 were compared and found to be 
significantly different (P = 0.0022) indicating that CD29 expression on day 14 
dropped below that observed at day 3. 
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CD44 (Hyaluronan receptor) 
 
A subpopulation of CD44 labelled cells resulting in a bimodal distribution (Figure 4.2 
A and B) was observed when cells were immunolabelled with CD44 after 3 and 7 
days in culture.  The geometric mean of CD44 labelled cells (+ve) was significantly 
different to the negative population (-ve; day 3; P= 0.0150, day 7; P = 0.0089).  After 
14 days in culture, all cells expressed CD44 and the geometric mean was significantly 
different to the control cells (P = 0.0250). 
 
 
 
Figure 4.2: CD44 FITC expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD44 (green) labelled cells were analysed for 
fluorescent intensity.  The bimodal distributions observed at 3 and 7 days (A and B) 
were divided into unlabelled cells (-ve) and labelled cells (+ve). 
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Geometric mean values 
Day 3 
  
CD44 
Control 
CD44 
-ve 
CD44 
+ve 
MFI ratio 
+ve/-ve 
MFI ratio 
-ve/control 
% 
+ve 
Sample 1 138.00 174.00 6819.00 39.1897 1.26 48.30 
Sample 2 113.00 146.00 4650.00 31.8493 1.29 62.30 
Sample 3 107.00 229.00 3935.00 17.1834 2.14 59.30 
      Mean 29.41 1.56 56.63 
 
Day 7 
  
CD44 
Control 
CD44 
-ve 
CD44 
+ve 
MFI ratio 
+ve/-ve 
MFI ratio 
-ve/control 
% 
+ve 
Sample 1 119.00 137.00 12940.00 94.4526 1.15 93.50 
Sample 2 110.00 131.00 17700.00 135.1145 1.19 96.70 
Sample 3 109.00 129.00 11475.00 88.9535 1.18 93.40 
      Mean 106.17 1.18 94.53 
 
Day 14 
  Control CD44 FITC MFI ratio 
Sample 1 156.00 5014.00 32.14 
Sample 2 122.00 4256.00 34.89 
Sample 3 95.10 7697.00 80.94 
Sample 4 195.00 15203.00 77.96 
  Mean 56.48 
 
 
Table 4.2: CD44 FITC expression from surface cells cultured for 3, 7 or 14 days 
The table contains the MFI for each cell sample acquired and the MFI ratios between 
CD44+ve and CD44-ve, and CD44-ve and control cells for days 3 and 7.  The 
highlighted region indicates the sample represented in each histogram (Figure 4.2). 
 
 
During monolayer culture the mean percentage of cells expressing CD44 increased 
from 56.63% to 94.53% from 3 to 7 days. The MFI ratio between labelled and 
unlabelled cells also increased (day 3 = 26.41 fold and day 7 = 106.17 fold; Table 
4.2), these changes were statistically significant (P = 0.0091).  No significant 
difference was observed in expression of CD44 between 7 and 14 days (P = 0.0546). 
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CD49e (Integrin !5) 
 
At day 3 and day 14 a small increase in fluorescence intensity was observed between 
CD49e and control cells, however, this change was shown not to be statistically 
different (day 3; P = 0.0987 and day 14; P = 0.1082; Figure 4.3 and Table 4.3).  
Following 7 days in monolayer culture the increase in geometric means of 
immunolabelled cells was shown to be significantly different to the control cells (P = 
0.0031). 
 
 
 
Figure 4.3: CD49e PE expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD49e (pink) labelled cells were analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD49e PE MFI ratio 
Sample 1 107.00 105.00 0.98 
Sample 2 135.00 200.00 1.48 
Sample 3 132.00 192.00 1.45 
  Mean 1.31 
 
Day 7 
  Control CD49e PE MFI ratio 
Sample 1 148.00 390.00 2.64 
Sample 2 147.00 346.00 2.35 
Sample 3 138.00 326.00 2.36 
  Mean 2.45 
 
Day 14 
  Control CD49e PE MFI ratio 
Sample 1 117.00 174.00 1.49 
Sample 2 98.40 178.00 1.81 
Sample 3 107.00 169.00 1.58 
Sample 4 605.00 1142.00 1.89 
  Mean 1.69 
 
 
Table 4.3: CD49e PE expression from surface cells cultured for 3, 7 or 14 days 
Table contains the MFI values for each sample recorded and the MFI ratio of CD49e 
labelled and control cells.  The highlighted region indicates the sample represented in 
each histogram (Figure 4.3). 
 
The expression levels of CD49e increase between day 3 and day 7 and decrease from 
7 to 14 days in culture; these changes in geometric mean were significantly different 
(days 3 - 7; P = 0.0036, days 7 - 14; P = 0.0025).  The expression of CD49e on day 14 
was shown to be equivalent to that on day 3 (P = 0.0801). 
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CD90 (Thy-1) 
 
Gated cells, labelled with CD90 were plotted against controls and the distributions 
compared (Figure 4.3).  Cells labelled with CD90 exhibited increased MFI compared 
with controls at day 3 (1.35 fold) and day 7 (1.38 fold; Figure 4.4 A and B and Table 
4.4).  The MFI of CD90 was significantly different to the control cells (day 3; P= 
0.0463, day 7; P = 0.0137).  There was no significant difference between 
immunolabelled cells and control cells at day 14 (P = 0.0682). 
 
 
 
Figure 4.4: CD90 FITC expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD90 (orange) labelled cells were analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD90 FITC MFI ratio 
Sample 1 138.00 152.00 1.10 
Sample 2 113.00 169.00 1.50 
Sample 3 107.00 156.00 1.46 
  Mean 1.35 
 
Day 7 
  Control CD90 FITC MFI ratio 
Sample 1 119.00 174.00 1.46 
Sample 2 110.00 153.00 1.39 
Sample 3 109.00 139.00 1.28 
  Mean 1.38 
 
Day 14 
  Control CD90 FITC MFI ratio 
Sample 1 122.00 146.00 1.20 
Sample 2 95.10 111.00 1.17 
Sample 3 195.00 256.00 1.31 
  Mean 1.23 
 
 
Table 4.4: CD90 FITC expression from surface cells cultured for 3, 7 or 14 days 
Table contains the geometric mean values for each sample tested and the MFI ratio.  
The highlighted region indicates the sample represented in each histogram (Figure 
4.4). 
 
 
The expression levels of CD90 were comparable at day 3 and day 7 with no 
significant difference observed (P = 0.8668).  The MFI appeared to decrease between 
day 7 and day 14, however, this difference was shown not to be statistically 
significant (P = 0.0990). 
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CD105 (Endoglin) 
 
There was no significant difference between CD105 labelled cells and control cells at 
day 3 (P = 0.0602).  By day 7, cells labelled with CD105 exhibited increased MFI 
compared to controls (1.86 fold; Table 4.5) that was significantly different (P = 
0.0106).  At day 14 a discrete subpopulation was observed when cells were 
immunolabelled with CD105 (Figure 4.5 C and D).  The geometric mean of CD105 
labelled cells (+ve) was significantly different to the negative population (-ve; P = 
0.0353), this discrete subpopulation accounted for on average 1.37% of the total 
surface population analysed. 
 
 
 
Figure 4.5: CD105 APC expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD105 APC (pink) labelled cells were analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD105 APC MFI ratio 
Sample 1 205.00 453.00 2.21 
Sample 2 187.00 323.00 1.73 
Sample 3 176.00 231.00 1.31 
  Mean 1.75 
 
Day 7 
  CD105 Control CD105 APC MFI ratio 
Sample 1 527.00 928.00 1.7609 
Sample 2 413.00 880.00 2.1308 
Sample 3 405.00 680.00 1.6790 
  Mean 1.86 
 
Day 14 
  
CD105 
Control 
CD105 
-ve 
CD105 
+ve 
MFI ratio 
+ve/-ve 
MFI ratio 
-ve/control 
% 
+ve 
Sample 1 25.30 47.90 435.00 9.0814 1.89 2.10 
Sample 2 27.10 49.30 1935.00 39.2495 1.82 1.61 
Sample 3 28.80 46.50 535.00 11.5054 1.61 0.90 
Sample 4 53.80 60.90 1074.00 17.6355 1.13 0.86 
   Mean 19.37 1.61 1.37 
 
 
Table 4.5: CD105 APC expression from surface cells cultured for 3, 7 or 14 days 
Table contains the MFI values for each sample acquired and the MFI ratio between 
labelled cells and control.  The highlighted region indicates the sample represented in 
each histogram (Figure 4.5). 
 
 
The expression levels of CD105 were comparable at day 3 and day 7 with no 
significant difference observed (P = 0.7344).  There was no significant difference in 
the MFI between 7 and 14 days in culture (P = 0.0837) but a discrete subpopulation 
was observed at 14 days that was not evident at 7 days. 
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CD117 (c-kit) 
 
The fluorescent intensity of CD117 labelled cells was equivalent to that of the control 
cells at day 3 (P = 0.0670). At day 7 cells labelled with CD117 exhibited increased 
MFI compared to controls (1.79 fold; Table 4.6) that was significantly different (P = 
0.0058).  At day 14, a discrete subpopulation was observed when cells were 
immunolabelled with CD117 (Figure 4.6 C and D).  The geometric mean of CD117 
labelled cells (+ve) was significantly different to the negative population (-ve; P= 
0.0246), this discrete subpopulation accounted for 1.31% of the total cell population 
analysed. 
 
 
 
Figure 4.6: CD117 APC expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD117 (green) labelled cells were analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD117 APC MFI ratio 
Sample 1 205.00 350.00 1.71 
Sample 2 187.00 612.00 3.27 
Sample 3 176.00 308.00 1.75 
  Mean 2.24 
 
Day 7 
  CD117 Control CD117 APC MFI ratio 
Sample 1 527.00 948.00 1.7989 
Sample 2 413.00 770.00 1.8644 
Sample 3 405.00 692.00 1.7086 
  Mean 1.79 
 
Day 14 
  
CD117 
Control 
CD117 
-ve 
CD117 
+ve 
MFI ratio 
+ve/-ve 
MFI ratio 
-ve/control 
% 
+ve 
Sample 1 25.30 49.20 384.00 7.8049 1.94 1.78 
Sample 2 27.10 52.80 1322.00 25.0379 1.95 1.65 
Sample 3 28.80 57.10 429.00 7.5131 1.98 0.87 
Sample 4 53.80 66.60 1060.00 15.9159 1.24 0.93 
   Mean 14.07 1.78 1.31 
 
 
Table 4.6: CD117 APC expression from surface cells cultured for 3, 7 or 14 days 
Table contains the geometric mean values for each sample recorded and the MFI ratio 
of labelled cells compared to controls.  The highlighted region indicates the sample 
represented in each histogram (Figure 4.6). 
 
The expression levels of CD117 were comparable at day 3 and day 7 with no 
significant difference observed (P = 0.4305).  There was no significant difference in 
the MFI between 7 and 14 days in culture (P = 0.0542) but a discrete subpopulation 
was observed at 14 days that was not evident at 7 days. 
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CD166 (ALCAM) 
 
At day 3 and day 7, cells labelled with CD166 exhibited increased MFI compared to 
controls (day 3 = 5.12 fold; day 7 = 17.48 fold; Table 4.7; Figure 4.7) that were 
significantly different (day 3; P= 0.0444, day 7; P 0.0326).  At day 14 increases were 
observed in the geometric mean of CD166 compared to the control (Figure 4.7 and 
Table 4.7) but these were shown not to be significantly different to the control cells 
(P = 0.0540). 
 
 
 
Figure 4.7: CD166 PE expression from surface cells cultured for 3, 7 or 14 days 
The gated control (grey line) and CD166 (green) labelled cells were then analysed for 
fluorescent intensity. 
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Geometric mean values 
Day 3 
  Control CD166 PE MFI ratio 
Sample 1 107.00 525.00 4.91 
Sample 2 222.00 1407.00 6.34 
Sample 3 187.00 771.00 4.12 
  Mean 5.12 
 
Day 7 
  Control CD166 PE MFI ratio 
Sample 1 181.00 4191.00 23.15 
Sample 2 173.00 4015.00 23.21 
Sample 3 282.00 1717.00 6.09 
  Mean 17.48 
 
Day 14 
  Control CD166 PE MFI ratio 
Sample 1 113.00 591.00 5.23 
Sample 2 118.00 2036.00 17.25 
Sample 3 121.00 1216.00 10.05 
  Mean 10.84 
 
 
Table 4.7: CD166 PE expression from surface cells cultured for 3, 7 or 14 days 
The table contains the MFI for each cell sample acquired and the MFI ratio between 
test and control.  The highlighted region indicates the sample represented in each 
histogram (Figure 4.7). 
 
 
The expression levels of CD166 were comparable at all three time points with no 
significant difference observed between day 3 and day 7 (P = 0.0974) or day 7 and 
day 14 (P = 0.3768). 
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4.3.3 Comparison of expression of directly conjugated antibodies from freshly 
isolated surface cells to day 14 in monolayer culture 
 
When the mean MFI of cells cultured for 24 hours was compared to freshly isolated 
cells an increase was observed with CD29 (P = 0.0042), CD44 (P = 0.0002), CD49e 
(P = 0.0037), CD105 (P = 0.0090), CD117 (P = 0.0331) and CD166 (P = 0.0039) 
(Figures 4.8 and 4.9). 
 
CD29 was the only antibody to demonstrate an increase between 24-hour culture and 
day 3 (P = 0.0127).  The other cell surface markers did not show any significant 
differences during this time. 
 
When the mean MFI of cells cultured for 3 days was compared to cells cultured for 7 
days, an increase in expression was observed with CD29 (P = 0.0009), CD44 (P = 
0.0091) and CD49e (P = 0.0036). 
 
Differences in mean MFI between cells cultured for 7 and 14 days was only observed 
with CD29 (P = 0.0003) and CD49e (P = 0.0025). 
 
It is interesting to note that expression of CD29 and CD49e demonstrated a similar 
pattern from days 3 to 7; both increased from day 3 to day 7 and declined in 
expression by day 14, with expression of CD49e at day 14 comparable to expression 
levels at day 3.  CD105 and CD117 also demonstrated similar expression levels 
during the culture period, both markers identifying a discrete sub-population of 
approximately 1-2% of the total superficial zone cells analysed. 
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Figure 4.8: Mean MFI of conjugated antibodies 
The graph illustrates the mean MFI of cells immunolabelled at each time point tested.  
Significant differences in MFI between the time points are represented by * (P < 
0.05), ** (P < 0.01) or *** (P < 0.001). 
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Figure 4.9: Mean MFI of CD44 
The graph illustrates the mean MFI of cells immunolabelled for CD44 at each time 
point tested.  Significant differences in MFI between the time points are represented 
by * (P < 0.05), ** (P < 0.01) or *** (P < 0.001). 
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4.4 Discussion 
 
 
Results from the previous Chapter demonstrated differences between cell surface 
marker expression in freshly isolated cells and cells cultured for 24 hours.  
Differences in cell surface marker expression were also evident between cultured cells 
and native tissue.  As cell labelling of the surface markers (CD29, CD44, CD49e, 
CD90, CD105, CD117 and CD166) differed in a 24-hour culture period, the aim of 
this Chapter was to investigate the cell surface profile of immature chondrocytes up to 
and including 14 days in monolayer to investigate dedifferentiation. 
 
As with the previous Chapter, cells were analysed using flow cytometry following 3, 
7 or 14 days in monolayer culture.  Cells were cultured at high density to minimise 
dedifferentiation (Watt, 1988).  Previous studies describe reductions in expression of 
chondrogenic markers, such as type II collagen and an adoption of a more fibroblastic 
phenotype, typified by the expression of type I collagen, after 14 days, so this time 
point was chosen to represent dedifferentiated chondrocytes (Diaz-Romero et al., 
2005, Schnabel et al., 2002). 
 
Expression of CD29 increased from freshly isolated cells to cells cultured for 24 
hours, and this trend continued to day 7.  At day 14, the expression had decreased to 
expression levels below those observed at day 3.  The expression levels of CD49e 
demonstrated a similar pattern to CD29, increasing from day 3 to day 7 and then, 
declining from day 7 to day 14; the expression levels at day 14 were shown to be 
equivalent to those at day 3.  The expression levels of CD49e were much lower than 
CD29 and remained low throughout culture. 
 
CD29 (!1) and CD49e ("5) are components of the "5!1 complex that binds 
fibronectin.  Although the levels of expression between these markers were quite 
different, the patterns of labelling displayed similarities, suggesting possible 
fibronectin binding.  Superficial zone cells that adhere to fibronectin, have been 
shown to demonstrate greater colony forming efficiency, indicative of stem cells.  
Fibronectin adherence has also been demonstrated in middle zone cells; however, 
 160 
these cells do not form colonies (Dowthwaite et al., 2004).  Fibronectin has since been 
used to enrich for chondroprogenitors within superficial zone cells and full-depth 
cartilage across species (McCarthy et al., 2011), (Williams et al., 2010) Williams et 
al. 2010).  In a recent study by co-workers, the majority of cultured human full-depth 
chondrocytes expressed CD29, but CD49e was only expressed by a discrete subset 
(less than 1%).  In addition, when chondroprogenitors were immunolabelled all 
expressed CD49e, suggesting that CD49e is upregulated within progenitor 
populations and could be a marker of such cells (Williams et al., 2010). 
 
CD44 expression continued to increase following overnight incubation.  By day 3, an 
average of 57% of cells expressed CD44, which increased to around 95% by day 7.  
By day 14, all cells expressed the receptor.  This increase in expression is most likely 
due to adhesion of the cultured cells to plastic.  CD44 is associated with cell adhesion 
so, although, interesting to investigate during monolayer culture it is not thought to 
represent a stem cell marker within articular cartilage.  Previous studies have also 
reported CD44 upregulation during extended monolayer culture in human 
chondrocytes (Williams et al., 2010, Diaz-Romero et al., 2008). 
 
CD90 expression remained low throughout culture and, although, no statistical 
differences in CD90 expression were calculated during culture in the present study; 
the trend was similar to that observed with CD29 and CD49e, with an increase from 
day 3 to day 7 and decrease in expression from day 7 to day 14.  These results are 
comparable to those observed by Fickert and co-workers, investigating CD90 
expression in expanded human OA chondrocytes (Fickert et al., 2004).  However, 
these data are dramatically different to observations recorded by Diaz-Romero and 
colleagues, who reported a 450-fold increase in expression of CD90, over a 14-day 
period in monolayer (Diaz-Romero et al., 2005).  In our laboratory, increased 
expression was observed following monolayer expansion of human 
chondroprogenitors; increased expression was also observed in culture expanded full-
depth human chondrocytes, but to a lesser extent than chondroprogenitors (Williams 
et al., 2010).  These differences in results could be species-specific or due to tissue 
maturity. 
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CD105 and CD117 expression in chondrocytes displayed similar trends towards 
increased expression throughout monolayer culture.  Unimodal distributions in 
expression were observed at day 3 and day 7, indicating in each case, a homogeneous 
population.  However, after immunolabelling cells at day 14, a distinct subpopulation 
of cells was observed.  This population was more immunofluorescent than at any 
previous time point and accounted for approximately 1-2% percentage of the total 
superficial zone population analysed.  This distinct subset of cells was further 
analysed by back-gating to determine the FSC and SSC of each subset.  The 
population of cells were distributed centrally within the main population of cells 
analysed, indicating they had equivalent size and cytoplasmic components as the rest 
of the population and were not dead or apoptotic.  This comparable expression pattern 
of CD105 and CD117 has not previously been reported in any tissue.  It is interesting 
to note, that CD117 has not been demonstrated in native articular cartilage, this may 
be because it is only present at low levels, undetectable by microscopy or, because it 
is upregulated during monolayer culture.  Further studies are needed to determine if 
these sub-populations of CD105 and CD117 are due to dedifferentiation and whether 
these sub-populations are present with ongoing culture.  Previous studies have 
reported high expression of CD105 in cultured human chondrocytes (Williams et al., 
2010, Alsalameh et al., 2004).  Co-workers reported that 1-2% of fibronectin-adherent 
cells from the superficial zone form colonies and that these colonies display 
stem/progenitor cell characteristics, such as multipotency and extended lifespan 
(Dowthwaite et al., 2004).  This equates to the percentage of cells expressing CD105 
and CD117, following 14 days in culture and may represent a progenitor sub-
population. 
 
Chondrocytes demonstrated a steady increase in CD166 expression from day 3 to day 
7 but by day 14 had decreased, which is similar to the pattern observed with CD29, 
CD49e and CD90.  CD105 and CD166 have been discussed previously as suitable 
candidates for progenitor markers (Alsalameh et al., 2004).  The latter markers have 
previously been described in both OA and normal human articular chondrocytes, but 
CD166, unlike CD105 was restricted to the surface and middle zones of the tissue.  In 
the study by Alsalameh and colleagues, the majority of chondrocytes expressed 
CD105, but only 0.5% expressed CD166 (Alsalameh et al., 2004).  CD166 expressing 
cells demonstrated increased osteogenic potential compared to non-expressing cells.  
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However, both cell types demonstrated adipogenic potential (Pretzel et al., 2011).  
Co-workers also recently observed differences in adipogenic potential between 
chondroprogenitors and full-depth chondrocytes (Williams et al., 2010). 
 
CD166 labelling observed in the aforementioned studies, as well as, labelling seen in 
this study (Chapter 2), suggest CD166 expression is indicative of a chondroprogenitor 
population.  However, in monolayer culture, no subpopulation was observed.  CD166 
is associated with cell adhesion, growth and migration (Pretzel et al., 2011, Arai et al., 
2002, Nelissen et al., 2000, van Kempen et al., 2001).  Hence, CD166 may be up-
regulated in monolayer culture conditions, resulting in the labelling of all cultured 
cells and thus, masking the labelling of chondroprogenitors. 
 
In conclusion, these results demonstrate that cell surface expression of immature 
chondrocytes change during monolayer culture.  The differences observed in this 
study vary from previous publications, which may be due to tissue maturity or 
species-specific expression variability.  The majority of cell surface receptors 
exhibited a unimodal increase in expression indicative of a homogeneous population 
of cells.  The number of cells expressing CD44 increased with time in culture, from 3 
to 14 days, characteristic of cells adhering to plastic, with all cells adhering by day 14. 
 
Bimodal distributions were also observed with CD105 and CD117, after 14 days in 
culture.  This expression has not previously been reported and demonstrates a distinct 
and discrete subset of cells equating to 1-2% of the total surface zone population 
analysed, equivalent to the percentage of chondroprogenitor cells theorised to be 
present in the surface zone of immature bovine articular cartilage. 
 
Unlike previous work, this study identified a general trend of increased expression to 
day 7, and then a decrease in expression to day 14.  The increase in expression of 
these cell surface markers during culture is probably associated with cell adhesion, 
proliferation and migration of the cells during culture.  In addition, CD90 and CD166 
have been implicated in the regulation of the cytoskeleton (Frame et al., 2002, 
Kasahara and Sanai, 2000, Nelissen et al., 2000).  Further characterisation of 
progenitors, should lead to a better understanding of the mechanisms of proliferation 
and differentiation within articular cartilage, improving our understanding of the role 
 163 
of these markers and may significantly contribute to the field of articular cartilage 
repair. 
 
  
 
 
 
 
 
 
 
 
CHAPTER 5: 
GENERAL DISCUSSION 
 
 
 164 
5.1 General Discussion 
 
 
Adult articular cartilage has a poor intrinsic response to injury, caused by a lack of 
blood vessels, nerve supply and low cellularity.  Tissue damage progresses from the 
articular surface to the subchondral bone resulting in loss of zonal arrangement, and 
painful, limited joint movement.  The majority of current repair strategies, rely on 
infiltration of stem cells from the bone marrow pool, resulting in an inferior, 
fibrocartilaginous repair tissue.  If resident stem/progenitor cells could be identified 
and isolated from within articular cartilage, these cells could be expanded in vitro and 
would ultimately result in an improved hyaline-like repair when re-implanted into the 
joint. 
 
Mature cartilage possesses an anisotropic structure critical for its functional integrity. 
Immature cartilage, differentiated from the mesenchymal lineage, is isotropic and 
functions as a scaffold for bone formation and synovial joint components (Hunziker, 
2010).  The re-organisation of immature cartilage to produce the mature tissue, 
involves resorption and replacement of all but the most superficial cells, where tissue 
specific stem cells reside (Hunziker et al., 2007).  Self-renewing, slowly proliferating 
stem cells are responsible for both lateral and appositional growth of articular 
cartilage.  These stem cells supply the rapidly dividing transit amplifying cells 
beneath (Hunziker et al., 2007).  It is only at sexual maturity that superficial zone 
cells are reprogrammed to produce mature articular cartilage.  The processes that 
govern the maturation of cartilage are not known but many studies have provided 
evidence for an appositional growth model including Hayes et al (2001), where BrDU 
incorporation identified slow-cycling cells within the superficial zone of immature 
cartilage, suggesting the presence of a stem cell population (Hayes et al., 2001).  In a 
more recent study, superficial zone cells expressed Notch1 and, on, adhesion to 
fibronectin, showed greater colony-forming efficiency than non-adherent cells from 
the same region.  Middle zone cells were more fibronectin adherent but did not form 
colonies (Dowthwaite et al., 2004). 
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Mesenchymal stem cells have been identified in virtually all tissues and organs 
(Saamanen et al., 2010).  Unlike hematopoietic stem cells, there is no single marker to 
identify MSCs.  This cell type appears to be heterogeneous with most being 
progenitors rather than true stem cells, but all are highly clonogenic and possess the 
potential to differentiate into multiple mesenchymal tissues (Pittenger et al., 1999, 
Saamanen et al., 2010).  CD44, CD49e, CD105 and CD166 are all expressed by 
MSCs and are thought to represent suitable markers of this cell type, however, they 
are not restricted to stem cells.  In the current study, these cell surface markers were 
all localised to the superficial zone of immature articular cartilage, which is a novel 
observation.  The identification of CD44, CD49e, CD105 and CD166 cell labelling 
within the superficial zone provides further evidence that chondroprogenitors reside 
in the superficial zone of immature articular cartilage and that cartilage develops by 
appositional growth. 
 
CD29, CD90 and CD117 are also expressed by MSCs, however, the expression varied 
from that observed with CD44, CD49e, CD105 and CD166.  CD29 was observed 
throughout the tissue and CD90 and CD117 were not detected in tissue. CD44, 
CD49e, CD105 and CD166 were all localised to the superficial zone.  These 
observations suggest that CD29 expression is not restricted to chondroprogenitors. 
 
The developmental markers Notch1, its ligands and Msx1 were located throughout 
the tissue but not all cells expressed these molecules.  As these markers are not 
confined to the superficial zone of the tissue, Notch1, Delta1, Jagged1, Jagged2 and 
Msx1 are not thought to be restricted to chondroprogenitors.  Notch1 and it ligands 
have previously been described as being present during development and maturation 
of articular tissue in mouse and chick limbs (Hayes et al., 2003, Williams et al., 
2010).  Notch1 has also previously been observed within the superficial zone of 
immature bovine articular cartilage, further contributing to the evidence for 
appositional growth.  Notch1 is expressed by stem cells but is not restricted to them 
(Dowthwaite et al., 2004).  This study was the first to investigate the expression of 
Notch1 and its ligands within immature bovine articular cartilage.  Although Notch1 
is highly expressed within the superficial zone, it is also expressed within the deeper 
zones, including the rapidly dividing transit amplifying population.  Notch1 is thought 
to be a marker of chondroprogenitors as Notch1 selected cells exhibit an increased 
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colony-forming efficiency compared with cells not expressing the protein but its 
expression is not restricted to these cells (Dowthwaite et al., 2004).  Notch1 has also 
been implicated in determining cell fate during differentiation, proliferation and 
apoptosis (Carlson and Conboy, 2007, Artavanis-Tsakonas et al., 1999). 
 
The restricted expression of the stem cell markers; CD44, CD49e, CD105 and CD166 
within the superficial zone greatly suggests that these markers may represent a cohort 
of progenitors/stem cells within articular cartilage.  These markers have been 
identified in MSCs (Majumdar et al., 2000, Segawa et al., 2009, Sudo et al., 2007) 
and within culture-expanded chondrocytes (Diaz-Romero et al., 2005, Diaz-Romero 
et al., 2008, Williams et al., 2010, Alsalameh et al., 2004, de la Fuente et al., 2004).  
The extent of expression of these markers reported in previous publications varies 
greatly; these disparities are most likely due to species differences, maturity or 
structural integrity of the tissue as well as cell isolation procedures and subsequent 
monolayer culture. 
 
Marker detection within chondrocytes is highly context dependent and also subject to 
differences brought about by variations in fixations and immunodetection protocols.  
A major obstacle in identifying receptors expressed by chondrocytes within the tissue 
is epitope masking caused by tissue preparation and fixation (such as dehydration and 
cross-linking) or extracellular matrix components.  A number of fixatives and antigen 
unmasking methods were investigated in this study to reduce epitope masking 
although little difference was observed between them.  To further investigate and 
quantify expression of cell surface and differentiation markers within articular 
cartilage, chondrocytes were isolated by enzymatic digestion and analysed by flow 
cytometry. 
 
Freshly isolated cells exhibited reduced or absent expression of cell surface markers, 
with the exception of CD29.  These data suggest that cell surface receptors are 
cleaved during incubation with pronase and collagenase, or, that they have low 
expression levels and, indicates that CD29 expression is either not affected by this 
digestion of the extracellular matrix or that it is rapidly re-expressed at the cell 
surface.  Notch1, its ligands and Msx1 expression were all comparable to expression 
observed in tissue, implying that these transmembrane or nuclear (Msx1) markers are 
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not affected by cell isolation.  These data suggest that the developmental markers 
would be suitable candidates to isolate progenitor cells, as their expression after 
isolation is maintained and comparable to that in vivo.  However, isolation using these 
markers would only enrich for stem cells are these receptors are not restricted to stem 
cells.  
 
As enzymatic digestion had a notable effect on cell surface marker expression, 
chondrocytes were cultured for 24 hours in monolayer to enable receptor 
re-expression.  The expression levels were markedly different to those observed in 
freshly isolated cells, and from the native tissue.  To determine if the expression 
levels differed throughout the tissue, middle and deep zone cells were isolated in 
addition to superficial zone cells and cultured for 24 hours.  There was considerable 
disparity between expression of these cells and that observed within the tissue.  These 
differences in expression could be due to improved sensitivity achieved by flow 
cytometry.  However, this is unlikely as the isolated middle zone cells, or in the case 
of CD166, deep zone cells, exhibited a greater degree of expression than superficial 
zone cells, this would have been observed in tissue.  This difference in expression 
may be due to contamination during explant removal from the tissue but is more 
likely due to cell adhesion and proliferation of the cells in culture.  Indeed, this was 
investigated by Siczkowski and Watt (1990) where middle and deep zone cells 
adhered more rapidly than superficial zone cells to plastic. Resulting in rapid 
dedifferentiation of these cells. 
 
A technique becoming increasingly applied within stem cell research is the Hoechst 
assay first developed by Goodell (1996) for murine HSCs.  Stem cells within a 
heterogeneous population are identified by differential efflux of Hoechst 33342 by 
ABC transporters producing a ‘side population’ by flow cytometry as the stem cells 
actively pump out the dye.  This has previously been shown by Hattori et al (2007) in 
immature bovine cartilage where surface, middle and deep zone cells were isolated 
and cultured in monolayer. A side population was observed with superficial zone cells 
but was absent from middle and deep zone chondrocytes.  Within the superficial zone, 
the side population relative to the total number of cells was around 0.1% and was 
absent in controls (Hattori et al., 2007).  This side population provides further 
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evidence of a stem cell population within the superficial zone of immature articular 
cartilage. 
 
Notch1, Delta1, Jagged2 and Msx1 were not expressed after 24-hours in culture, this 
depletion once again suggests a change in expression from tissue to cultured cells.  As 
all markers were affected by cell isolation and subsequent monolayer culture, the 
effects of continued monolayer culture were investigated.  It is appropriate to consider 
repair strategies at this point, as tissue-engineering procedures using autologous 
MSCs or chondrocytes, involve expansion of these cells in culture.  Any variation in 
expression in vitro may affect their suitability as chondroprogenitor markers.  So 
determining changes in expression during culture will provide evidence for their 
suitability as markers of stem cells. 
 
On further expansion in monolayer, increases in expression of stem cells markers 
continued, suggesting adaption and possible dedifferentiation of chondrocytes in 
monolayer.  Comparable expression was observed between CD29 and CD49e and 
between CD105 and CD117.  CD105 and CD117 were the only receptors to exhibit 
bimodal labelling at day 14, indicating a discrete sub-population of cells that were 
considerably brighter than the remaining cell population.  CD44 expression was also 
initially distributed bimodally, with the percentage of cells expressing the receptor 
increasing at each time point until at day 14, all cells expressed CD44.  This protein 
has a key role in cell adhesion and the distribution profile almost certainly highlights 
the increasing cell-cell and cell-plastic adhesion that occurs during continued 
monolayer culture. 
 
The remaining cell surface markers (CD29, CD49e, CD90 and CD166) all presented 
with unimodal distributions, characteristic of homogeneous populations.  Within adult 
articular cartilage, stem cell markers have been shown to increase in expression with 
continued monolayer culture (Bocelli-Tyndall et al., 2006, Diaz-Romero et al., 2005, 
Diaz-Romero et al., 2008, Tallheden et al., 2003).  Differences in expression of these 
cell surface antigens is most likely due to dedifferentiation of cultured chondrocytes 
to a more naive cell type, exhibiting a similar surface antigen profile to MSCs (Diaz-
Romero et al., 2008).  Dedifferentiation of chondrocytes within monolayer culture has 
been reported previously, the phenotype is lost and cultured cells switch synthesis 
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from type II to type I collagen (Benya et al., 1978, Benya and Shaffer, 1982, Archer et 
al., 1990, Darling and Athanasiou, 2005).  In vitro culture dedifferentiated 
chondrocytes demonstrate phenotypic plasticity, displaying multilineage potential, 
capable of chondrogenic, osteogenic and adipogenic differentiation (Barbero et al., 
2003, Tallheden et al., 2003). 
 
Evidence from this study and previous studies on cultured adult human chondrocytes 
(de la Fuente et al., 2004, Williams et al., 2010, Diaz-Romero et al., 2008), suggest 
stem cell markers are generally upregulated in monolayer culture, probably due, in 
part, to increased proliferation and cell adhesion and also dedifferentiation as 
previously discussed.  Data from this study suggest that chondroprogenitor 
sub-populations, as observed within the surface zone of the tissue, could potentially 
be masked by upregulation of the total cell population during monolayer culture.  The 
expression levels of these markers would need to be considerably higher on 
chondroprogenitors, than the expression levels of dedifferentiated cultured cells, to 
enable identification of progenitor cells within the total population.  This marked 
difference in expression levels was observed with both CD105 and CD117, following 
14 days in monolayer culture.  There was a bright, discrete, subset of cells accounting 
for 1-2% of the total superficial zone cell population analysed, which was comparable 
to chondroprogenitor percentages previously reported (Dowthwaite et al., 2004). 
 
In conclusion, from the experiments conducted, CD49e, CD105, CD117 and CD166 
are all potentially useful cell surface markers to investigate in order to specifically 
isolate tissue specific stem cells.  CD49e, CD105 and CD166 were all restricted to the 
superficial zone of immature cartilage in patterns consistent with the known 
localisation of stem cells at the surface of immature articular cartilage.  The CD49e 
cell labelling pattern appeared to parallel that of CD29, suggesting an ability to bind 
fibronectin, which has previously been shown to significantly enrich for a 
stem/progenitor cell population in immature articular cartilage (Dowthwaite et al., 
2004).  Co-workers also observed a subset of CD49e expressing cells in full-depth 
human chondrocytes after extended time in monolayer (Williams et al., 2010).  
CD105 and CD117 also require further investigation as they were expressed by a 
subset of superficial zone cells following monolayer culture.  CD166, in addition to 
its expression at the articular surface has also been reported primarily in the surface 
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and middle zones of adult articular cartilage and in low numbers of cultured 
chondrocytes (Pretzel et al., 2011, Alsalameh et al., 2004). 
 
In terms of future work, it would be interesting to investigate CD49e, CD105, CD117 
and CD166 by multicolour flow cytometry, to establish any co-expression.  It would 
be particularly interesting to determine whether the sub-population of CD105 and 
CD117 expressing cells observed at day 14 were the same population of cells.  Also, 
it would be informative to establish the differentiation potential of cells labelled for 
the above stem cell markers by cell sorting and establish whether stem cell marker 
expressing cells exhibit a greater colony-forming efficiency than non-expressing cells 
and their osteogenic and adipogenic potential as well as their redifferentiation to a 
chondrogenic phenotype.  This would provide us with the most suitable markers to 
isolate cartilage stem cells, potentially producing a functional repair tissue in vivo, 
and thus, improving tissue engineering procedures for cartilage defects. 
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INTRODUCTION: Previous studies have 
shown that articular cartilage grows by 
apposition from the articular surface driven by 
proliferation of a progenitor cell sub-population 
that resides in the surface zone. This study 
concentrates on identifying markers for this 
progenitor cell population. Cell surface 
receptors CD105 and CD166 are known 
markers of progenitor/stem cells in endothelial 
cells, bone marrow constituents as well as other 
tissues and have recently been reported within 
normal and osteoarthritc human articular 
cartilage 
1,2
. Notch 1, Delta and Jagged 1 and 2 
are  known to be expressed by stem/progenitor 
cells during various stages of limb development 
3
. Localisation of these markers to progenitor 
cells in articular cartilage would enable 
selective isolation facilitating further 
characterisation of the chondroprogenitor. 
 
METHODS: Full depth cartilage explants were 
taken from 7-day-old bovine metacarpal-
phalangeal joints.  The tissue was then snap 
frozen and cryosectioned.  Immunofluorescence 
was carried out using antibodies for the cell 
surface markers CD105, CD166 (Ancell, USA), 
Notch 1, Delta, Jagged 1 and Jagged 2 (Santa 
Cruz, USA).  Surface zone explants were also 
enzymatically digested and the resulting cell 
suspension, filtered and counted.  Cells were 
plated in monolayer at 30,000 cells/cm
2
 and 
cultured for 4 days.  Cells were lifted using 
accutase (Sigma,UK), then immunolabelled 
using directly conjugated CD105RPE and 
CD166FITC (Ancell).  Cells were analysed 
using flow cytometry (BD FACSCanto). 
 
RESULTS: Positive immunolabelling was 
observed for all markers.  Jagged 2 occurred 
throughout the thickness of the cartilage, Delta 
was also present throughout the tissue at low 
levels but highly expressed at the articular 
surface.  CD105, CD166 and Jagged 1 were 
localised to the superficial zone cells.  Notch 1 
labelling was found within the superficial layer 
and also in the deep zone.  Labelling of CD105, 
CD166, Jagged 1 and Notch 1 were 
predominately present as clusters within the 
superficial layer (Figure 1).  
Using flow cytometry surface zone cells were 
labelled for all the previous mentioned markers.   
CD105 labelled 10% of the surface population 
and CD166 labelled 45% of the surface 
population.  
 
Fig.1: Immunofluorescence showing superficial 
zone labelling of CD105 (A), CD166 (B) Notch 
1(C), Delta (D) and Jagged 1 (E) and uniform 
labeling throughout the tissue for Jagged 2 (F) 
 
DISCUSSION & CONCLUSIONS: The 
above results demonstrate that CD105, CD166, 
Jagged 1, Delta and Notch 1 are promising 
markers for chondroprogenitor cells. At present, 
studies are concentrating on sorting labelled 
cells using flow cytometry (BD FACS Aria) to 
select the progenitor cells that can be expanded 
for use in monolayer and pellet systems. 
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Abstract
Background: Articular cartilage displays a poor repair capacity. The aim of cell-based therapies for cartilage defects is to
repair damaged joint surfaces with a functional replacement tissue. Currently, chondrocytes removed from a healthy region
of the cartilage are used but they are unable to retain their phenotype in expanded culture. The resulting repair tissue is
fibrocartilaginous rather than hyaline, potentially compromising long-term repair. Mesenchymal stem cells, particularly
bone marrow stromal cells (BMSC), are of interest for cartilage repair due to their inherent replicative potential. However,
chondrocyte differentiated BMSCs display an endochondral phenotype, that is, can terminally differentiate and form a
calcified matrix, leading to failure in long-term defect repair. Here, we investigate the isolation and characterisation of a
human cartilage progenitor population that is resident within permanent adult articular cartilage.
Methods and Findings: Human articular cartilage samples were digested and clonal populations isolated using a
differential adhesion assay to fibronectin. Clonal cell lines were expanded in growth media to high population doublings
and karyotype analysis performed. We present data to show that this cell population demonstrates a restricted differential
potential during chondrogenic induction in a 3D pellet culture system. Furthermore, evidence of high telomerase activity
and maintenance of telomere length, characteristic of a mesenchymal stem cell population, were observed in this clonal cell
population. Lastly, as proof of principle, we carried out a pilot repair study in a goat in vivo model demonstrating the ability
of goat cartilage progenitors to form a cartilage-like repair tissue in a chondral defect.
Conclusions: In conclusion, we propose that we have identified and characterised a novel cartilage progenitor population
resident in human articular cartilage which will greatly benefit future cell-based cartilage repair therapies due to its ability to
maintain chondrogenicity upon extensive expansion unlike full-depth chondrocytes that lose this ability at only seven
population doublings.
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Introduction
Articular cartilage displays a poor repair capacity. Consequently,
the aim of cartilage cell therapy procedures is to repair damaged
joint surfaces with a functional replacement tissue. As an avascular
tissue, cartilage comprises a single cell type – the chondrocyte,
which is organised into three distinct layers – the surface, mid and
deep zones [1]. Chondrocytes required for cell-based therapies are
isolated and expanded in vitro to generate sufficient numbers of cells
for surgical procedures. However, extensive expansion results in the
progressive dedifferentiation of the chondrocytes. In culture, human
chondrocytes show an inability to retain a chondrogenic potential
past 7 population doublings, even after cultivation in a chondro-
genically permissive environment [2,3,4]. In order to combat this
problem of dedifferentiation, research has focussed on the use of
growth factors and 3D culture systems as a way of maintaining the
chondrogenic potential of these cells [5,6,7,8]. Although these
modifications, to some extent, have proved successful they would be
unsuitable as a method of expanding cells for use in cell-based repair
therapies and, as such, monolayer culture is a limiting factor for
chondrocyte efficacy. Additionally, when chondrocytes are used in
cell-based tissue engineering, the resulting repair tissue is unpre-
dictable and often fibrocartilagenous. It is argued that this
fibrocartilage is biochemically and biomechanically inferior to
native cartilage thus compromising long-term repair of the cartilage
defect [9,10,11].
The loss of the chondrogenic phenotype during monolayer
culture means that the size of defect that can be treated is limited
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13246
since only a defined amount of cartilage can be harvested from the
joint periphery. One way to overcome this cell source limitation
would be to use an alternative cell type that maintains its inherent
proliferative capacity, such as a mesenchymal stem cell (MSC)
population [12]. Recently, studies have demonstrated that cells
obtained from a range of adult tissues eg. adipose, epidermal,
dental pulp and bone marrow exhibit mesenchymal/progenitor
type properties; they can differentiate into multiple lineages and
express putative stem cell markers and as such, could be used for
cell-based repair therapies [13,14,15,16,17,18,19,20]. In particu-
lar, studies have highlighted that MSCs obtained from bone
marrow could be used in cartilage repair procedures as bone
marrow stromal cells (BMSC) can be directed towards the
chondrogenic lineage [21]. However, articular cartilage is a
permanent cartilage and the phenotype generated by BMSCs is
endochondral, which will terminally differentiate, an unfavourable
outcome if one wants to repair permanent articular cartilage. At
present, the type of cartilage generated by stem cells from other
tissue types is poorly characterised [22,23].
Instead of utilising MSCs from different tissue sources for
cartilage repair strategies, it would be logical to use cells from the
same tissue as these cells may possess the developmental repertoire
of the native tissue, impacting on the morphogenesis of the repair
tissue in a beneficial way. Previously, research has hypothesised
that foetal and immature articular cartilage develops apposition-
ally – that is from the surface to the deep zone [24]. In support of
these data, the identification of a chondroprogenitor population in
the surface of bovine articular cartilage has been described and
this has opened up the possibility that human cartilage could also
contain a cartilage progenitor population [25,26]. Identification
and characterisation of this cartilage progenitor population in
human tissue has begun in earnest. Many studies relying on the
use of several putative stem cell markers to determine a method by
which these cells can be isolated from a full-depth articular
chondrocyte population [27,28,29]. As of yet, however, no suitable
single marker has been established and it is becoming increasingly
evident that a high percentage of mature chondrocytes also
express these markers thus confounding previous studies, especially
in the absence of clonal analysis [30,31]. As cell surface marker
expression can alter in monolayer culture, then it is important that
other classical stem cell characteristics are relied on to determine
whether a true cartilage progenitor population has been isolated
[31,32].
This study describes the isolation of a distinct cartilage
progenitor population resident in normal human cartilage of
varying ages. The methodologies employed result in the
generation of large numbers of cells from a single cell. Upon
characterisation of this cell population derived from a single cell,
we demonstrate its progenitor-like properties. As such, we propose
that the human cartilage progenitor population characterised in
this study is a suitable candidate for advancing cell-based tissue
repair therapies for cartilage defects.
Materials and Methods
Ethics Statement
Cartilage tissue samples were obtained from patients who
underwent knee surgery. South East Wales NHS Research Ethics
Committee specifically approved this study and institutional safety
and ethical guidelines were followed. Written informed consent
was obtained from each patient, and extensive precautions were
taken to preserve the privacy of the participants donating tissue.
All caprine in vivo studies were approved by the Office for Food
Safety and Animal Health Graubunden, permitting the project to
take place under the title PROCART. Experiments were carried
out under the strict guidelines of the AO Research Institute,
Switzerland.
Cell isolation & fibronectin adhesion assay
Full-depth normal human articular cartilage samples from
femoral chondyles (n = 9; mean age 30.0 yrs, range 10–57) were
obtained. Chondrocytes were isolated by sequential pronase
(70 U ml21, 1 hour at 37uC) and collagenase (300 U ml21,
3 hours at 37uC) digest. Isolated cells were plated down as a
full-depth chondrocyte population (total cell mass from surface,
mid and deep zones) or subjected to a fibronectin adhesion assay
as described [33]. Briefly, six well plates were coated with
10 mg ml21 fibronectin (FN; Sigma, UK) in 0.1 M phosphate
buffered saline (PBS, pH7.4) containing 1 mM MgCl and 1 mM
CaCl2 (PBS+) overnight at 4uC. Control dishes were treated with
PBS+ containing 0.1% BSA overnight at 4uC. Isolated full-depth
chondrocytes (4000 cells ml21) were seeded onto the coated plates
for 20 mins at 37uC in Dulbeccos Modified Eagle Medium
(DMEM). In all experiments, a minimum of 3 fibronectin and 3
BSA coated dishes were used. After 20 mins, media and non-
adherent cells were removed. Fresh DMEM containing Penicillin
10000 mg ml21/Streptomycin 10000 U ml21, 0.1 mM ascorbic
acid, 0.5 mg ml21 L-glucose, 100 mM HEPES, 1 mM sodium
pyruvate, 2 mM L-glutamine and 10% fetal bovine serum (FBS)
(DMEM+) were added to the remaining adherent cells. Within
18 hours of plating, the number of cells adhered was counted.
Twelve days after plating, colonies (defined as a cluster of more
than 32 cells, as this represents a population of cells derived from
more than 5 population doublings of a single cell, thereby
discounting a transit amplifying cell cohort) were counted and
colony forming efficiency calculated [33]. Colonies were selected
and isolated using sterile cloning rings (Sigma, UK). Colonies were
expanded in DMEM+ plus 1 ng ml21 Transforming Growth
Factor – b2 (TGF-b2; PeproTech, UK) and 5 ng ml21 Fibroblast
Growth Factor-2 (FGF-2; PeproTech, UK). At each passage, the
number of cells obtained and re-plated was recorded. From these
data, population doublings from 4 specimens, with at least 3 clones
from each specimen, were calculated using the equation: n = [log
(final cell count) - log (number of cells initially plated)]/0.301
[34].a
Flow cytometry
One million full-depth chondrocytes (passage 5) were washed in
PBS and incubated for 1 hour at 4uC with conjugated antibodies
to CD105-FITC (Ancell), CD166-RPE (Ancell), CD44-FITC
(Pharminogen), CD29-FITC (Chemicon) or CD49e-PE (Chemi-
con) at a concentration of 10 mg ml21. Cells were centrifuged at
20006g, supernatants removed and cells washed three times in
PBS. Finally, labelled cells were re-suspended in 1 ml PBS and
subjected to single channel Fluorescently Activated Cell Sorting
(FACS) analysis. The appropriate IgG controls were run in
parallel. A minimum of three clones were analysed for each
antibody.
Immunocytochemistry
Monolayer cultures of full-depth chondrocytes and cartilage
progenitors were fixed and subjected to immunofluorescence for
antibodies to anti-human Notch 1 (Developmental Studies
Hybridoma Bank, USA), anti-human CD90 (BD Pharminogen,
USA), anti-human STRO-1 (R&D Systems, USA), anti-rabbit
Jagged 1 (Santa Cruz Biotech, USA) and anti-goat Delta 1 (Santa
Cruz Biotech). Monolayer cultures subjected to chondrogenic
induction were analysed for anti-mouse Sox9 (Abcam, UK),
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aggrecan-IGD; 6B4+ and 2B6 (both kind gifts of Professor Bruce
Caterson, Cardiff University), collagen type I (10 mg ml21;
Abcam) and collagen type II (DSHB). Full protocols can be found
in supporting information (Text S1). Pellets from a minimum of 3
different clonal cell lines were labelled for each antibody.
Cell differentiation assays
Expanded clonal cell lines and full-depth chondrocytes were
trypsinised and aliquots of 0.56106 cells per 1 ml of media were
centrifuged at 20006g for 5 mins in 1.5 ml Eppendorf tubes to
form spherical pellets. For chondrogenic differentiation, pellets
were suspended in DMEM supplemented with ITS (10 mg ml21
insulin, 5.5 mg ml21 transferrin, 5 ng ml21 selenium; GIBCO,
UK), 100 mg ml21 Gentamicin, 50 mg ml21 L-ascorbic acid,
1 mg ml21 L-glucose, 2 mM L-glutamine, 10 mM HEPES, 1027
M dexamethasone, 2% FBS and 10 ng ml21 TGF-b2. For
osteogenic differentiation pellets were suspended in DMEM,
10% FBS, 10 mM b-glycerophosphate, 10 nM dexamethasone
and 0.1 mM L-ascorbic-acid-2-phosphate. Pellets were cultured
for 21 days with a medium change every other day.
Monolayer cultures of cartilage progenitor cell lines and full-
depth chondrocytes were also established and cultured in
chondrogenic differentiation media or adipogenic differentiation
was induced using cycles of treatment with adipogenic induction
media or adipogenic maintenance media as previously described
[35]. Cell monolayers cultured in adipogenic medium were fixed
in 10% NBFS for 10 mins. For lipid detection, a stock solution
(0.5% Oil Red O in 100% isopropanol) was diluted at a ratio of
4:6 with dH2O and the cells incubated for 1 hour.
Preparation of pellets for analysis
At 21 days, cell pellets were fixed in 4% para-formaldehyde,
embedded in paraffin and cross-sectioned at 8 mm or following
fixation in 10% neutral buffered formalin, the pellets were fully
dehydrated and processed into Technovit 9100 NewH (TAAB
Laboratories, UK) using the chemical catalytic method fully
described by Yang et al, [36] with fully destabilised resin at all steps
[37]. The pellets embedded in Technovit 9100 NewH resin
sections were cut using glass knives to a thickness of 1 mm.
Pellet analysis
Wax embedded pellet sections were dewaxed in xylene and
hydrated in a decreasing graded alcohol series. Technovit
9100HNew embedded pellets were de-acrylated in 2-methoxyethyl
acetate (Sigma, Dortset, UK) for 3–4 hours followed by rehydration
through xylene, and a series of graded ethanol. Resin autofluores-
cence was quenched by immersing tissue sections in 1% sodium
borohydride and equilibrated in PBS as previously described [37].
Pellets sections were then subjected to standard histological
protocols for safranin O and toluidine blue staining for proteoglycan
detection. Alizarin red and von Kossa staining were used to
determine the extent of mineralisation and picro-sirius red staining
was performed to demonstrate collagen fibril synthesis within the
pellet matrix. Immunofluorescent analysis for cartilage (Collagen
type I & II, 2B6, aggrecan) and osteogenic (Collagen type X,
alkaline phosphatase) components was performed, as described
above and more fully in supporting information (Text S1).
PCR analysis
At 21 days, cell pellets cultured in osteogenic differentiation
media were placed into buffer RLT (Qiagen, UK). Cell
monolayers from adipogenic cultures were lysed from the tissue
plastic using buffer RLT (Qiagen, UK). RNA was extracted from
pellet and monolayer cells using a kit (RNAEasy, Qiagen, UK)
with a DNAseI incubation step. RNA was quantified using a
Nanodrop 2000c spectrophotometer and 100 ng of each sample
was used for reverse transcription. Polymerase chain reactions
were performed using the following primer combinations for lipo-
protein lipase forward 59CTGAAGACACAGCTGAGGAC39,
reverse 59CTGGTGAATGTGTGTAAGAC39, osteonectin for-
ward 59TCCACAGTACCGGATTCTCTCT39, reverse 59TCT-
ATGTTAGCACCTTGTCTCCAG39, 18S rRNA forward 59G-
ATGGGCGGCGGAAAATAG39, reverse 59GCGTGGATTC-
TGCATAATGGT39. PCR reactions were amplified using the
following conditions 95uC 2 min-1 cycle, 95uC 30 sec, 53uC
30 sec, 72uC 30 sec-35 cycles, 72uC 5 min-1cycle.
Cytogenetic analysis
Cytogenetic investigations were undertaken on 1 clonal cell line
from 1 specimen (10 year-old female; PD=31.3) and 2 clonal cell
lines from a different specimen (54 year-old female; PD=23.6 &
28.5). Cultures were selected for harvest when cell growth was
almost confluent. Chromosome preparations were obtained using
a modification of conventional techniques explained in detail in
supporting information (Text S2) [38]. The karyotype was
determined by microscopic examination after modification of the
Giemsa staining and banding analysis [39,40].
Telomere length analysis
Two full-depth chondrocyte populations (1 at PD10 and 1 at
PD12) and 3 clonal cell lines (1 at PD 29, the second at PD26 and
PD39 and the third at PD29 and PD38), were washed in sterile
PBS, pelleted at 1.06106 cells and frozen in liquid nitrogen for
telomere length analysis. DNA extractions and single length
telomere analysis (STELA) reactions at the 17p and XpYp
telomeres were carried out as described previously and in full in
supporting information (Text S3) [41]. Corresponding telomerase
activity using real time quantitative repeat amplification procedure
(RTQ-TRAP) was carried out for the corresponding full-depth
chondrocyte and clonal cell lines, described in full in supporting
information (Text S4).
In ovo injections and tissue processing
Cell engraftments: Clonal cells were expanded, harvested, and
aliquots of between 16104–16105 cells re-suspended in media and
immediately injected into the limb bud of 3-day-old (st23) [42]
chick embryos which had previously been windowed. Eggs were
resealed with adhesive tape and re-incubated up to day 10 (st36–
37). Embryos were killed by cervical dislocation, a note of their
developmental stage taken and the hind-limbs removed. The limbs
were washed in 0.1 M PBS (pH 7.4) and fixed in 10% NBFS for
1 hour at room temperature before being processed to wax.
Sections were cut (8 mm) and subjected to immunohistochemistry,
protocol previously described, for anti-human collagen-1 (Abcam,
UK) at a dilution of 1:1000 to detect engrafted cells. The antibody
did not cross-react to chick type I collagens or to other chick
collagens. To determine specificity of the antibody, positive
controls were carried out on human cartilage tissue sections and
negative controls were run on non-injected chick limbs.
In situ hybridisation for human-specific Alu genomic repeats: In
situ hybridisation for human Alu genomic repeats was performed
as described previously [4,43].
Caprine in vivo repair study
In order to obtain proof-of principle, a pilot study was carried
out using 6 young, mature female goats. In the first surgical
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procedure a circular 6 mm defect was created in the lateral
femoral condyle whilst preserving the calcified layer. The protocol
followed for cartilage digestion and chondroprogenitor isolation
was identical to that described here for human cartilage
progenitors. Colony forming efficiency and population doublings
for the goat chondroprogenitors were calculated. Cells were
pelleted into a 3D culture system and cultured in chondrogenic
induction media, as described previously in this manuscript.
Immunohistological analysis was performed on goat chondropro-
genitor pellets for Collagen type II (10 mg/ml21; DSHB) and
aggrecan-IGD;6B4 (king gift from Professor Bruce Caterson,
Cardiff University) as described previously. RNA was isolated
from the chondrogenic induced pellet cultures, transcribed to
cDNA and polymerase chain reaction (PCR) performed to
determine Collagen type II and Sox 9 mRNA expression.
Three weeks after the initial isolation, in a second surgical
procedure, 26105 cells were loaded onto a 5 mm diameter type I/
III collagen membrane (Chondro-GideH, Geistlich AG). Three goats
received a membrane with goat chondroprogenitors (mean
population doubling, 21.4) whilst another three goats received a
membrane seeded with full-depth goat chondrocytes (mean
population doubling, 3.5). After debridement of the margins of
the lesion from the previous surgery the membrane was inserted
into the defect and sutured with 8 individual suture points. The
operated limb was immobilised for 2 weeks using a sling. The
animals were sacrificed at 20 months after the second surgery. The
operated knees were dissected, formalin fixed, decalcified and
prepared for routine histology and immunocytochemistry as
described above. Repair tissue grading was performed indepen-
dently, in a blinded manner, by 3 researchers, based on the
International Cartilage Repair Society (ICRS) scoring system.
Results
FACS analysis
Fluorescently activated cell sorting (FACS) analysis was utilised to
label the full-depth chondrocytes for a series of putative cartilage
stem cell markers. Analysis of full-depth chondrocytes for CD105
(endoglin), CD166 (ALCAM), CD44 and CD29 (b1 integrin) all
showed expression in over 95% of the viable cell population
(Fig. 1A–1D). However, expression of CD49e, a5-integrin, was
observed in a distinct population, 0.7%, within the viable full-depth
chondrocyte population (Fig. 1E). On analysis of the clonal
population, isolated using the fibronectin adhesion assay, almost
100% of the cells labelled for CD49e expression (data not shown).
Fibronectin adhesion assay
Fifty percent of the samples showed a CFE (colony forming
efficiency) of less than 0.1 with the remaining 40% demonstrating a
CFE of 0.2 (Fig. 2A). Discrete colonies that form (comprising more
than 32 cells) were selected and cultured in monolayer (Fig. 2C) and
clonal cell proliferative capacity calculated. The cells were able to
proliferate to over 60 population doublings, taking over 200 days
(Fig. 2B). Clones obtained from the same sample proliferated at
similar rates. Differences in growth kinetics were observed between
the clones from different samples. Morphologically, the clonal cell
lines showed a fibroblastic phenotype in early population doubling
monolayer cultures that were retained in long-term cultures. There
were no obvious differences in the size of the cells between early and
late population doublings (Fig. 2D & E).
Monolayer cultures
Monolayer cultures of cartilage progenitors at population
doublings greater than 30 demonstrated positive labelling for stem
cell markers CD90 (Fig. 3A) and STRO-1 (Fig. 3B). Notch 1
receptor and its’ corresponding ligands, Delta 1 and Jagged 1, which
are involved in signalling pathways of stem cell differentiation, were
also expressed in the cartilage progenitor monolayers (Fig. 3C–3E).
Although expression of these putative stem cell markers were
observed in full-depth chondrocytes, it was to a lesser extent
(Fig. 3K, 3L). Analysis of chondrogenic phenotype markers, in
monolayer clonal cell lines post-30 population doublings and
subjected to chondrogenic induction by TGFb2, resulted in the
observed expression of collagen type I, collagen type II, chondroitin-
4-sulphate (2B6), aggrecan-IGD (6B4+) and the chondrogenic
transcription factor, Sox9 (Fig. 3F–3J). The induction of cartilage
gene expression and immuno-detectable matrix synthesis in
monolayer clonal cell lines after 30 population doublings is
significant and noteworthy. Corresponding immunoglobulin con-
trols for the antibodies were all negative (Fig. 3M–3O).
Differentiation assays
At 30 population doublings or greater, clonal cells were
pelleted into 3D Eppendorf cultures and maintained for 21 days
in media containing factors to promote either chondrogenic or
osteogenic differentiation. Four clonal cell lines and a full-depth
chondrocyte sample cultured as pellets in chondrogenic differen-
tiation media, both showed a smooth surface morphology
(Fig. 4A, 4C). Toluidine blue and safranin O staining demon-
strated glycosaminoglycan synthesis 21 days after chondrogenic
culture (Fig. 4B, 4C, 4F, 4G). The presence of collagen fibrils
within the cartilage progenitor pellet matrix was indicated by
picro-sirius red staining (Fig. 4D) and on further analysis,
detection of collagen type I (Fig. 4I) and collagen type II
(Fig. 4J), by immunohistochemical methods, was revealed and
indicated a differentiation process similar to that found during
early development [44]. Positive labelling for aggrecan core
protein, 6B4, was observed intensely in the outer regions of the
pellet with weaker labelling demonstrated in central regions
(Fig. 4K). Labelling for 2B6 was present throughout the pellet
matrix (Fig. 4L). Significantly, neither alkaline phosphatase
(Fig. 4M) nor collagen type X (Fig. 4O) were observed in pellets
cultured in chondrogenic media.
The cartilage progenitor pellets cultured in osteogenic differen-
tiation media showed a rough surface topography and were
slightly smaller in size compared to the full-depth chondrocyte
pellets (Fig. 5A, 5D). When stained for mineralisation, cartilage
progenitor pellets showed extensive regions of calcium deposition
as indicated by both von Kossa (Fig. 5E) and alizarin red stain
(Fig. 5F). The full-depth chondrocyte pellets displayed only small
regions of mineralisation (Fig. 5B). PCR analysis for osteonectin, a
marker for early bone development, demonstrated mRNA
expression in both the full-depth and cartilage progenitor pellets
(Fig. 5M). Osteogenic differentiation was not evident as alkaline
phosphatase activity (Fig. 5G) was seen at a very low level and
collagen type X (Fig. 5I) expression was entirely absent in the
cartilage progenitor pellets.
Clonal cells and full-depth chondrocytes cultured as monolayers
in adipogenic media stained positively for lipid deposition (Fig. 5J,
5K) whereas those cultured in control media did not (Fig. 5L).
PCR analysis for lipo-protein lipase showed mRNA expression in
the full-depth and cartilage progenitor population (Fig. 5M).
Cytogenetic Analysis
Examination of the GTG-banded preparations from 3 flasks
from a clonal cell line from one specimen (54 year old, PD=31.3)
revealed a normal female karyotype, 46, XX (Fig. 5A). However, 2
of 12 cells examined from one of the culture flasks showed a
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terminal deletion of the long arm of chromosome 20, from q11.2
to qter (Fig. 6B). This anomaly was not observed in the other 2
culture flasks. The clonal cell line from the second specimen (10
year old, PD=23.5) showed a normal female 46, XX karyotype in
70 cells examined. However, 10 of the 70 cells examined had an
apparently balanced translocation involving the short arm of
chromosome 7 and the long arm of chromosome 16. The
breakpoints appeared to be at p13 and q22 respectively. The
karyotype from the second clonal cell line (PD=28.5) from the
second specimen showed a normal female karyotype, 46, XX in 50
cells examined from 2 flasks.
Telomere length and telomerase activity analysis
Two clonal cell lines were analysed, one of which is depicted for
greater clarity although data from both were very similar. The
clonal cell line and the full-depth chondrocyte population undergo
telomere erosion with progressive cell divisions (Fig. 6C). It is
interesting to note that the distributions within the clonal cell lines
display less heterogeneity that is normally observed in bulk
populations of cells or tissues where a typical SD of around 3 kb
would be expected. In the clonal cell line, it is apparent that
subsets of cells with a larger distribution are present and the
proportion of cells within this subset is increasing with time in
Figure 1. Flow cytometric analysis of full-depth chondrocytes. Full-depth chondrocytes were labelled for the putative stem cell surface
markers CD105 (A), CD166 (B), CD44 (C), CD29 (D) and CD49e (E). Note the subpopulation of cells labelled for CD49e. Corresponding immunoglobulin
control samples were analysed for each marker at each experimental run (F–I).
doi:10.1371/journal.pone.0013246.g001
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culture (Fig. 6C, arrowed). Full-depth chondrocytes displayed
almost baseline levels of telomerase activity in both low (PD12)
and high (PD49) population doubling cultures (Fig. 6D). The
clonal cell line at a high population doubling (PD39) exhibited the
greatest telomerase activity, even higher than that of the low
population doubling (PD26) clonal cell line, possibly due to the
presence of a subset of cells showing a high telomere length. When
converted to HL60 cell equivalent units, the clonal cell line showed
Figure 2. Population data from clonal cell lines. Colony forming efficiency calculated from 8 samples that were subjected to the fibronectin
adhesion assay (as described in Materials & Methods) (A). Population doublings data from 2 representative samples demonstrating proliferative rate
of the clonal cell lines during a period of over 200 days (B). Phase contrast microscopic appearance of a representative fibronectin adhered colony (C)
and clonal monolayers at low (,30) and high (.30) population doublings (D & E respectively). Scale bar = 100 mm.
doi:10.1371/journal.pone.0013246.g002
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3.1-fold greater telomerase activity than full-depth chondrocytes at
low population doubling and at the high population doubling this
figure increased to a 10.3-fold difference.
Engraftment of cartilage progenitor cell lines
In order to test for in vivo plasticity, cartilage progenitor cells
were injected into st23 chick hind limbs. A high number of cells
Figure 3. Phenotype of cartilage progenitor and full-depth chondrocyte cell lines.Monolayer cultures of expanded clonal cell lines at over
30 population doublings express the putative stem cell markers, CD90 (A) and STRO-1 (B) when localised using immunofluorescent labelling (green).
Members of the Notch signalling family, Notch 1 (C), Delta 1 (D) and Jagged 1 (E) were expressed in clonal monolayer cultures. Markers of the
chondrogenic phenotype, collagen type II (G), 2B6 (H), aggrecan-IGD (I), Sox9 (J), and also, collagen type I (F) were present in clonal monolayer
cultures at over 30 population doublings. Full-depth chondrocytes show fewer cells with positive expression of CD90 (K) and Notch 1 (L) within the
monolayer cultures. Corresponding immunoglobulin controls, rabbit (M), goat (N) and mouse (O), were all negative. Scale bars = 50 mm.
doi:10.1371/journal.pone.0013246.g003
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labelling positively for human collagen type I were observed in the
perichondrium and alongside the prehypertrophic region of the
developing anlagen (Fig. 7A, 7B). Controls determined that the
human collagen type I antibody was specific for human collagen
type I and did not recognise chick collagen type I or other chick
collagens (Fig. 7D, 7E). In situ hybridisation for human Alu repeats,
on a representative section from a chick limb 7 days after human
clonal cell transplantation showed human Alu-positive nuclei
stained black in the peri-articular tissues (Fig. 7C). Control sections
were negative (Fig. 7F).
Caprine in vivo repair study
In order to determine whether articular cartilage progenitors
are suitable candidates for cartilage repair, we carried out a proof
of principle pilot study on goats. Chondroprogenitors obtained
from the goat study demonstrated an average CFE of 0.2. Positive
collagen type II and aggrecan labelling was observed by both
immunohistological and PCR analysis in the 3D chondrogenic
pellet cultures.
The ICRS scoring system designed by Brittberg and Peterson
[45] was used to evaluate cartilage repair in the goat tissue
sections. Histological repair scores for full-depth chondrocytes
ranged from 5 (abnormal) to 10 (nearly normal) whilst repair
scores for chondroprogenitors ranged from 7 (abnormal) to 10
(nearly normal). Overall, full-depth chondrocytes had a mean
score of 7.8 and chondroprogenitors had a mean score of 8.2 thus
suggesting no overall differences between the two experimental
groups. Examples of excellent lateral integration in both full-depth
chondrocyte (Fig. 7G, 7I) and chondroprogenitor (Fig. 7H, 7J)
treatment groups were observed. In some of the samples, there was
no obvious demarcating border and it was difficult to tell where
the defect actually was. In all of the samples, both full-depth
chondrocyte (Fig. 7K) and chondroprogenitor seeded membranes
(Fig. 7L) showed evidence of collagen type II positive repair tissue.
Discussion
Previous research has relied on cell surface markers, originally
designated to characterise bone marrow stromal cells, as a means
of isolating possible stem cell populations from articular cartilage
[27,29,46]. In particular, research suggested that CD105 and
CD166 as possible candidates of cartilage stem cell markers but
our study and others have demonstrated that a sub-population of
cartilage stem cells cannot be isolated from these markers alone as
Figure 4. Chondrogenic differentiation of cartilage progenitor and full-depth chondrocyte populations.Gross morphology of a representative
3D cartilage progenitor (A) and full depth chondrocyte (B) pellet cultured in chondrogenic media for 21 days. Pellets display a shiny smooth surface.Toluidine
blue (B, F) and safranin O (C, G) stained pellets demonstrate the presence of glycosminoglycans within the pellet matrix. Picro-sirius red staining highlights
synthesis of collagen fibres in the pellet matrix (D, H). Immunohistochemistry of the clonal pellets demonstrates bothcollagen type I (I) and collagen type II (J)
within the chondrogenic pellet matrix. Aggrecan labelling was present on the outer edge of the chondrogenic pellet (K) and 2B6 expression was present
throughout the pellet matrix (L). Pellets culturedin chondrogenic media show no alkaline phosphatase (M) or collagen type X expression (N). Representative
examples of negative controls for mouse monoclonal (O) and rabbit polyclonal (P) antibody protocols. Scale bars = 50mm.
doi:10.1371/journal.pone.0013246.g004
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Figure 5. Lineage differentiation of clonal and full depth cell populations. Pellets cultured in osteogenic differentiation media show a
rough surface topography in the full depth chondrocytes (A) and in cartilage progenitor cell pellets (D). Regions of mineralisation are indicated in the
pellets cultured in osteogenic media by von Kossa (B, E) and alizarin red staining (C, F). Alkaline phosphatase (G;arrowed) was present in a small
region of the osteogenic cartilage progenitor cultured pellets and collagen type X was absent (I). Representative example of a negative control for
mouse monoclonal antibody protocol (H). Monolayer clonal cells cultured in adipogenic differentiation media show positive staining with Oil Red O
in both cartilage progenitor cells (J) and full depth chondrocytes (K). Control cultures did not stain with Oil Red O (L). Scale bars = 50 mm. mRNA
expression for lipo-protein lipase (bp 505) and osteonectin (bp 107) in non-treated monolayer (ML) chondrocytes, treated full-depth chondrocytes
(FD) and treated cartilage progenitors (CP) (M).
doi:10.1371/journal.pone.0013246.g005
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Figure 6. Cytogenetic Analysis. Normal female, 46, XX karyotype was observed in a clonal cell line at 31.3 population doublings (A). In one flask
from the same cell line, 2 out of 12 cells displayed an abnormal karyotype; a deletion on the long arm of chromosome 20 at q11.2 (B; arrowed).
Telomere length analysis and real-time quantitative telomere repeat amplification procedure (RTQ-TRAP) of telomerase activity in
clonal cell lines and full-depth chondrocyte populations. STELA reveals both clonal cell lines and full-depth chondrocytes undergo telomere
erosion (C). It is interesting to note a subpopulation of cells in the clonal cell line show a larger distribution which is increasing with time in culture
(arrowed). RTQ-TRAP analyses of telomerase activity in HL60 cell equivalents showed low population doubling (,30) clonal cells displaying a 3.1-fold
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they are widely expressed by mature chondrocytes in the native
tissue [29,30,47]. Isolating a possible stem cell population reliant
on stem cell marker expression, however, could prove problematic
for cell-based repair therapies. In a clinical situation, isolation of
the correct cell population in suitable numbers would be
dependent on an extremely consistent method of cartilage
digestion and culture conditions, as these parameters play a
significant role in cell surface marker expression. Indeed, work
from our own laboratory and others have demonstrated that these
putative markers vary during culture [48]. Additionally, clinically
accredited FACs machines have yet to come on-stream.
In light of these studies, we decided to isolate what we now
characterise as a cartilage progenitor population using the
fibronectin adhesion assay, selecting for discrete colonies (of over
32 cells to eliminate transit amplifiers) which could then be
expanded to high numbers [33]. Currently, generation of high
numbers of chondrogenically competent full-depth chondrocytes
for cell-based repair strategies is not achievable due to the loss of
Sox-9 expression and concomitant loss of the cartilage phenotype
[26,49]. Expansion of our cartilage progenitor clonal populations
to a high population doubling suggests that this method of isolation
is indeed selecting for cartilage progenitor populations.
It is interesting to observe that a sub-population (0.7%) of cells
within the total chondrocyte cell mass express CD49e (a5 integrin)
and indeed the clonal cell lines obtained by adhesion to fibronectin
express this marker (99%) when expanded. The expression of this
marker may explain the high affinity of these progenitor cells for
fibronectin. Whether or not CD49e can be utilised as a specific
marker for this cartilage progenitor cell population remains to be
determined. However, the colony forming efficiency of these cells
indicates that they are present at a ratio of 1:100, which is in the
order of 0.7%.
The cytogenetic analyses demonstrated that cartilage progen-
itors that had undergone 31.3 population doublings are largely
normal but with some anomalies that are likely due to the high PD
number and culture conditions. This was particularly apparent in
the deletion of the short arm of chromosome 20 in one flask yet
not apparent in the other two flasks containing the same clonal cell
line. It can be considered cautionary and underlies the necessity of
carrying out a karyotype analysis when generating cells for clinical
application.
It is well documented that when full depth chondrocytes in
monolayer culture lose their rounded cell configuration, there is a
loss of phenotype associated with the number of division cycles the
cell undergoes and the eventual loss of Sox9 expression
[5,50,51,52,53]. Monolayer cartilage progenitor populations that
have been isolated in this study, although demonstrating a
flattened morphology in culture, show expression of putative stem
cell markers, yet when induced to undergo chondrogenic
differentiation by addition of TGFb2, markers of the chondro-
genic phenotype are expressed and translated into immuno-
detectable proteins. Using the bovine equivalent progenitor cells,
we have demonstrated that the extended chondrogenic potential of
these cells is related to the maintenance of Sox9 expression during
extended monolayer culture and we would suggest that this is
likely with the human equivalent cells [26].
Another effect of long-term chondrocyte culture is cell
senescence due to a shortening of telomeres, the DNA sequences
necessary for chromosome replication [54,55,56]. As true stem
cells maintain their telomere length and show unlimited replicative
capacity, this provided a way of characterising the isolated
cartilage progenitor population and also strengthened the case
for their suitability for cell-based repair therapies [57]. Full-depth
chondrocytes and cartilage progenitors investigated in our study
displayed eroded telomeres with time in culture consistent with
growth kinetic data. However, if we study the results in more
detail, a sub-population of cells within the cartilage progenitor
population is observed that maintain their telomere length.
Indeed, this sub-population of cells maintains their telomere
length and increases in number with time in culture. However, we
do not find this sub-population expanding beyond 60 PDs and
may senesce in a telomere independent fashion.
The cartilage progenitor population express a number of
chondrogenic markers and matrix components when induced to
undergo chondrogenesis in vitro, including collagen type I and
collagen type II. In culture, collagen type I is often considered an
indicator of fibrocartilage. However, the expression of collagen type
II in the chondrogenic cell pellets suggests that the cartilage
progenitors are following a developmental process in their matrix
synthesis, synthesising firstly collagen type I and secondly collagen
type II as the cells mature [44]. Evidence of co-localisation of the
two collagens at the articular surfaces was described in a study by
Archer et al [58] and it is interesting to note that collagen type 1 is
observed in the pellets in the outer layer of cells, which appear
flattened – similar to the flattened interzone cells and perichondri-
um in the developing limb, as described in the same study.
Osteogenically induced cultures show signs of mineralisation when
cultured as a 3D pellet. However, there is no evidence of bone
formation per se; neither collagen type X protein expression nor
alkaline phosphatase activity were evident in the chondrogenic or
osteogenically induced 3D cultured pellets. These data highlight
that cartilage progenitors neither undergo chondrogenic terminal
differentiation nor true osteogenesis. Notably, many published
studies assay osteogenesis of stem cells in monolayer culture through
analysis of expression of alkaline phosphatase and the appearance of
calcification by von Kossa staining that de facto, is not an assay for
bone formation. Indeed, if the cells are demonstrating a restricted
differentiation potential in vitro, then the ability of these cells to form
stable ectopic cartilage that doesn’t undergo terminal differentiation
in vivo would be a very desirable factor for using these cells in clinical
applications for cartilage repair strategies. In contrast, current
research into BMSCs for cartilage regeneration procedures
demonstrates terminal differentiation and extracellular matrix
(ECM) calcification in vitro upon chondrogenic induction, ultimately
resulting in failure of transplantation [16,22,59,60].
Multi-lineage potential is often used to characterise a
mesenchymal stem cell population. The results from our study
demonstrate that the cartilage progenitor cells have the capacity
to differentiate into the adipogenic lineage, whilst retaining a
restricted differentiation potential during osteogenic differentia-
tion, as discussed above. However, the full-depth chondrocytes
are also positive for differentiation into these lineages, albeit to a
lesser extent. This can be explained as such; during the isolation
procedure, progenitor cells are part of the full-depth chondrocyte
culture and are likely to have become enriched during the cell
expansion process. This small progenitor population within the
full-depth chondrocytes would, therefore, undergo differentia-
tion when cultured in the appropriate media, as we have
observed.
greater activity than low population full depth chondrocytes (D). High population doubling clonal cells show a 10.6-fold greater activity than full
depth chondrocytes at a high population doubling (.30). PD = population doubling.
doi:10.1371/journal.pone.0013246.g006
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Characteristically, mesenchymal stem cells can migrate and
engraft into tissues, including regions of injury, and undergo site-
specific differentiation [61,62,63]. It is encouraging to see that data
from our engraftment studies demonstrated that the cartilage
progenitor population can migrate to its specific milieu within the
developing limb. The isolated cartilage progenitor populations
largely engrafted within the perichondrium – an already known
niche of stem cells and the cells also migrated to the surface of the
articular cartilage – where data by Dowthwaite et al [25] has
demonstrated the presence of a progenitor population. However,
engrafted cells were observed in other connective tissues including
dermis but were not seen outside tissues of the connective tissue
lineage, lending further support to progenitor status.
To determine the potential of chondroprogenitors in in vivo
cartilage repair, we have used the goat as our model. The goat
chondroprogenitors were isolated and characterised in the same
manner as the human chondroprogenitors. The caprine in vivo
repair study revealed examples of excellent integration in cartilage
defects treated with Chondro-GideH membrane seeded with goat
chondroprogenitors. When subjected to the ICRS scoring system
to evaluate cartilage repair, however, there was no difference in
repair between defects that were treated with chondroprogenitors
and those treated with the current gold standard of expanded full-
depth chondrocytes. Although, no differences in repair tissue were
observed at the 20-month end point of the study, the main
advantage of these cells over full-depth chondrocytes is the ability
to generate very large cell numbers that retain their phenotype,
from a single cell. As a result, it would be feasible to treat much
larger defects than is currently possible.
Conclusion
The main findings from these data lead to the conclusion that
human articular cartilage contains a cartilage progenitor population
that retains a stem cell-like phenotype until appropriate induction of
chondrogenic differentiation is required. As such, we propose that
this cell population is an ideal candidate to use in the development
of enhanced protocols for future cell-based tissue engineering
procedures that require cells with an extensive replication capacity
and restricted differentiation potential. As a single cell can generate
millions of cells that retain their chondrogenic phenotype in vivo, this
isolation procedure would ensure sufficient numbers of cells, that
maintain their ability to form cartilage, are readily available for
surgical procedures. These characteristics are favourable if the
transplanted cells are to physically contribute to the repair and
maintenance of the cartilage defect long-term.
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